The role of endothelin-1 in the regulation of vascular tone in deconditioning and aging. by Thijssen, D.H.J.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/30049
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
 The role of endothelin-1 in the regulation of 
vascular tone in deconditioning and aging
Dick Thijssen
 The role of endothelin-1 in the regulation of  
vascular tone in deconditioning and aging  
 
 
 
 
 
 
 
 
 
 
 
Dick Thijssen
  
 
 
 
 
 
 
 
 
 
  
  
  
The role of endothelin-1 in the regulation of  
vascular tone in deconditioning and aging  
 
 
 
 
Een wetenschappelijke proeve op het gebied van de 
Medische Wetenschappen 
 
 
Proefschrift 
 
 
ter verkrijging van de graad van doctor 
aan de Radboud Universiteit Nijmegen 
op gezag van de Rector Magnificus prof. dr. C.W.P.M. Blom, 
volgens besluit van het College van Decanen 
in het openbaar te verdedigen op woensdag 28 maart 2007 
om 15.30 uur precies door 
 
 
Dick Henricus Julianus Thijssen 
 
 
 
geboren op 21 maart 1979  
te Boxmeer
 Promotor:  
Prof. dr. P. Smits 
 
Copromotores:  
Dr. M.T.E. Hopman 
Dr. G.A. Rongen 
 
 
Manuscriptcommissie:  
Prof. dr. A.F.H. Stalenhoef (voorzitter) 
Prof. dr. M.G.M. Olde Rikkert 
Prof. dr. D.J.G.M. Duncker, Erasmus Universiteit Rotterdam 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ISBN-10: 90-9021471-2 
ISBN-13: 978-90-9021471-9 
 
Cover design door Bregina Kersten 
Drukwerk: Ponsen & Looijen B.V., Wageningen 
 
Het verschijnen van dit proefschrift werd mede mogelijk gemaakt door de steun van 
de Nederlandse Hartstichting en de Stichting Spinal Cord Europe Education and 
Research. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table of Contents 
 
 
Chapter 1         9 
General introduction and outline of the thesis 
 
Chapter 2                 39 
Reproducibility of blood flow and post-occlusive reactive 
hyperemia as measured by venous occlusion plethysmography 
Clin Sci (Lond) 108: 151-157, 2005     
 
Chapter 3                    55 
The sympathetic nervous system contributes to the age-related 
impairment of flow-mediated dilation of the superficial femoral artery 
Am J Physiol Heart Circ Physiol 291(6): H3122-3129, 2006 
 
Chapter 4                   75 
Local vascular adaptations after hybrid training in spinal cord-injured subjects 
Med Sci Sports Exerc 37: 1112-1118, 2005 
 
Chapter 5                   91 
Rapid vascular adaptations to training and detraining 
in persons with spinal cord injury 
Arch Phys Med Rehabil 87: 474-481, 2006 
 
Chapter 6                107 
A causal role for endothelin-1 in vascular adaptation to 
skeletal muscle deconditioning in spinal cord injury 
Arterioscler Thromb Vasc Biol 27: 325-331, 2007     
  
Chapter 7                123 
Leg vascular changes to 8 weeks cycling training in older men 
Acta Physiologica, In Press, 2007 
 
Chapter 8                139 
Endogenous endothelin-1 contributes to the increased baseline 
leg vascular tone in healthy older men 
Submitted  
 
  
Chapter 9                155 
Hematopoietic stem cells and endothelial progenitor cells in 
healthy men: effect of aging and training 
Aging Cell 5: 495-503, 2006       
 
Chapter 10                173 
General discussion 
 
Summary                187 
 
Samenvatting                193 
 
Dankwoord                199 
 
Publications + Curriculum Vitae             203 
     
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1
 
General introduction and
outline of the thesis
Dick H.J. Thijssen
Gerard A. Rongen
Paul Smits
Maria T.E. Hopman
 
 
 
 
 
 
Manuscript in preparation 
Chapter 1 
10 
Physical inactivity is defined as lack of a sufficient amount of physical activity. In a 
consensus meeting in 2000, sufficient activity was defined as at least 30 minutes of 
physical activity of moderate intensity on at least five days per week (Nederlandse 
Norm Gezond Bewegen, (93)). According to this definition, about half of the Dutch 
middle-aged population is physically inactive (170). The importance of physical 
inactivity as a modifiable behavioral risk factor for cardiovascular disease is well 
established. For example, physically active men and women have a 40-50% lower 
risk for cardiovascular disease than their sedentary peers (196). Moreover, exercise 
has been proven to reduce cardiovascular mortality (157, 196). The latter finding is a 
strong argument for a causal relationship between inactivity and cardiovascular 
disease.  
 
 
The cardiovascular system adapts to changes in physical demand. For example, the 
conduit and resistance arteries undergo an inward remodeling process during 
deconditioning, which denotes a decrease in lumen size. A low blood flow, a direct 
consequence of deconditioning, is suggested to cause this inward remodeling. In 
addition, the function of the endothelium changes during deconditioning and may 
contribute to the inward remodeling. Apart from being the barrier between the 
circulating blood and the surrounding tissue, the endothelium is ideally located to 
detect changes in blood or blood flow that may result from physical (in)activity. In 
response to these changes, the endothelium can vary its release of various circulating 
vasoactive substances and serves as a source of local and systemic vasodilator and 
vasoconstrictor mediators (27, 117) (table 1). The most important endothelium-
derived vasodilators are prostacyclin, nitric oxide (NO), and endothelial derived 
hyperpolarizing factor. The endothelium also produces a counterbalancing 
vasoconstrictor substance, endothelin (ET). This thesis will focus on the vascular 
adaptation to deconditioning, and in particular on the role of ET in this process   
 
 
Table 1. Normal functions of the vascular endothelium and a partial list of factors elaborated 
and regulated by the endothelium to maintain vascular homeostasis (200). 
 
Vascular tone Blood coagulation Control of inflammation 
Nitric oxide 
Prostaglandins 
Endothelin-1          
Angiotensin II 
C-type Natriuretic peptide  
Endothelial hyperpolarizing factor 
Nitric oxide 
Tissue plasminogen activator 
Heparins 
Thrombomodulin 
Prostaglandins 
Tissue factor 
Monocyte chemotactic factor-1 
Adhesion molecule expression 
Interleukins 1, 6, and 18 
Tumor necrosis factor 
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Parallel to inactivity, aging is associated with an increased incidence of 
cardiovascular disease as well. Moreover, advanced age is characterized by an 
increase in vascular tone (41, 42) and by an impairment of endothelial function (25). 
Therefore, this thesis also examines vascular changes with aging and the contribution 
of ET to these vascular adaptations.  
In this chapter the physiological actions of ET are reviewed, followed by an 
introduction on the possible role of ET in the cardiovascular adaptations to physical 
(in)activity and aging. 
 
 
 
Production and clearance of endothelins 
 
Endothelin (ET) is a long-acting vasoconstricting peptide that was isolated and 
sequenced from endothelial cell cultures in the late 80’s. Subsequently, four 
isopeptides of ET have been identified; ET-1, ET-2, ET-3, and ET-4. ET-1 is mainly 
secreted by the endothelium and is the pre-dominant isoform expressed in the 
vasculature. Besides the endothelium, endothelin-1 (ET-1) is also produced by other 
cells (i.e. leukocytes, macrophages, and smooth muscle cells (52, 118)) and by 
organs (i.e. heart, kidney, posterior pituitary, and central nervous system (67)). 
Whereas the endothelial cells predominantly produce ET-1, the endothelial cell also 
produces limited amounts of ET-2, but not ET-3 or ET-4. The other subtypes of 
endothelin are mainly expressed in other organs, such as heart, kidney, intestinal 
system or central nervous system. This introductory chapter will focus on the various 
actions of ET-1 on the vascular wall.  
ET-1 is not stored in secretory granules within the endothelial cells, but specific 
stimuli can induce a rapid transcription of ET-1 mRNA, eventually leading to a 
synthesis and secretion of ET-1 within minutes (150). Under physiological conditions 
the production of ET-1 is regulated by a variety of stimulating and inhibitory stimuli, 
including vasoactive hormones, growth factors, and physical factors (table 2).  
 
Synthesis of endothelin  
The major site of ET-1 synthesis is the endothelial cell (81, 82). In contrast to the 
large amounts of ET-1 that can be secreted, only limited quantities of ET-2 are 
produced in endothelial cells, heart, and kidney (76, 158). In addition to the smaller 
amount of ET-2, the ETA-receptors have a lower affinity for ET-2 than ET-1 (3), while 
the ETB-receptors are not isopeptide selective (167). This results in a less pronounced 
physiological action of ET-2 compared with ET-1. ET-3 appears to be selectively 
expressed in the endocrine, gastro-intestinal and central nervous system (62). The last 
isoform, named ET-4, is a selective intestinal constrictor (165). 
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Table 2. Stimulators and inhibitors of the expression of pre-pro ET-1 gene.  
 
Humoral Physical stimuli  
Endogenous Exogenous  
Stimulators: Adrenalin      
Angiotensin
Vasopressin   
Insulin 
Cortisol         
Cytokines 
Interleukin-1       
TGF-β 
Endotoxin           
Trombin 
Glucose              
Oxidized LDL 
A23187 
Cyclosporin 
Shear stress (low) 
Osmolarity 
Hypoxia 
Pulsatile stretch 
Inhibitors: Prostacyclin
Estrogens 
Nitric Oxide
Natriuretic 
peptides  
Heparin 
 Shear stress (high) 
(TGF-β, transforming growth factor-β; LDL, low-density lipoprotein) 
 
 
 
The pathway for generation of ET-1 (figure 1) starts with the stimulation of the ET 
genes, which express a code for a large precursor-protein mRNA (preproET mRNA). 
The biological half-life of ET-1 mRNA is approximately 15-20 minutes (205). This 
translation results in the production of the preproET-1 peptide (212 amino acids), 
which is cleaved by a furin convertase to the peptide Big ET-1 (38 amino acids). This 
peptide has no direct actions. The formation of mature ET-1 finally requires cleavage 
of Big ET-1 by ET-converting enzymes (ECE) (203, 206). At least 2 ECE-isoforms (ECE-
1 and ECE-2) are identified and seem to be relatively selective for Big ET-1, while 
having much less activity in cleaving Big ET-2 or Big ET-3. Conversion of Big ET-1 
occurs via action of vascular ECE in the endothelial cells (155). After this conversion, 
ET-1 is secreted into the extra-cellular space or to the lumen where it has a biological 
half-life of 4-7 min (172). At least 75% of the endothelial cell derived ET-1 is released 
abluminally (toward the muscular media), suggesting a paracrine/autocrine role to 
regulate vascular homeostasis (46). 
 
Uptake of endothelins  
Although ET-1 is rapidly eliminated from the circulation after an intravenous bolus 
injection, its pressor effects are sustained for up to 60 min (178, 194). A sustained 
increase of cytosolic calcium in the smooth muscle cell and an increased sensitivity 
of the contractile apparatus to changes in calcium are hypothesized to cause this 
prolonged vascular effect. The pharmacokinetic characteristics of ET-1 and its 
receptors are discussed later in this chapter. Rapid uptake of ET-1 seems to be an 
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effective countermeasure for the powerful prolonged vasoconstrictive action of ET-1. 
A substantial part of the ET-1 uptake occurs in the pulmonary circulation; plasma ET-
1 is mostly eliminated by the lungs during first passage (37, 45). However, a 
substantial part of the synthesis of ET-1 is located in the pulmonary tissue. This 
eventually leads to a neutral arterial-venous difference in the lungs (45). As such, a 
small change in pulmonary uptake or production of ET-1 may contribute to a change 
in circulating levels of this peptide. In an animal experiment, it was shown that the 
single pass extraction of ET-1 by the pulmonary circulation is completely abolished 
during selective blockade of the ETB-receptor subtype (44). This suggests that the ETB-
receptor is exclusively responsible for the uptake of ET-1 in the pulmonary system. In 
addition to the lungs, also the liver and kidneys participate in the rapid clearance of 
ET-1 in rats (51). The uptake of ET-1 in the kidneys, but not in the liver, was 
importantly inhibited by selective blockade of ETB-receptor subtype (51). These 
results indicate that ETB-receptors play an important role in the uptake of ET-1. 
Recently, it was demonstrated that the magnitude of increase in plasma levels of ET-1 
in endothelial ETB-receptor knockout mice (7) is comparable to the change in ET-1 
plasma levels in ETB-deficient rats. This may suggest that the endothelium-derived 
ETB-receptors are involved in the uptake of ET-1, rather than the smooth muscle cell 
ETB-receptor. Given the relatively short biological half-life of ET-1 (~5 minutes (172)) 
and the mainly abluminally secretion of ET-1 (46), ET-1 seems to be a locally active 
peptide. The rapid endothelial uptake of ET-1 through the ETB-receptors further limits 
the systemic action of ET-1. 
 
 
 
Actions of endothelins 
 
Endothelin Receptors 
ET-1 exerts its biological effects via activation of two receptor subtypes (68): the ETA-
receptor and the ETB-receptor (table 3). Both ET-receptor subtypes reflect a 
transmembrane topology similar to other G protein-coupled receptors (3, 167). The 
vascular expression of the ETA-receptor occurs selectively in smooth muscle cells and 
cardiac myocytes (75), whereas the ETB-receptor is located on both endothelial cells 
and in smooth muscle cells (171). Activation of the ETA- and ETB-receptor on the 
smooth muscle cell mediates the vasoconstrictor action of ET-1 (177) (figure 1). The 
binding of ET-1 to these receptors causes a long-lasting vasoconstriction, which is 
induced through activation of phospholipase C. This activation leads to the 
production of inositol trisphosphate, which causes a rapid increase of intracellular 
calcium through its release from intracellular stores (71, 159). A sustained increase of 
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cytosolic calcium in the smooth muscle cell occurs via opening of plasma membrane 
calcium channels (71). In addition, phospholipase C also leads to the generation of 
diacylglycerol. Via production of protein kinase C, diacylglycerol increases the 
sensitivity of the contractile apparatus to changes in calcium (100). Taken together, 
these effects on the calcium homeostasis of the smooth muscle cell lead to the 
prolonged vasoconstriction, even after ET-1 is removed from the receptor. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ET-1 gene 
↓ 
Prepro ET-1 
↓ 
Big ET-1 
↓ 
ET-1 
← Furin
 
 
 
← ECE
LUMEN 
ENDOTHELIUM 
SMOOTH-MUSCLE 
ET-1
Vasoconstriction
ETA ETB
ETB 
ET-1
Vasodilation 
Nitric Oxide 
Prostacyclin 
+ -
Stimulation  Inhibition 
Figure 1. Regulation and secretion of proteins of the ET pathway in endothelial cells (ET-1;
endothelin-1, ECE; endothelin-converting enzyme, ETA; endothelin A receptor, ETB;
endothelin B receptor). 
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On the other hand, activation of the ETB-receptors on the endothelium mediates the 
release of endothelium-dependent vasodilator substances such as nitric oxide and 
prostacyclin (70), leading to a vasodilation. In addition, activation of the latter 
receptor also prevents apoptosis (173) and inhibits ECE-1 expression in the 
endothelial cells (30). The ETB-receptor also mediates the pulmonary and renal 
uptake of ET-1 by endothelial cells. The ETB-receptor on the endothelium, therefore, 
has several beneficial effects on the vascular homeostasis and largely opposes the 
vasoconstrictive and proliferative effects of the ET-receptors on the smooth muscle 
cell. Due to the opposite actions of endothelial versus smooth muscle cell-localized 
ETB-receptors and the marked expression of the ETB-receptor on the endothelium, the 
net result of the actions of the ETB-receptors is a minor vasodilation (21, 23, 193).  
 
 
Table 3. Classification and properties of endothelin receptors. 
 
 ETA ETB 
Potency ET-1 > ET-2 >> ET-3 ET-1 = ET-2 = ET-3 
Affinity (Kd) ET-1 ~ 10-9 mol⋅l-1 
ET-3 ~ 10-6 mol⋅l-1 
ET-1 ~ 10-9 mol⋅l-1 
ET-3 ~ 10-9 mol⋅l-1 
Tissue Vascular smooth muscle    Endothelium Vascular smooth muscle 
Vessel type Conduit/resistance vessels  All vessels Resistance/capacitance 
vessels 
Action Constriction 
Proliferation 
Leukocytes-activation 
 Dilation 
Uptake ET-1 
Constriction 
 
 
 
 
Vascular tone 
The vascular wall is the most important site of action of ET-1, where it can induce a 
marked vasoconstriction, which seems to be present in the large, medium, and small 
sized arteries (92). ET-1 has a potency 10-fold higher than those of other constrictors 
(206). Infusion of exogenous ET-1 into the brachial artery of humans slowly 
decreases forearm blood flow in a dose-dependent manner (28, 31), indicating the 
powerful constrictive potency of ET-1. The vasoconstrictive action of ET-1 on 
peripheral resistance vessels can eventually lead to an increase in blood pressure 
(206). Interestingly, the pressor effect of ET-1 is usually preceded by transient ETB-
mediated hypotension when ET-1 is given as a bolus (82). Systemic ET-receptor 
blockade, which leads to vasodilation, leads to a 10-20% decrease in arterial 
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pressure in humans (66). Although it is widely recognized that ET-1 regulates arterial 
pressure and basal vascular tone, there is some debate regarding the individual 
contributions of the ETA- and ETB-receptors. Especially the latter has received much 
attention, which is mainly based on the dual vasoactive effect of the ETB-receptor 
(i.e., vasoconstriction and vasodilation).  
The best way to assess the physiological actions of ET-1 is to examine the 
hemodynamic effects of drugs that selectively block the generation/actions of ET-1. 
For example, inhibition of the endothelin-converting enzyme slowly decreases 
arterial pressure in normotensive animals (29). Interestingly, in humans ETA-receptor 
antagonism causes more pronounced vasodilation compared with the combined 
ETA/B-receptor blockade (193). This suggests that the ETB-receptor opposes the 
constrictive actions of the ETA-receptor. Indeed, administration of BQ-788, a 
selective ETB-receptor blocker, results in a minor but significant vasoconstriction 
(193).  
The overall cardiovascular effect of endogenous ET-1 importantly depends on the 
balance between ETA- and ETB-mediated effects. The dilatory and blood pressure 
lowering effects of the endothelial ETB-receptor opposes the vasoconstrictive and 
blood pressure elevating action of the smooth muscle cell located ETA/B-receptors. In 
physiological conditions there seems to be a relatively stable balance between the 
effects of both receptors, resulting in a small constrictive and pressor effect. 
Obviously, the cardiovascular effect of ET-1 alters if there are changes in the 
numbers and/or function (i.e. sensitivity to ET-1) of the ETA- or ETB-receptors.  
 
Nitric Oxide 
Several cardiovascular conditions characterized by an impaired availability of nitric 
oxide (NO) have been associated with enhanced synthesis of ET-1, and vice versa, 
thereby suggesting that these two factors have a reciprocal regulation (2). Also 
experimental studies have provided evidence for a crosstalk between ET-1 and NO. It 
is well established that ET-1 increases NO production via ETB-receptors located in 
the endothelial cells (70, 193). The activation of the endothelial ETB-receptors not 
only stimulates the synthesis of NO, but also increases the expression of endothelial 
NO synthase (115). In animals (8) as well as in humans (22), it was demonstrated that 
the vasoconstriction during a NO synthase inhibitor can be blunted using a non-
selective ET-receptor or selective blockade of the ETB-receptor. This suggests that low 
levels of ET-1 are involved in the stimulation of basal release of NO, thereby 
opposing its vasoconstrictor effect on the smooth muscle receptors. Elevated ET-1 
levels, however, are demonstrated to impair the NO production (161, 197). This 
supports the importance of the crosslink between both vasoactive substances.   
Conversely, NO released from endothelial cells can inhibit the synthesis of ET-1 (17, 
105). This was demonstrated by the application of hypoxia (a profound stimulus for 
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ET-1 production) in combination with administration of an NO-donor or NO-
synthase blocker. While administration of the NO-donor decreased the synthesis of 
ET-1, the NO-synthase blocker increased the baseline production of ET-1 (105). 
Endothelium-derived NO is suggested to inhibit the formation of ET-1 via a cGMP-
dependent mechanism (17).  
Interestingly, it has been suggested that under hypoxic conditions ET-1 has 
angiogenic effects, resulting in the formation of new vessels (angiogenesis). 
Experiments in human and rat tissue have indicated that ET-1 has angiogenic effects 
that are mediated through the ETB-receptor (58). However, functional endothelial NO 
synthase is a requisite for this action, which emphasizes again the link between ET-1 
and NO. Taken together, the ET-NO interplay seems to have a great relevance in the 
(patho)physiological regulation of vascular tone and blood pressure, as well as in 
vascular remodeling. A right balance between NO and ET-1 production seems to be 
crucial in maintaining cardiovascular homeostasis (22). Altered function of the 
endothelium may result from an absolute decrease in bioavailability of NO, but also 
from a relative increase in ET-1 synthesis, release, or activity. 
 
Sympathetic nervous system 
In addition to the direct effects of ET-1 on the vascular system, it may also have an 
indirect effect by affecting the sympathetic nervous system. The interaction between 
ET-1 and the sympathetic nervous system is rather complex. Injection of ET-1 in the 
cerebral ventricles increases the post-ganglionic sympathetic nerve activity and 
blood pressure in a dose-dependent manner, primarily through the action of the ETA-
receptors (113, 149, 151, 156). A widespread pattern of ET-1 transcription is present 
in the central nervous system, with a great density of ET-1 identified in areas actively 
involved in the vasoregulation (i.e. hypothalamus) (113, 149). We are not aware of 
any studies on the potential effect of ET-1 in ganglionic transmission. ET-1 is 
synthesized in and secreted by postganglionic sympathetic neurons (32). On 
postganglionic sympathetic nerve endings both ETA and ETB-receptors are 
pharmacologically identified. The ETA-receptor inhibits the re-uptake of 
norepinephrine (NE) (6), while the ETB-receptor inhibits NE release (40, 88, 132, 146, 
148). In healthy rats, the overall effect of ET-1 is probably an increase of NE levels in 
the sympathetic cleft (6). In vascular smooth muscle cells, ET-1 augments the 
vasoconstrictor response to NE (184, 201), probably through an increased calcium 
sensitivity of the contractile apparatus. Taken together, ET-1 has the ability to 
potentiate norepinephrine(NE)-induced effects on vascular smooth muscle cells (53, 
69, 97, 207).  
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Cell growth  
ET-1 is a potent mitogen for vascular smooth muscle cells and cardiac myocytes in a 
dose-dependent manner (86, 102). This mitogenic action of ET-1 is most probably 
mediated through the changes of the intracellular calcium homeostasis and increase 
in protein kinase C (86, 154, 195). Based on the potent proliferative activity in 
vascular smooth muscle cells, ET-1 is implicated in the progression of atherosclerosis 
(102, 136, 163).  
 
 
 
Target organs of endothelins 
 
Lungs  
The role of ET-1 in the regulation of the pulmonary resistance is not fully understood. 
In some studies in the porcine and human circulation, ET-receptor blockade at 
baseline conditions had no effect (50, 72, 135), whereas vasoconstriction is found by 
others (1, 90). Nevertheless, the lungs represent a primary target for ET-1 effects and 
seem to be a special site for ET-1 metabolic pathways. ET-1 mRNA expression is 
present in the human lung tissue (56), and ETA- and ETB-receptors seem to be 
variably distributed in all components including vessels, bronchi, and alveoli. The 
vasoconstrictor effect of ET-1 in the pulmonary circulation is mediated by ETA-
receptors in the large pulmonary arteries, whereas it is mediated by ETB-receptors in 
the smaller resistance vessels (121). The importance of the pulmonary circulation is 
illustrated by its central role in clearance and production of ET-1.  
 
Heart 
ET-1 is a potent constrictor of the coronary vessels (85), which may cause myocardial 
ischemia and even fatal ventricular arrhythmias in pigs when given as an intra-
coronary bolus (47). The ET-1-mediated constriction in the coronary circulation is 
ETA-receptor mediated (38, 59, 120). Dose response curves to ET-1 in isolated 
coronary arteries (91) and arterioles (112) indicate that the sensitivity for ET-1 
increases with decreasing vessel size. In addition, ET-1 is suggested to have other 
physiological effects on the heart. Ishikawa and coworkers (84) reported that ET-1 
increased the sino-arterial nodal rate (84) and contractility of myocardial fibres (85). 
This suggests that ET-1 has potential positive chronotropic (affecting the heart rate) 
and inotropic effects (affecting the contractility) on the heart. In addition, the 
production of ET-1 is hypothesized to represent an important paracrine mechanism 
for the in vivo regulation of cardiac growth and hypertrophy of myocardial cells 
(175). 
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Kidney 
Through the contraction of afferent and efferent arterioles, ET-1 reduces both renal 
plasma flow and glomerular filtration rate (49, 94, 116). This action is suggested to 
regulate salt and water transport in the nephron. Besides the renal vasoconstriction 
through the action of the ETA-receptor (128), ET-1 has another main action in the 
kidney. At low doses, ET-1 increases urinary excretion of sodium through the use of 
ETB-receptors (189). The importance of this renal action of ET-1 is indicated by the 
finding of salt-sensitive hypertension in ETB-knockout mice (54). Thus, ET-1 may 
contribute to renal ion and water homeostasis.  
 
 
 
Endothelins and inactivity 
 
The importance of physical inactivity, defined as an insufficient amount of physical 
activity, as a modifiable behavioral risk factor for cardiovascular disease is well 
established. Physical inactivity is the second actual cause of death after smoking, and 
accounts for 16.6% of deaths in the United States (141). Models of inactivity in 
animals (e.g. hindlimb unloading) as well as in humans (e.g. bed rest, unilateral 
lower limb suspension, spinal cord injury) uniformly result in structural changes of 
the conduit arteries and arterioles (16, 174, 210). In addition, also the functional 
properties of the vessel wall change, e.g. an increased vascular tone. Vascular tone is 
regulated through the secretion of numerous vasoactive substances. Knowledge 
about the changes in ET pathway during inactivity or deconditioning is sparse. Here, 
the current knowledge about the role of ET-1 in local vascular control during 
physical inactivity will be discussed.  
Animal studies. A frequently used animal model of physical inactivity, e.g. hindlimb 
unloading in rats, showed an increase in circulating plasma levels of ET-1 after only 
10 days (15).  
Human studies. Although time-consuming and the interaction of microgravity, 
spaceflights can be used as a model of physical inactivity. Weightlessness leads to a 
profound physical inactivity, which results in cardiovascular deconditioning. In 23 
astronauts, ET-1 plasma levels were determined before and after a 5-18 days 
spaceflight (134). Although ET-1 levels tended to increase, this did not reach 
statistical significance. The large variation and relatively short duration of the 
spaceflight may in part underlie the lack of change in ET-1 plasma levels. Although 
one may speculate about the strength of this model, also detraining (e.g. the rapid 
deterioration after cessation of strenuous exercise training) is used to examine the 
effects of inactivity. Maeda et al. (125) reported that the decreased plasma levels of 
Chapter 1 
 
20 
ET-1 after 8-week training in healthy subjects are reversed to baseline after 8 weeks 
of detraining.  
Spinal cord-injured individuals (SCI) are subject to paralysis and extreme inactivity 
below the level of the spinal cord lesion. Therefore, SCI can serve as a “model of 
nature” for vascular adaptations to localized deconditioning of the legs. Robergs et 
al. (162) reported very high levels of plasma ET-1 in SCI individuals of 11.7 ± 1.5 
pg⋅ml-1. This represents a ~5 times higher concentration of circulating ET-1 than in 
healthy controls (125, 126, 129, 130, 153). The finding that levels of stimulators of 
ET-1 such as angiotensin II (131) and vasopressin (119, 191) are higher in SCI 
subjects than in healthy controls, may suggest an altered regulation of the ET 
pathway in SCI. Important to note, is that altered levels of ET-1 do not necessarily 
indicate changes in the ET pathway. Theoretically, an increased level of ET-1 may 
compensate for an attenuated sensitivity of the ET-receptors, leading to preservation 
of the physiological vasoconstrictor tone. In addition, plasma levels do not 
necessarily correlate with concentrations of ET-1 in the media layer of arteries, given 
the fact that ET-1 is mainly secreted abluminally. 
 
Current scientific data on the possible link between physical inactivity and the ET 
pathway is limited and some methodological pitfalls are present. However, recent 
animal studies as well as human models of deconditioning indicate that the ET 
pathway may contribute to inactivity-related vascular adaptations.  
 
 
 
Endothelins and physical activity 
 
Regular physical activity is an important non-pharmacological intervention with 
marked cardioprotective effects (196). An improved function of the endothelium 
seems to underlie the beneficial cardiovascular changes after exercise training (144). 
To examine the conduit artery endothelial function, a suprasystolic pressure is 
applied and the response of the diameter during the post-occlusive hyperemia is 
investigated. As a result of the marked increase in shear stress on the vessel wall 
during the post-occlusive period, the endothelium secretes vasodilators (i.e., nitric 
oxide) leading to a flow-mediated dilation of the conduit artery (FMD). Regular 
activity has been demonstrated to be associated with a larger FMD-response, 
reflecting an increase in nitric oxide-bioavailability. However, shear stress will also 
influence the release of ET-1 (206, 208). As such, an increase in FMD-response could 
also be the result of a change (e.g. inhibition) in the ET pathway. This is supported by 
Berger et al. (14), who observed that blockade of ETA-receptors improves the FMD-
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response in patients with chronic heart failure. This indicates that an enhanced 
endothelial function (e.g. observed after exercise training) is not solely related to an 
increase in vasodilator substances (95), but may also be related to an attenuation of 
the vasoconstrictor actions.  
 
Exercise training  
Animal studies. To a large extend, the current understanding of the adaptations of the 
ET-system to exercise training is based on animal studies. In a cross-sectional study, 
Jones et al. (91) examined the ET-1 sensitivity of isolated coronary arteries of 
sedentary and exercise-trained swine. They demonstrated a reduced contractile 
responsiveness to ET-1 after a 12-week exercise program in male pigs. Similar results 
are reported in aortic and cerebellar arteries of sedentary and exercise-trained rats 
(111). In addition, the post-ischemic sensitivity to ET-1 in rat coronary arteries was 
significantly lower in endurance-trained rats than in sedentary rats (183). Previous 
studies demonstrated that these adaptations in the ET pathway after exercise training 
might be regulated through a decrease in intracellular calcium release (18, 192). A 
diminished release of calcium is associated with a diminished smooth muscle 
contraction, leading to a decrease in vascular tone. 
In addition to the role of the ET pathway in vascular adaptations, it contributes to 
molecular mechanisms of cardiac hypertrophy in rats (86, 87). Besides the actions of 
the ET pathway during pathologic cardiac hypertrophy in heart failure (79), it most 
likely participates in physiological cardiac hypertrophy. Recently, Iemitsu et al. (78) 
assessed the changes in ET-1 mRNA in cardiac tissue in sedentary and exercise-
trained rats. They demonstrated increased levels of ET-1 mRNA in the heart of 
exercise-trained rats, suggesting that ET-1 is a candidate gene in the molecular 
mechanism of exercise training-induced cardiac hypertrophy.  
Human studies. Previous studies examining the effect of exercise training in healthy 
subjects mainly focused on the adaptations of the NO pathway. Based on the cross-
talk between the NO pathway and the ET-system, Maeda et al. (125) examined the 
alterations in circulating levels of ET-1 and NO (measured as nitrite/nitrate, NOx) 
before and after an 8-week training protocol in healthy young humans. Indeed, a 
significant negative correlation between plasma levels of NO and ET-1 was present; 
while NO-concentration increased, ET-1 levels showed a significant decrease after 
exercise. In agreement with these results, also resistance training decreases ET-1 
plasma levels in healthy young men (123).  
 
Training and cardiovascular disease 
The ET pathway may also potentially contribute to the beneficial effects of exercise 
training in people with various states of disease. Especially in ET-related 
cardiovascular pathology, exercise training may cause its cardioprotective effects (in 
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part) through the ET-system. Three pathological situations, in which the ET pathway 
is involved, will be discussed in relation to exercise training. 
 
Chronic Heart Failure. Chronic heart failure (CHF) is associated with a marked 
increase in prevalence, mortality, and morbidity (176). The pathology of CHF, 
clinically characterized by fluid retention, dyspnea, and fatigue, involves 
neurohumoral activation (increase in sympathetic nerve activity and increased levels 
of (nor)adrenaline and angiotensin II) that leads to a marked peripheral 
vasoconstriction. Regarding the ET pathway, significant elevations of plasma ET-1 are 
observed in animal models of CHF (137, 188) and in humans with CHF (133, 181). 
These circulating levels of ET-1 are inversely correlated with functional status and 
survival (77, 198). In addition, animal studies demonstrate an increased expression of 
both cardiac ETA/B-receptors (99, 204). The pivotal role of ET-1 in CHF is supported 
by the finding of an improved functional condition and survival in rats after selective 
ETA- (166) or dual ETA/B-receptor antagonism (145) in experimental CHF. 
Traditionally, CHF was considered as a contraindication for exercise training. During 
the last 15 years, however, studies demonstrated that exercise training in stable CHF 
is safe and even improves the prognosis and quality of life of these subjects. 
Beneficial effects include reduced neurohumoral activation, reduced inflammatory 
responses, and improved exercise capacity (65, 110). Interestingly, resting (96) and 
exercise-induced (107) ET-1 plasma levels are inversely correlated with physical 
fitness, suggesting that ET-1 may contribute to exercise intolerance, possibly via 
limiting the exercise-induced peripheral vasodilation. Nevertheless, current 
intervention studies in patients with CHF, which examined the effect of exercise 
training, do not support this hypothesis. For example, 8 weeks of physical training in 
CHF improved physical condition, whereas plasma ET-1 levels did not change (20). 
A finding supported by others after 8 (180) or 12 weeks cycling training in CHF (98).  
Stimulators of ET-1 release (i.e. vasopressin and angiotensin II), however, are 
significantly reduced in CHF after exercise training (19). 
 
Atherosclerosis. Atherosclerosis reflects functional and structural adaptations of the 
vascular wall, leading to vascular injury. The atherosclerotic process is characterized 
by an imbalance between relaxing and contracting factors. For example, ET-1 plasma 
levels are increased (202, 209) and seem to correlate with the extent of 
atherosclerosis in hypertensive patients (168). Moreover, ET-1 has a potent 
proliferating activity on vascular smooth muscle cells (102, 136). This is supported by 
the finding that prolonged blockade of ETA-receptors inhibits vascular lesion 
formation (11, 106). Previous studies demonstrated the potential effect of exercise 
training to prevent atherosclerosis. Interestingly, Wamhoff et al. (195) found that 
highly fit healthy swine (16-20 weeks of exercise) have a reduced ET-1-mediated 
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DNA increase in coronary arteries compared with their sedentary peers. Because 
intracellular levels of DNA synthesis correlate with the proliferating activity of the 
individual cell (and therefore the process of atherosclerosis), the authors suggest that 
the protective effects of exercise to prevent atherosclerosis are in part mediated via 
the ET pathway. 
 
Pulmonary Hypertension. Pulmonary hypertension is characterized by a progressive 
increase of pulmonary vascular resistance, leading to right ventricular failure. The 
pathological understanding concentrates on the concept of vasoproliferation, i.e. 
uncontrolled growth within pulmonary arterioles (143). ET-1 is suggested as a major 
determinant of this proliferation (33) and the increase in pulmonary vascular tone. As 
such, plasma levels of ET-1 are increased (182) and correlate with the disease state 
(56) as well as with the pulmonary resistance (152). The significance of the ET 
pathway is emphasized by the beneficial health effects and improved survival after 
pharmacological ET-receptor antagonism (dual (26, 164, 179) or selective ETA-
inhibition (9)).  
Exercise prescription in patients with pulmonary hypertension should be handled 
carefully, because the pulmonary resistance remains elevated during physical activity 
(which may worsen the clinical symptoms) (114). Exercise training is widely used in 
the therapeutic approach of pulmonary hypertension because it improves physical 
fitness and increases the quality of life (122). Surprisingly little is known about 
pulmonary endothelial adaptations to exercise training. The only study that examined 
pulmonary vascular effects after 5 weeks of exercise training in pulmonary 
hypertensive rats, found improved vasomotor function of pulmonary arteries (61). 
However, pulmonary vasoreactivity to vasoactive agents (i.e. acetylcholine, 
epinephrine, and ET-1) did not change.  
 
Thus, studies in healthy animals and/or humans are promising and suggest a potential 
role for the ET pathway in cardiovascular adaptations to exercise training. Because 
knowledge is limited, further research is necessary to elucidate the exact role of the 
ET pathway in exercise-induced cardiovascular changes in healthy humans. Studies 
in ET-related disease states (chronic heart failure, atherosclerosis, and pulmonary 
hypertension) demonstrate dispersed results regarding the exercise-induced changes 
of the ET pathway. This, however, does not indicate that the ET pathway has no 
contribution to the beneficial exercise-induced changes. Recently, it was 
demonstrated that long-term activity is required to alter the ET pathway (34). The 
severe deterioration of physical fitness in these disease states (chronic heart failure 
and pulmonary hypertension) and insufficient training intensity or duration may in 
part explain these results. In addition, most current knowledge is based on measuring 
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plasma levels ET-1. This, however, does not provide information about the 
functionality of the ETA/B-receptors and its physiological effects.  
 
 
 
Endothelins and aging 
 
In Western countries, the number of older humans is rapidly increasing, which will 
have implications for the health care system in these countries. Aging is associated 
with an increased incidence of several pathologies, such as cardiovascular disease, 
which leads to elevated mortality and morbidity rates. It is suggested that a decrease 
in physical fitness in older humans, in part, contributes to the cardiovascular 
adaptations observed during aging (190). Important cardiovascular characteristics 
associated with aging are an increase in vascular tone (41, 42) and impaired 
endothelial function (25). Based on the profound constrictive actions of ET-1, the ET 
pathway could theoretically contribute to vascular adaptations during physiological 
aging. 
 
Animal studies. Several studies examining the ET pathway demonstrated increased 
ET-1 plasma levels and an enhanced ET-1-converting enzyme activity in renal and 
coronary arteries in older rats (10, 12, 57, 80). To further explore the role of the ET 
pathway in advanced age, more recent studies examined the vascular response to ET-
1 in intact vascular beds. For example, Goodwin et al. (60) reported an increased 
coronary vasoconstrictor response to ET-1 in rats. Similar to these findings, increased 
constriction to ET-1 with aging is indicated in monkey total vascular bed (5) and in 
the large coronary arteries (104) and gastrocnemius vascular bed of older rats (43). 
Interestingly, some contrasting results were demonstrated when the aorta instead of 
peripheral arteries was subject of investigation. For example, a decrease in aortic 
mRNA expression in older rats was found (124). In addition, the constrictive response 
of ET-1 in the aorta in aged rats has been reported to be reduced (48, 83) or 
unaltered (24, 109). These results suggest a site-specific effect of the ET pathway in 
advanced age. 
Recently, some studies examined the individual contribution of both ETA- and ETB-
receptors to the altered ET pathway in the peripheral arteries in older rats. Korzick et 
al. (104) assessed the ET-1-mediated coronary artery constrictive responsiveness in 
young and aged rats during infusion of a selective ETA- or ETB-receptor antagonist. 
While the increased ET-1-mediated constriction in older rats persisted during ETB-
inhibition, the selective ETA-receptor antagonists abolished the difference between 
young and older rats. In addition, Donato et al. (43) used a similar approach to 
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examine the ET pathway in muscular arterioles in rats. They found no change in 
sensitivity to ET-1 during ETB-receptor blockade, while ETA-inhibition abolished the 
age-related sensitivity of arterioles. These recent findings suggest an important role 
for ETA-receptors in the age-related changes of the ET pathway. However, a study in 
older monkeys suggests that the ETB-receptors could be involved (5). 
The beneficial health effects of exercise training with advanced age are frequently 
reported. However, only few studies examined the effects of exercise training on the 
ET pathway. Eight weeks of swimming exercise in rats results in an increased 
expression of aorta and heart ET-1 mRNA (80, 124). This increase in ET-1 mRNA is 
most probably related to the beneficial effects of ET-1 to alter cardiac contractility 
(85) and to induce myocardial hypertrophy (175), both representing exercise-induced 
cardiac adaptations. Recently, the effects of 12-week exercise training on the 
peripheral vasoconstrictor response to ET-1 were examined in a group of aged rats 
(43) and no change in ET-1 responsiveness of muscle arterioles was reported. 
 
Human studies. In healthy older human subjects, several studies demonstrated 
increased levels of circulating ET-1 (13, 101, 127, 138). In addition, ET-1 mRNA 
expression in aortic endothelial cells of older healthy human (76-years) was 
increased compared to young or middle-aged humans (108). This suggests that the 
increased levels of ET-1 with advancing age are mainly achieved via an increase in 
the amount of ET-1 mRNA. However, one may also argue that changes in clearance, 
possibly by a decrease of the ETB-receptor, may explain these findings. To date, only 
one single study examined the effects of endurance training on the ET pathway in 
healthy older women and found that the age-related increase in ET-1 plasma levels 
was decreased after 12 weeks of training (127).  
 
Thus, several animal studies emphasize the importance of the ET pathway in general, 
and the contribution of the ETA-receptors specifically, in age-related adaptations of 
the cardiovascular system. Knowledge of the ET pathway in older humans, however, 
is sparse and only based on plasma concentrations of ET-1. This stresses the value of 
exercise training studies in older humans that examine the role of the ET pathway. 
 
 
 
Outline of the thesis  
 
Aim of the present studies 
Physical inactivity and advancing age are important risk factor for cardiovascular 
disease. Nevertheless, the underlying physiological mechanism of this increase in 
Chapter 1 
 
26 
cardiovascular risk has not been elucidated. An important common feature of 
physical inactivity and aging is an increase in vascular tone. Based on the constrictor 
actions of ET-1 and its role in the increased vascular tone in some cardiovascular 
diseases, the ET pathway may be important for vascular adaptations to 
deconditioning and aging. Therefore, the general aim of this thesis is to generate 
more insight into the physiology of vascular changes to deconditioning and aging 
with special interest in the role of the ET pathway.  
 
In Chapter 2 the reliability of venous occlusion strain gauge plethysmography 
measurements of baseline and reactive hyperemic blood flow in the thigh are 
assessed and compared with measurements in the forearm and calf. This is a 
frequently used technique to examine the vascular resistance in a peripheral vascular 
bed. 
 
An important characteristic in older men is the chronically elevated sympathetic 
nerve activity. In Chapter 3 we examine whether acute changes in the sympathetic 
nervous system (stimulation or attenuation of the sympathetic responsiveness) can 
alter the flow-mediated dilation of the superficial femoral artery. We hypothesize that 
a diminished flow-mediated dilation is present in older men, which can be restored 
by an attenuation of the sympathetic responsiveness of the chronically elevated 
sympathetic nerve activity. 
 
Based on the extreme inactivity in the legs of SCI, the paralyzed legs represent ‘a 
model of nature’ for deconditioning. Functional electro-stimulation (FES)-cycling in 
spinal cord-injured (SCI) individuals is an effective method to exercise the extremely 
inactive legs of these subjects. To study the effects of this training, the focus of 
Chapter 4 is on the localization of vascular adaptations to 4 weeks FES cycling. We 
examined whether vascular adaptations are present in the active areas only (thigh) or 
also in adjacent non-active areas (calf) of the legs. Chapter 5 deals with the time 
course of the vascular adaptations to FES cycling and to detraining in SCI individuals. 
In addition, the contribution of ET-1 to baseline leg vascular tone in healthy controls 
and in SCI individuals is examined in Chapter 6. We hypothesize that the 
contribution of ET-1 to baseline leg vascular tone is increased in SCI compared with 
able-bodied controls. Deconditioning may contribute to a possible change in the ET 
pathway. Therefore, Chapter 6 determines whether FES cycling alters the 
contribution of ET-1 to leg vascular tone in SCI.  
 
Advanced age is an important cardiovascular risk factor and alters vascular function, 
but is also subject to physical inactivity. In Chapter 7 we assess the effect of 8 week 
endurance training in a group of healthy older sedentary men on vascular 
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characteristics in trained (legs) and non-trained areas (forearm and carotid artery). To 
further extent our knowledge about the age-related vascular changes, we examine 
the contribution of ET-1 to leg vascular tone in healthy older men (Chapter 8). We 
hypothesize that the aging leads to an increased contribution of ET-1 to leg vascular 
tone, which in part is mediated through the age-related physical inactivity. Therefore, 
we also examine the ability of exercise training (cycling) to alter the contribution of 
ET-1 to baseline leg vascular tone in older men.  
In the late 90-ties, circulating bone marrow-derived stem cells were isolated in the 
human body (4). Based on the ability of these circulating stem cells to improve 
vascular function and induce angiogenesis, these stem cells may play an important 
role in the vascular adaptation to the aging process and to physical (in)activity. In 
Chapter 9, baseline and exercise-induced numbers of circulating stem cells are 
studied in a population of young and older sedentary men. To study the effect of 
physical activity, inactive and trained young men are compared. In addition, the 
sedentary older men will train for 8 weeks.  
 
In Chapter 10 the current knowledge on the ET pathway and physical (in)activity in 
humans is reviewed and discussed from previous studies and available data from this 
thesis. In addition, we speculated about a framework that may help to understand 
vascular changes to physical inactivity and aging. 
 
 
Models used in this thesis  
Spinal Cord Injury 
Spinal cord-injured individuals (SCI) are subject to paralysis and extreme inactivity 
below the level of the spinal cord lesion. Therefore, SCI can serve as a “model of 
nature” for local extreme deconditioning. In SCI, the diameter of the conduit arteries 
of the leg (the common and superficial femoral artery) is approximately 20-30% 
lower than in healthy controls (36, 74, 169). This adaptation of the femoral artery 
diameter is completed within 6 weeks after the spinal cord injury (36). At the 
arteriolar level, baseline blood flow is more than 50% reduced and vascular 
resistance is more than doubled in SCI compared with control subjects (73). The fact 
that these changes in blood flow and vascular resistance in SCI are reversible by 
training suggests that most of these changes are due to deconditioning rather than 
denervation.  
Functional Electrical Stimulation. The paralyzed muscles in the legs of SCI 
individuals can be activated by electrical stimulation. In this thesis, a stationary 
computer-controlled functional electrical stimulation (FES)-ergometer is used for 
hybrid exercise, which includes stimulated leg cycling (asynchronous) and voluntary 
arm cranking (synchronous). The FES ergometer provides stimulation through surface 
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electrodes placed bilaterally over the hamstring, gluteal, and quadriceps muscles. 
Each training session starts with a warming-up of 5 minutes arm activity. 
Subsequently, intensity of stimulation of the leg muscles begins at 50 mA, which is 
increased with steps of 10 mA to a maximum of 150 mA. Stimulation is increased 
based on a decrease in power output, which indicates fatigue of the stimulated 
muscle groups. SCI individuals train for ~25 minutes with electrical stimulation.  
This method of hybrid FES cycling exercise is based on the original FES cycling 
ergometer, which stimulates leg muscles only. This conventional FES cycling 
ergometer emerged as a training modality that increases oxygen uptake (147, 199), 
leg blood flow (73, 187), muscular contractile properties (55, 139), and bone density 
(140) in SCI individuals. 
 
Aging 
Aging is regarded as an important cardiovascular risk factor, which leads to elevated 
mortality and morbidity rates. In the conduit arteries, several important vascular 
changes are observed that may contribute to the increased cardiovascular risk. For 
example, an impaired brachial artery endothelial function is reported in older men 
(25). In addition, a decreased compliance (142) and increased intima-media 
thickness (185, 186) of the carotid artery are observed in older men. In the resistance 
arteries, a ~30% increase in vascular resistance is observed in older humans (41, 42). 
These cardiovascular changes may be the result of the normal aging process 
(senescence). However, it is also suggested that a decrease in physical fitness in older 
humans, in part, contributes to these adaptations (190). This view is supported by the 
beneficial restorative capacity of exercise training in older humans (63, 89, 160).  
Cycling training. Cycling exercise is performed on a cycling ergometer (Lode, 
Angio300, Groningen, The Netherlands). Each session starts with 10 minutes 
warming-up. Subsequently, the exercise protocol continues with a period of 20 
minutes cycling at an intensity of 65% of the individual heart rate reserve 
(HRR=HRrest + (0.65*(HRmax-HRrest))). As the exercise tolerance improves, the 
intensity of the exercise training will be increased (39). Adherence to the exercise 
prescription is documented through the use of heart rate monitors (s610, Polar, 
Brooklyn, NY, USA).  
This method of cycling training has proven to increase maximum oxygen uptake (89), 
decrease vascular resistance (160) and improve vascular function (63).  
 
 
Methods applied in this thesis 
Ultrasound measurements 
Baseline red blood cell velocity, diameter and intima-media thickness of the main 
conduit arteries are measured using an echo Doppler device (Megas, ESAOTE 
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Firenze, Italy) with a 5-7.5 MHz broadband linear array transducer (35, 36). For 
reactive hyperemia and endothelium-dependent dilation (flow-mediated dilation, 
FMD) of the superficial and common femoral artery, a cuff is placed around the 
upper thigh to examine the FMD of the leg conduit arteries. The cuff is inflated to a 
supra-systolic pressure of 220 for a pre-determined period (varying between 5-13 
min) to produce local ischemia. To assess the brachial artery FMD, a cuff is placed 
around the forearm, distally from the elbow. After cuff deflation, hyperemic flow 
velocity in the conduit artery is recorded on videotape for the first 25 seconds, 
followed by a continuous registration of the vessel diameter for 5 minutes to 
determine FMD. After a resting period of at least 20 minutes to re-establish baseline 
conditions, nitroglycerin (400 μg) will be administered sublingually. Nitroglycerin 
causes endothelium-independent vasodilation, which is indicative for nitric oxide 
sensitivity and smooth muscle function. Vessel diameter is recorded continuously 
until 8 minutes after nitroglycerin administration. The reproducibility for the resting 
measurements in the superficial femoral artery was reported as 1.5% for diameter, 
and 14% for blood flow. The reproducibility for the relative FMD change was 15% 
(35). 
 
The perfused upper leg model 
The technique of leg blood flow measurements in combination with drug infusions 
into the femoral artery is developed collectively by the department of physiology and 
pharmacology-toxicology (103). A cannula (Angiocath 16 gauge, Becton Dickinson, 
Sandy, Utah, USA) is introduced into the femoral artery of the leg using a modified 
Seldinger technique. The intra-arterial cannula is used for drug administration and for 
blood pressure measurement. In control subjects, local anesthesia is used.  
Bilateral upper leg blood flow is measured by electrocardiography-triggered venous 
occlusion plethysmography using mercury-in-silastic strain gauges placed 
approximately 10 cm proximal to the patella. The thigh cuffs are simultaneously 
inflated to 50 mmHg using a rapid cuff inflator (Hokanson E-20, D.E. Hokanson, 
Bellevue, Washington, USA) (64). 
 
Apart from the afore mentioned hemodynamics, we also examined some humoral 
parameters in the final chapters from this thesis. We assessed the plasma levels of ET-
1 and the vascular endothelial growth factor (VEGF). In addition, numbers of 
hematopoietic stem cells (HSCs) and endothelial progenitor cells (EPCs) are 
examined. These latter cell lines represent a subset of circulating stem cells derived 
from the bone marrow. 
 
In summary, in this thesis we will utilize the afore mentioned methods to examine 
the following issues; 1) reproducibility of venous occlusion plethysmography to 
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examine baseline blood flow, 2) whether the sympathetic nervous system contributes 
to the lower superficial femoral artery FMD in older men, 3) the ability of exercise 
training in SCI and older men to alter vascular characteristics, 4) the contribution of 
ET-1 to leg vascular tone in deconditioning and aging and whether exercise training 
can change this contribution, and 5) the effect of deconditioning and aging on the 
numbers of circulating stem cells. 
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Abstract 
 
Venous occlusion plethysmography is commonly used as a tool to assess blood flow 
(BF) and vascular resistance (VR) at baseline and during post-occlusive reactive 
hyperemia (PORH). However, little is known about the reproducibility of this 
method. 
Purpose. To investigate short-term (hours) and medium-term (week) reproducibility 
of forearm, calf and thigh BF and VR at baseline and during PORH. 
Methods. Reproducibility was assessed by the coefficient of variation (CV). In eight 
subjects, baseline BF and VR of the forearm, calf, and thigh were measured, using 
venous occlusion plethysmography (50 mmHg). PORH and minimal VR were 
measured after 13 min of arterial occlusion (220 mmHg).  
Results. Reproducibility of baseline forearm and calf BF was acceptable and in 
agreement with previous studies (CV: 12.9-21.2%). Short- and medium-term 
reproducibility of thigh BF was good (CV: 5.9% and 8.7%, respectively). Baseline VR 
showed acceptable to good reproducibility for forearm, calf, and thigh (8.3-22.5%). 
Forearm PORH showed a CV of 6.1% (short-term) and 8.6% (medium-term), this was 
6.1% (short-term) and 6.4% (medium-term) for the calf, and 6.4% (short-term) and 
8.0% (medium-term) for the thigh. Minimal VR showed good to acceptable 
reproducibility (CV: 6.1-11.7%).  
Conclusions. Forearm, calf and thigh BF and PORH measured by plethysmography 
has an acceptable to good short- and medium-term reproducibility. Short- and 
medium-term reproducibility of forearm and calf baseline BF are acceptable and 
thigh baseline BF has a good short- and medium-term reproducibility. Therefore, 
plethysmography is a suitable, low cost tool to assess thigh baseline BF and PORH.  
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Introduction 
 
Venous occlusion strain gauge plethysmography is a valuable, non-invasive, 
practical, and low cost tool to assess blood flow (BF) in forearm, calf, and thigh. A 
good reproducibility of a technique is a prerequisite for the interpretation of studies 
using these techniques, and even more so for studies with repeated measurements, 
such as training- or intervention-studies. Previous studies demonstrated a reasonable 
reproducibility of baseline calf and forearm blood flow (BF) for short (hours) and 
medium (week) term reproducibility (1, 8, 34, 45) (table 1). Since blood flow 
critically depends on arterial pressure, vascular resistance can provide more 
information than blood flow alone. Moreover, reproducibility of VR may be better, 
because the influence of day-to-day blood pressure changes is limited. Only one 
study (33) assessed reproducibility of forearm VR and found a coefficient of variation 
(CV) of 27 and 29% in right and left forearm, respectively. 
 
 
Table 1. Results of previous reproducibility studies. 
 
 CV of BF  CV of PORH 
 forearm calf forearm calf 
Walker (2001) 16-19†    
Petrie (1998) 39-31†    
Engelke (1996) 8.2*  9.8*  
Altenkirch (1989) 24.9* 12.5* 10.5* 7.1* 
Rubba (1983)  17.2*   
38.1† 
 19.9*   
23.2† 
Roberts (1986) 10.5† 11.5†   
Coefficient of Variation (CV) for blood flow and the post-occlusive reactive hyperemic 
response in forearm and calf. * Short-term reproducibility (on one day). † Medium-term 
reproducibility (between days-weeks). 
 
 
 
The thigh muscles represent a large part of the total muscle mass and thigh arterial 
blood flow is regularly examined in training studies such as cycling, running or 
rowing. In most studies, not thigh but total leg blood flow is assessed by echo-
Doppler of the common femoral artery (11, 13, 15, 18, 25). Venous occlusion 
plethysmography, however, is a low cost and easy applicable tool to specifically 
assess baseline thigh BF (12, 19, 21, 22, 29). Despite the accuracy of strain gauge 
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plethysmography to measure forearm and calf BF, the thigh represents a different 
vascular bed and no studies exists on the short- and medium-term reproducibility of 
plethysmography of the thigh. 
Venous occlusion plethysmography can also be used to measure post-occlusive 
reactive hyperemia (PORH) (8, 14, 28, 36, 38). PORH refers to the phenomenon of 
increased BF that follows relief of ischemia and is a result of dilatation of resistance 
vessels. This vasodilation has been attributed to myogenic relaxation of the vessels 
(40) and local release of mediators and metabolites such as adenosine (41), 
prostaglandins, and nitric oxide (6, 8). Measuring PORH is frequently used to 
evaluate structural changes in the circulation (20). In previous studies, mainly the 
short-term reproducibility (hours or 1 day) of the maximal BF was assessed. Short-
term reproducibility was 7.1 - 19.9% for the calf (1, 37) and 8.2 - 24.9% for the 
forearm (1, 8) (table 1). Despite the frequent use of forearm PORH to assess 
circulatory adaptations over time (3, 7, 27, 44), no data are published on the 
medium-term reproducibility of the forearm PORH. In addition, reproducibility of 
thigh PORH has not been examined before, while data on calf PORH is very limited. 
Only one study assessed calf PORH and showed a poor medium-term reproducibility 
of 23.3 % (37). 
Therefore, the purpose of this study was to assess short- and medium-term 
reproducibility of the baseline BF and PORH, as well as of the vascular resistance, in 
the thigh, forearm and calf in healthy young male individuals. Subjects were 
measured at day one (twice) and approximately seven days later.  
 
 
 
Methods 
 
Subjects 
Eight healthy male subjects (age 27 ± 3 years, height 183 ± 4 cm, weight 84 ± 10 kg) 
volunteered to participate in this study. Each subject signed a written informed 
consent. The hospital ethics committee approved the study. All subjects gave their 
written informed consent before participation. All studies were performed according 
to the Declaration of Helsinki. 
 
Design 
All subjects were tested on 2 separate days. On day 1, the protocol was performed 
twice with a time-interval of 3 h between both measurements to assess short-term 
reproducibility. Between the two measurements, subjects were allowed to walk and 
sit. The protocol was repeated 6-10 days later to assess medium-term reproducibility. 
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Measurements  
Baseline Blood Flow and Vascular Resistance. Baseline skeletal muscle BF and VR 
were examined unilaterally (at the right side) for 5 min using venous occlusion 
plethysmography. The occlusion cuff was inflated, ECG-triggered and within one 
heart beat, to a cuff pressure of 50 mmHg (12). This pressure was sustained for 9 
heart beats after which the cuff was deflated instantaneously (for 10 heart beats). 
Blood Flow and Vascular Resistance After Ischemia. After measurement of BF, PORH 
was assessed after 13 min of unilateral (right side) arterial occlusion with a 
suprasystolic cuff pressure of 220 mmHg. During the last minute of ischemia, a 
dynamic exercise (20-30 hand contractions during the forearm measurement and 
foot peddling during the thigh and calf experiments) was added to ensure maximal 
dilatation (30, 31). The initial BF during PORH was obtained within 10 s of releasing 
the arterial occlusion cuffs and the highest flow of the subsequent QRS-triggered BF 
measurements was accepted as the maximal BF and the minimal VR. Maximal flow 
has previously been shown to occur within 30-45 s after cuff release (31). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic presentation of measurement protocol. During ‘baseline’, baseline blood 
flow and vascular resistance are examined. During PORH (post-occlusive reactive hyperemia) 
the peak blood flow and minimal vascular resistance are assessed. 
 
 
 
Protocol 
After a 12 h overnight fast, each experiment started at 8:30 AM. All subjects refrained 
from caffeine, nicotine, chocolate, vitamin C supplements, and alcohol for at least 18 
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h before the test. Room temperature was controlled at 22.5 ± 1 °C. After completing 
a health questionnaire, subjects were positioned comfortably on a bed in the supine 
position with a slight elevation of the head. During an acclimatization period of at 
least 30 min supine rest, strain gauges and cuffs were positioned. 
Forearm position. The experiment started with a measurement of the forearm BF and 
reactive hyperemia (figure 1). The right arm was positioned ~5 cm above heart level. 
A standard blood pressure cuff (10 cm width) was placed around the right upper arm 
and was attached to a rapid cuff inflator (Hokanson, Inc., Bellevue, WA, USA). A 
mercury-in-silastic strain gauge (Hokanson, Inc., Bellevue, WA, USA) was placed at 
the widest girth of the forearm. The perpendicular distance to the elbow crease was 
registered and carefully controlled throughout the experiment. One minute before 
and during the measurement of the BF, the hand circulation was excluded by 
inflating a cuff (8 cm width) around the wrist to a suprasystolic pressure of 220 
mmHg to minimize the contribution of hand skin blood flow (23). After BF-
assessment, a 5 min rest period followed in order to allow BF to return to baseline 
after wrist cuff release, prior to the start of the period of arterial occlusion. 
Thigh position. The experiment continued with registration of thigh baseline BF and 
PORH (figure 1). A 12 cm width cuff was placed proximally around the upper leg. 
Both legs were elevated and the lower legs rested on a 14 cm high platform. The 
strain gauges were placed at mid-thigh, at least 10 cm above the patella and at least 
4 cm below the cuff to avoid displacement of the strain gauge during cuff inflation. 
The position of the strain gauge was carefully controlled during all three experiments.  
Calf position. After a resting period of 30 min in order to restore leg BF to baseline 
level, the protocol was concluded with the measurements of calf baseline BF and 
PORH (figure 1). Both heels rested on a 20 cm high platform. The legs were 
supported at the level of the lateral thigh in order to relax the calf muscles. The strain 
gauges were applied to the widest girth of the right calf. This position was marked 
and was kept constant throughout the experiments. 
Before each BF and prior to cessation of the arterial occlusion cuff, blood pressure 
was measured twice at the left brachial artery using the standard auscultatory 
method. During testing, arterial blood pressure was measured continuously by a 
portable blood pressure device (Finapres; TNO, Amsterdam, the Netherlands) that 
was connected to the middle phalanx of the index or middle finger of the left hand. 
An electric thermometer (Genius®, Kendall Company, Mansfield, MA) was used to 
measure surface skin temperature. Temperature was measured before each BF 
measurement at the forearm flexor muscles, the medial head of the quadriceps 
muscle, and at the lateral gastrocnemius muscle. 
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Data analysis 
Data were digitalized with a sample frequency of 100 Hz (MIDAC, Instrumentation 
Department, Radboud University Nijmegen Medical Centre, The Netherlands) and 
analyzed by a customized computer program (Matlab, Mathworks Inc., USA). 
Arterial BF (in ml⋅min-1⋅dl-1) was calculated from the slope of the volume change 
over a 4 s interval. To avoid measuring during an artefact, the initial 2 s of the slopes 
in the thigh and 1 s in the forearm and calf measurements were excluded from 
analysis. Registrations with movement-artefacts were excluded. The number of slopes 
was, depending on the heart rate and exclusion of registrations with artefacts, 
between 10 and 15 per measurement. Baseline VR was calculated as mean arterial 
pressure (MAP; in mmHg) divided by the relative arterial BF (in ml⋅min-1⋅dl-1) and 
expressed in arbitrary units of resistance (AU). Finapres and auscultatory blood 
pressure MAP-values were used to calculate VR. Reproducibility of the VR was 
calculated for both methods. The PORH (in ml⋅min-1⋅dl-1) was calculated from the 
slope of the volume change over a 1 s interval. To obtain the most accurate value, 
assessment started after the cuff inflation artefact (after 1.5 s in the thigh and after 0.5 
s in the forearm and calf). The highest BF after release of arterial occlusion was 
accepted as the PORH, representing the maximal BF. Minimal VR after ischemia was 
calculated from the highest blood flow and the corresponding MAP.  
 
Statistical analysis 
Short-term (3 hours) and medium-term reproducibility (7 days) of the baseline BF and 
VR and PORH were assessed by calculating the coefficient of variance (CV) from two 
measurements. Previous to calculation of the CV, a natural logarithmic 
transformation was applied to correct for heteroscedasticity of the data. The CV was 
calculated following the approach based on the pooled SD, as described previously 
(32). Briefly, the root mean square of the error term (square root of the error term of 
the adjusted mean squares) of an Analysis of Variance is used to calculate the pooled 
variance (SPSS Inc., Chicago, Illinois, USA). After log transformation, the CV can be 
calculated by taking the square root of the exponent of the pooled variation minus 1, 
times 100 ((exp(var)-1)*100). In addition, a 95%-confidence interval was calculated 
of the CV, based on the variation of the logarithmic transformed data and the chi 
square distribution ((exp(df*variation/chi square distribution)-1)*100) (26). Forearm, 
calf, and thigh baseline BF was represented in Bland-Altman plots to show the 
distribution of the individual data. A paired Student’s t-test was used to assess 
changes in skin temperature. Data are presented as mean ± SD. For biological 
variables, a CV <10% is considered good and <20% acceptable (39).  
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Results 
 
Skin temperature was constant over all experiments except for a significantly higher 
forearm surface skin temperature during the 2nd test on the first day (25.3 ± 0.5 °C) 
compared with the 1st test (24.6 ± 0.4 °C, P= 0.03). 
 
Forearm. Short- and medium-term reproducibility of baseline forearm BF and 
baseline and minimal VR are represented in table 2. Baseline BF is also represented 
in a Bland-Altman plot in figure 2. Maximal forearm BF during PORH showed a 
reproducibility of 6.1 (short-term) and 8.6% (medium-term). Using the two highest 
BF-values instead of the single highest value resulted in a CV of forearm PORH of 8.1 
and 6.6% for short- and medium-term reproducibility, respectively. 
 
Calf. Coefficients of variance for baseline calf BF and baseline and minimal VR 
reproducibility are shown in table 2. Baseline BF is also represented in a Bland-
Altman plot in figure 2. Short- and medium-term reproducibility for calf BF during 
PORH showed CV’s of 6.1 and 6.4%, respectively. Calf short- and medium-term 
reproducibility of PORH using the 2 highest values resulted in CV’s of 7.4 and 7.3%, 
respectively. 
 
Thigh. Table 2 shows the CV’s for baseline thigh BF and baseline and minimal thigh 
VR for short- and medium-term reproducibility. Baseline BF is also represented in a 
Bland Altman plot in figure 2. Thigh BF during PORH showed a CV of 6.4% for 
short-term and 8.0% for medium-term reproducibility and 6.7% and 10.6% 
respectively using the two highest values. 
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Figure 2. Relative difference (%) between responses for short- (closed circles) and medium-
term (open circles) plotted against mean response for each individual subject for baseline 
blood flow (BF) in forearm (A), calf (B), and thigh (C).  
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Table 2. Reproducibility of forearm, calf, and thigh baseline and maximal blood flow and 
baseline and minimal vascular resistance (n=8).  
 
 Trial CV (95%-CI) 
FOREARM 1st 2nd 3rd short medium 
 Baseline BF, ml⋅min-1⋅dl-1 1.6 ± 0.4 1.6 ± 0.4 1.7 ± 0.4 16.9% 
(10.6-30.7) 
21.2% 
(13.1-38.2) 
 Baseline VR Finapres, AU 63 ± 25 
 
63 ± 15
 
56 ±
 
21 
 
23.2% 
(14.2-41.6) 
29.7% 
(17.7-53.1) 
 Baseline VR auscultatory, AU 62 ± 16 
 
64 ± 15
 
56 ±
 
17 
 
18.0% 
(11.2-32.5) 
22.5% 
(13.8-40.4) 
 PORH  BF, ml⋅min-1⋅dl-1 30 ± 6 31 ± 6 31 ± 5 6.1% 
(4.0-11.3) 
8.6% 
(5.6-15.9) 
 PORH VR Finapres, AU 3.3 ± 0.9
 
3.5 ± 1.1
 
3.2 ±
 
0.5 
 
12.2% 
(7.8-22.4) 
14.7% 
(9.3-26.8) 
 PORH VR auscultatory, AU 3.2 ± 0.8
 
3.3 ± 0.8
 
3.0 ±
 
0.5 
 
7.9% 
(5.2-14.7) 
8.5% 
(5.5-15.7) 
 
CALF  
           
 Baseline BF, ml⋅min-1⋅dl-1 1.6 ± 0.5 1.4 ± 0.3 1.5 ± 0.3 14.0% 
(8.8-25.4) 
12.9% 
(8.2-23.6) 
 Baseline VR Finapres, AU 62 ± 17 
 
75 ±
 
16
 
68 ±
 
14 
 
24.2% 
(14.8-43.4) 
16.9% 
(10.6-30.6) 
 Baseline VR auscultatory, AU 61 ± 17 
 
73 ±
 
14
 
66 ±
 
14 
 
17.3% 
(10.8-31.2) 
15.7% 
(9.9-28.6) 
 PORH  BF, ml⋅min-1⋅dl-1 31 ± 5 31 ± 5 31 ± 5 6.1% 
(4.0-11.3) 
6.4% 
(4.2-11.9) 
 PORH VR Finapres, AU 3.3 ± 0.9
 
3.3 ±
 
0.8
 
3.4 ±
 
0.8 
 
17.0% 
(10.7-30.8) 
15.8% 
(9.9-28.6) 
 PORH VR auscultatory, AU 3.2 ± 0.6
 
3.3 ±
 
0.6
 
3.3 ±
 
0.6 
 
6.1% 
(4.0-11.4) 
6.8% 
(4.5-12.7) 
 
THIGH 
           
 Baseline BF, ml⋅min-1⋅dl-1 2.9 ± 1.1 2.9 ± 1.1 3.0 ± 1.3 5.9% 
(3.9-11.0) 
8.7% 
(5.6-16.0) 
 Baseline VR Finapres, AU 37 ± 13 
 
37 ±
 
11
 
38 ±
 
14 
 
11.9% 
(7.6-21.8) 
14.6% 
(9.2-26.5) 
 Baseline VR auscultatory, AU 35 ± 12 
 
36 ±
 
10
 
36 ±
 
13 
 
8.3% 
(5.4-15.3) 
9.7% 
(6.2-17.8) 
 PORH  BF, ml⋅min-1⋅dl-1 25 ± 6 26 ± 8 25 ± 8 6.4% 
(4.2-11.9) 
8.0% 
(5.2-14.7) 
 PORH VR Finapres, AU 4.0 ± 1.3
 
4.0 ±
 
1.2
 
4.0 ±
 
1.5 
 
10.6% 
(6.8-19.5) 
18.0% 
(11.2-32.4) 
 PORH VR auscultatory, AU 4.1 ± 1.1
 
4.2 ±
 
1.4
 
4.2 ±
 
1.7 
 
7.9% 
(5.2-14.7) 
11.7% 
(7.5-21.5) 
Mean ± SD and coefficient of variation (CV) with 95%-confidence intervals (95%-CI, below) 
are presented. The dark grey, light grey, and non-accentuated cells represent a good 
(CV<10%), acceptable (CV<20%), and poor reproducibility (CV>20%), respectively. 
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Discussion   
 
The major novel findings in this study are the following. Thigh baseline BF has a 
good short- and medium-term reproducibility. In addition, this study shows good 
short- and medium-term reproducibility for PORH of the forearm, calf and thigh. 
Furthermore, reproducibility of baseline and post-ischemic VR were assessed and 
demonstrated to be acceptable to good when auscultatory MAP-values were used. 
 
Absolute values for baseline and peak calf and forearm BF obtained in this study are 
in agreement with those reported in the literature using similar measuring techniques 
(1, 4, 8, 16, 37). In addition, our values for baseline and post-ischemic thigh BF are 
in the same range as the results presented in previous studies (12, 22, 29). Values 
obtained in our study on short- and medium-term reproducibility for baseline forearm 
(16.9 and 21.2%, respectively) and calf BF (14.0 and 12.9%, respectively) 
correspond with those from previous studies (table 1). Previous studies usually 
assessed total leg blood flow by echo-Doppler measurement of the common femoral 
artery and not thigh blood flow. Venous occlusion plethysmography specifically 
assesses blood flow in the thigh, but is used less often. However, this study is the first 
to demonstrate a good reproducibility and may serve to advocate a more widespread 
use of plethysmography of the thigh. The small internal and biological variation of 
thigh flow indicates that plethysmography is a suitable and accurate method to 
measure baseline thigh BF and to assess alterations in thigh BF over time. Therefore, 
measuring thigh BF is a suitable method to assess vascular adaptations over time to 
large muscle exercise (cycling or running) or deconditioning. However, it has to be 
kept in mind that arterial infusion in the thigh is more complex than in the forearm. 
Therefore, measuring forearm BF is more feasible for intra-arterial infusion of drugs in 
pharmacological studies. In addition, although reproducibility of thigh baseline BF 
seems to be better compared with forearm BF, from analysis of the 95%-confidence 
intervals this cannot be demonstrated. Based on these arguments, we believe that the 
choice of the thigh or forearm model depends on the question of interest and not on 
the reproducibility of the method itself, since the reproducibility of both methods is at 
least acceptable. 
 
In the present study, reproducibility of the baseline and minimal VR of the calf and 
thigh were assessed for the first time, and an acceptable to good reproducibility was 
demonstrated. In contrast with a previous study (33), no difference between forearm 
VR and forearm BF was found. In addition, since lower CV’s and smaller 95%-
confidence intervals were found for VR measured with auscultatory MAP, 
auscultatory-MAP may be preferred over Finapres-MAP. However, this trend cannot 
be statistically validated in this study. This small, however not significant, difference 
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may be explained by the working mechanism of the Finapres. An important 
limitation of Finapres is the incapability to assess absolute blood pressure levels (17, 
35). In the early reports on Finapres, that demonstrated a good reproducibility even 
for absolute blood pressure values, Finapres was calibrated to an intra-arterial blood 
pressure signal (9, 10). This calibration is rarely performed in later studies. In 
addition, comparing the 95%-confidence intervals, reproducibility of VR may be 
slightly better using auscultatory MAP than using Finapres MAP. However, both 
methods do not significantly differ and therefore both methods can be used to 
calculate VR.  
The 95%-confidence intervals of the CV’s for all sites overlapped. Nevertheless, the 
95%-confidence interval of the CV of the baseline forearm and calf BF was larger 
compared to thigh BF. This variation may be caused by several mechanisms. First, a 
change in sympathetic tone may cause a variation of baseline forearm BF. However, 
an equal heart rate between measurements and lack of correlation between heart rate 
and forearm BF (r=0.03, P=0.89) suggest that the sympathetic system did not have a 
major influence on BF. Second, differences in surface skin temperature and 
concomitant changes in skin blood flow may explain these results. Obviously, the 
ratio skin-muscle of the forearm is different compared to the thigh, which makes the 
forearm more sensitive to the influence of temperature differences. In our experiment, 
forearm skin surface temperature was higher during the second test compared with 
the first test. However, no significant correlation between increase in skin 
temperature and increase in baseline forearm BF was found (r=-0.29, P=0.28). 
Therefore, we suggest variations in forearm skin temperature and skin blood flow 
changes have only minimally influenced forearm baseline BF. Third, variation in 
baseline forearm BF could be attributed to variations in the circulation of the hand. 
However, this circulatory bed was excluded by inflating a wristcuff to suprasystolic 
pressure (23). In conclusion the variations in BF can only be attributed to variations 
in blood flow itself or in venous plethysmography assessment. 
 
The short- and medium-term reproducibility of thigh PORH have not been studied 
previously. This study shows that the reproducibility for this method is good, which 
implicates that venous occlusion plethysmography is a suitable and accurate method 
to assess structural vascular function over a longer time period in the thigh vascular 
system. Forearm PORH short-term reproducibility in this study shows comparable 
results to previous studies (1, 8). However, medium-term reproducibility of this 
frequently used method has never been investigated before. This study demonstrates 
that the medium-term reproducibility of the maximal forearm BF is good and can be 
applied in future studies. For calf PORH, this study found a good short- and medium-
term reproducibility (6.1 and 6.4%, respectively). Previous studies showed conflicting 
results regarding short-term reproducibility, ranging from a CV of 7.1 (1) to 19.9% 
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(37). The marked differences between our results and these previous studies may be 
explained by several precautions. First, in our experiment, positioning of the cuff, 
strain gauge, and assessed limb were registered, repeated and controlled throughout 
the whole experiment (29). Second, the same strain gauges were applied for each test 
and conditions during the test were kept constant. Third, based on the physiological 
diurnal rhythm, all measurements were performed in the morning. Fourth, because a 
relationship between smoking (2, 24), food intake (43), and coffee (5, 42) and 
changes in basal BF and PORH has been proven, all subjects refrained from any food 
at least 12 h before the start of the experiment and did not drink coffee, tea or 
alcohol 18 h before the test. All the aforementioned precautions have certainly 
added to the reproducibility levels achieved in the present study and are important to 
bear in mind for future studies. 
Reproducibility of the post-ischemic minimal VR was acceptable to good when VR 
was calculated with auscultatory MAP-values. The use of Finapres MAP-values 
resulted in a non-significant trend towards slightly higher CV’s with concomitant 
larger 95%-confidence intervals. PORH is regarded as the maximal dilating response 
of the peripheral vascular system and reflects a structural property and is therefore 
minimally influenced by other regulating factors. This may explain the better 
reproducibility of PORH compared to baseline BF. We wondered if using the two 
highest BF values would further improve the reproducibility of PORH. However, 
using the two highest BF values, short- and medium-term CV’s for forearm, calf, and 
thigh did not significantly improve.  
 
In conclusion, forearm, calf and thigh BF, VR, and PORH measured by 
plethysmography has an acceptable to good short- and medium-term reproducibility. 
Short- and medium-term reproducibility of forearm and calf baseline BF are 
acceptable, and thigh baseline BF has a good short- and medium-term 
reproducibility. Therefore, plethysmography is a suitable, low cost tool to assess thigh 
baseline BF and PORH and can be used in training or inactivation studies of leg 
muscles. 
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Abstract 
 
The physiological aging process is associated with endothelial dysfunction, as 
assessed by flow-mediated dilation (FMD). Aging is also characterized by increased 
sympathetic tone.  
Purpose. To assess whether acute changes in sympathetic activity alter leg FMD. 
Methods. The FMD of the superficial femoral artery was determined in 10 healthy 
young (22 ± 1 years) and 8 healthy older (69 ± 1 years) men in three different 
conditions; 1) at baseline, 2) during reduction of sympathetic activity, and 3) during 
sympathetic stimulation. Reduction of sympathetic activity was achieved by 
performing a maximal cycling exercise, leading to post-exercise attenuation of the 
sympathetic responsiveness in the exercised limb. A cold pressor test was used to 
increase sympathetic activity. Nitroglycerine (NTG) was used to assess endothelium-
independent vasodilation in all 3 conditions.  
Results. In older men, the FMD and NTG responses were significantly lower 
compared with young men (P=0.001 and P=0.02, respectively). In older men, 
sympathetic activity significantly affected the FMD response (RM-ANOVA: P=0.01), 
with a negative correlation between the level of sympathetic activity and FMD      
(r=-0.41, P=0.049). This was not the case for the NTG-responses (ANOVA; P=0.48). 
FMD and NTG responses in young men did not differ between the 3 conditions (RM-
ANOVA: P=0.32 and P=0.31, respectively). 
Conclusions. In older men, FMD of the femoral artery is impaired. Local attenuation 
of the sympathetic responsiveness partly restores the FMD in these subjects. In 
contrast, in young subjects acute modulation of the sympathetic nervous system 
activity does not alter flow-mediated vasodilation in the leg.  
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Introduction 
 
The endothelium plays an essential role in vascular homeostasis and is able to 
respond to physical and chemical stimuli by the synthesis and release of vasoactive, 
thromboregulatory, and growth factor substances (32). The flow-mediated dilation 
(FMD) represents endothelial function and reflects the ability of a conduit artery to 
dilate in response to a marked increase in blood flow (2). An impaired FMD has been 
reported as a key early event in the development of atherosclerosis (26), even before 
structural lesions are present (1). In addition, impaired FMD is also present with 
advancing age (6, 35) and is associated with cardiovascular diseases (2, 3, 25, 34, 
36).   
The sympathetic nervous system serves as a key modulator of cardiovascular and 
other physiological functions in humans (33). Interestingly, several conditions with 
impaired FMD responses are also characterized by an increased sympathetic activity 
(8, 11). Moreover, when acute stimulation of the sympathetic nervous system in 
healthy subjects is applied, an impaired FMD is observed in the brachial artery (9, 
17, 23). However, these findings are not universal and seem to depend on the nature 
of the stress stimulus (9, 15).  
Advancing age is associated with a chronic increased sympathetic activity (29), 
augmented vasoconstrictor responsiveness to acute sympathetic stimulation during 
exercise (19) and enhanced post-exercise FMD in the brachial artery of older women 
(16). In addition, the age-related reductions in limb blood flow are reported to be 
mediated largely by the chronically elevated α-adrenergic sympathetic tone (7). 
However, the effects of the age-related chronically elevated sympathetic tone on the 
impaired FMD-responses of the superficial femoral artery are unknown. Therefore, 
the aim of the study is to assess the effects of reduction of the sympathetic 
responsiveness or stimulation of the sympathetic nervous system on the FMD of the 
superficial femoral artery in healthy older and young men. We hypothesize that 
reducing the sympathetic responsiveness of the chronically elevated sympathetic 
nerve activity in older men will restore flow-mediated vasodilation. This implies that 
local reduction of sympathetic activity enhances flow-mediated vasodilation. 
 
 
 
Methods 
 
Subjects 
Ten young healthy men (22 ± 3 years) and eight healthy older men (69 ± 2 years, 
table 1) volunteered to participate in this study. All subjects were normotensive 
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(blood pressure <160/90), non-smoking, and were free of overt chronic 
cardiovascular disease as assessed by medical history and physical examination. 
None of the subjects used medication known to interfere with the cardiovascular 
system and were further evaluated by ECG at rest. The individuals with ankle-
brachial pressure index <0.90, plaque formation, and/or clinical characteristics of 
arthrosclerosis were excluded. The hospital ethics committee approved the study. All 
subjects gave their written informed consent before participation. All studies were 
performed according to the Declaration of Helsinki. 
 
 
Table 1. General characteristics and incremental maximal test in young and older men. 
 
 Young (n=10) Older (n=8) 
Age, years 22  ± 3 69  ± 2† 
Length, cm 185  ± 6 179  ± 7 
Weight, kg 78  ± 6 86  ± 9* 
Body fat, % 17  ± 3 29  ± 5† 
Systolic pressure, mmHg 118  ± 10 136  ± 11* 
Diastolic pressure, mmHg 
 
Incremental maximal test 
70  ±
 
7 
 
 
83  ± 
 
 
11* 
 
 
  Maximal workload, W 342  ± 30 177  ± 19† 
  Maximal heart rate, bpm 193  ± 8 154  ± 12† 
  Respiratory exchange ratio 1.23  ± 0.10 1.18  ± 0.11 
  Lactate, mmol⋅l-1 11  ± 3 5  ± 1† 
  Maximal O2 uptake, ml⋅min-1⋅kg-1 51  ± 7 29  ± 5† 
Values are means ± SD. * P<0.05 and † P<0.005 between young and older men. 
 
 
 
Design 
All subjects were tested on four separate days, all at the same time of the day. On 
day 1, baseline endothelium dependent (flow-mediated dilation (FMD)) and 
independent (nitroglycerine (NTG)) dilation of the superficial femoral artery was 
measured. Day 2 started with an exercise test, which leads to local sympatholysis in 
the exercised limb, immediately followed by measurement of the FMD and NTG 
responses. The third day, the FMD and NTG responses were measured during 
sympathetic stimulation using the cold pressor test (CPT). The sequence of day 1-3 
was randomized. During day 4, peripheral vascular changes were assessed during 
the CPT and the exercise test.  
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Protocol 
Day 1: Baseline. After a 12 h overnight fast, experiments were performed in the 
morning. Subjects refrained from caffeine, nicotine, chocolate, kiwi, vitamin C 
supplements, and alcohol for at least 18 h before the test. Room temperature was 
controlled at 23 ± 1 °C. Subjects were positioned comfortably on a bed in the supine 
position. The lower legs rested on a 14 cm high platform. A cuff (12 cm) was placed 
proximally around the upper leg, and was connected to a rapid cuff inflator 
(Hokanson Inc., Bellevue, WA, USA). After an acclimatization period of 30 min, 
resting characteristics of the superficial femoral artery were measured (figure 1). 
Subsequently, the occlusion cuff was inflated to 220 mmHg suprasystolic pressure for 
10 min to measure FMD. After a resting period of at least 30 min, a single spray of 
sublingual nitroglycerin (NTG, 400 μg), an exogenous nitric oxide (NO) donor, was 
administered to determine the endothelium independent vasodilation of the 
superficial femoral artery (4), which is indicative for smooth muscle function. During 
testing, arterial blood pressure was measured continuously using a portable blood 
pressure device (Finapres; TNO, Amsterdam, the Netherlands) that was connected to 
the middle phalanx of the index or middle finger of the left hand.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Experimental protocol. Each individual part of the experimental protocol is indicated 
in an ‘open’ block. The ‘filled’ blocks represent sympathetic stimulation (CPT; cold pressor 
test) or reduction of sympathetic control (exercise).  
 
 
Day 2: Maximal Cycling Exercise. A maximal exercise bout was added to the 
experiments performed on day 1. It is well known that exercise leads to local 
changes in sympathetic activity of the active limbs during exercise, commonly 
referred to as functional sympatholysis (18). This physiologic phenomenon provides 
an optimal homeostasis for the exercising muscles without neglecting the vital 
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organs. In a sub-group of the present subjects (see Day 4), subsequent studies 
revealed that the maximal exercise bout leads to a local attenuation of the 
sympathetic responsiveness in the exercise limb (legs), which persists at least during 
the time-window in which we examine the post-exercise FMD. Important to notice is 
that we can only speculate about the physiological mechanism for this integrated 
response. Theoretically, the blunted local sympathetic responsiveness can be caused 
by; 1) a decrease in nerve firing of sympathetic fibres, 2) a decrease in 
norepinephrine-release due to pre-synaptic inhibition, and/or 3) a decrease in the 
responsiveness of the post-synaptic α-adrenergic receptors (or its signalling).  
After measuring the resting characteristics of the superficial femoral artery, subjects 
performed an incremental maximal cycling test. The exercise bout was performed on 
a leg cycling ergometer (Lode, Angio300, Groningen, the Netherlands), using a 
multistage protocol. Young men increased their workload by 20 W per minute, 
starting at 20 W, until exhaustion, whereas older men used steps of 10 W per minute. 
Oxygen consumption was measured continuously to determine physical fitness of 
both groups using a gas-analyzer (Jaeger Benelux BV, Breda, the Netherlands). 
Maximal (VO2max) oxygen consumption was analyzed as the mean of the last minute 
of the maximal exercise test. In addition, blood lactate levels (Roche Diagnostics 
GmbH, Mannheim, Germany) were measured and heart rate was recorded 
continuously. Within 3 min after cessation of the exercise test, subjects were placed 
in the supine position and an occlusion cuff was inflated to 220 mmHg for 5 min to 
assess the FMD during the period of local blunted sympathetic responsiveness (figure 
1). To account for differences in oxygen consumption compared with the previous 
days, the time of occlusion was adapted to equalize the shear stress stimulus (16). 
After a resting period of 15 min, nitroglycerine was administered to assess the 
endothelium-independent dilation of the superficial femoral artery. This time-
window is associated with local post-exercise sympatholysis (14). 
Day 3: Cold Pressor Test. Experiments performed on day 1 were repeated with 
addition of the CPT. This is a widely accepted and well-validated model to stimulate 
the sympathetic nervous system. After 9 min of arterial occlusion, the CPT was 
started by immersing the left hand into ice water (4°°C) (10, 39) and was continued 
for 5 min (figure 1). Using this protocol we ensured that maximal sympathetic 
stimulation, normally present during the initial minutes of the CPT (40), was present 
during measurement of the FMD. Leg vascular resistance was assessed prior to and 
during the CPT. The mean of the 3 highest values of leg vascular resistance during 
the CPT was used to calculate the percent change in vascular resistance compared 
with baseline (20). After a 30 min break, the CPT was also performed in combination 
with the endothelium independent dilation. The CPT started 1 min after sublingual 
administration of nitroglycerine. Using this protocol we ensured that maximal 
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sympathetic stimulation (i.e., initial minutes of the CPT (40)) coincided with the 
maximal response of NTG (i.e., 3-6 min after administration (data not shown)). 
Day 4: Additional experiments. To assess the effect of the CPT and exercise bout on 
hemodynamics and sympathetic control, additional experiments were performed. 
Leg blood flow and vascular resistance, superficial femoral artery diameter, heart 
rate, and mean arterial pressure were measured before, during, and after a CPT. Leg 
blood flow was examined using venous occlusion plethysmography, while the 
diameter was simultaneously measured with an echo-Doppler machine. 
Subsequently, an incremental maximal test was performed to induce functional 
sympatholysis. To examine changes in the regulation of sympathetic control, a 
second CPT was performed within 3 min after cessation of the cycling exercise. 
Again, hemodynamics were recorded before, during, and after the post-exercise CPT. 
These additional experiments were extended in a sub-group of healthy young men 
(23 ± 3 years), who performed a CPT and an incremental maximal test as described 
above. To examine the duration of the local attenuation of the sympathetic system, 
leg blood flow (plethysmography) and vascular resistance were examined in 2 
subjects until 20 min post-exercise. To examine the localization of the attenuated 
sympathetic responsiveness, the two other subjects underwent a post-exercise CPT, 
while we simultaneously examined leg and forearm blood flow (plethysmography) 
and vascular resistance. In this sub-group of the present subjects, the CPT-induced 
change in leg vascular resistance has an acceptable coefficient of variation (CV) of 
13.7% (n=4). 
 
Measurements 
Resting diameter, FMD, and Nitroglycerine. Systolic and diastolic vessel diameters of 
the superficial femoral artery were measured with an echo Doppler device (Megas, 
ESAOTE, Firenze, Italy) with a 5 to 7.5 MHz broadband linear array transducer. 
Diameter images were made 3 cm distal to the bifurcation of the femoral artery. To 
measure resting diameter, two consecutive images in the longitudinal view were 
frozen at the peak systolic and end-diastolic phase. The mean diameter (D) was 
calculated by using the formula: 1/3⋅systolic diameter + 2/3⋅diastolic diameter. Before 
measurement of diameter images, from each artery, 4 images with a total of 12 
velocity profiles were obtained and manually traced afterwards by a single 
investigator. The average of these waveforms was used to calculate mean and peak 
blood flow (5). The angle of insonation for the velocity measurements was 
consistently at 60º, and the vessel area was adjusted parallel to the transducer. Mean 
blood flow (in ml⋅min-1) was calculated as 1/4⋅π(D)2⋅Vmean(cm⋅s-1)⋅60; peak blood 
flow (in ml⋅min-1) was calculated as 1/4⋅π(Ds)2⋅Vpeak(cm⋅s-1)⋅60; and mean wall shear 
rate (MWSR) was calculated as 4⋅Vmean/D (s). Post-occlusion diameters were 
obtained at 50, 60, 70, 90, 120, 180, and 240 s. Measurement of the post-NTG 
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diameters started 2 min after administration of sublingual NTG and the diameter was 
measured every 30 s for 6 min. FMD and NTG-response were expressed as the 
maximal relative diameter change in end-diastolic diameter from the baseline resting 
end-diastolic diameter. On Day 2, 15 min of post-exercise rest was not sufficient for 
the diameter to return to baseline level. Therefore, we used the baseline diameter of 
the FMD-response. The ratio between the relative FMD response (%FMD) and the 
primary stimulus for vessel dilation (mean wall shear rate; MWSR) was calculated. 
Delta MWSR (ΔMWSR) was defined as the difference between rest and peak 
response and was used to calculate the amount of vasodilation per stimulus during 
the FMD (21). This hyperemic velocity was recorded on videotape for the first 25 s 
after cuff release. The velocity profiles between 10-15 s after cuff release were 
analyzed by a single investigator. The average of these profiles was used to calculate 
the mean wall shear rate. 
Leg blood flow and vascular resistance. To measure leg blood flow and calculate 
vascular resistance during the CPT on Day 4, a 12 cm width cuff was placed 
proximally around the upper leg. The strain gauge was placed at mid-thigh, at least 
10 cm above the patella (37). The occlusion cuff was inflated, ECG-triggered and 
within one heart beat, to a cuff pressure of 50 mmHg (13). This pressure was 
sustained for 9 heart beats after which the cuff was instantaneously deflated (for 10 
heart beats). In our lab, this method to measure baseline leg blood flow 
(plethysmography) or vascular resistance is demonstrated to have a CV of 5.9 and 
8.3%, respectively (37). Data were digitalized with a sample frequency of 100 Hz 
(MIDAC, Instrumentation Department, Radboud University Nijmegen Medical 
Centre, The Netherlands) and analyzed by a customized computer program (Matlab, 
Mathworks Inc., USA). Blood flow (in ml⋅min-1⋅dl-1) was calculated as the slope of 
the volume change over a 4 s interval, starting directly after the cuff artifact (2 s). 
Mean arterial pressure (MAP) data of the Portapress were used to calculate vascular 
resistance (MAP/blood flow, in mmHg⋅ml-1⋅min-1⋅dl-1; arbitrary units (AU)).  
 
Statistical analysis 
The main goal of this study is to compare the FMD-responses between the different 
conditions. With a SD of 45% (16, 17), a relevant effect of the intervention of 50%, 
and an alpha of 0.05, we calculated that at least 8 subjects per group would be 
needed to achieve a power of 80%. Statistical analyses were performed using SPSS 
12.0 computer software (SPSS Inc., Chicago, Illinois, USA). The effect of the 3 
different sympathetic conditions on the FMD (dependent variable) in both groups 
(independent variable) was evaluated by a two-way ANOVA for repeated 
measurements. Differences were subsequently analyzed with the Least Squares 
difference post-hoc test. A Student’s t-test for independent groups was used to 
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examine differences in physical characteristics between the young and older men. 
Data are presented as means ± SD. Level of statistical significance was set at α=0.05. 
 
  
 
Results 
 
Physical characteristics. Table 1 shows the physical characteristics of both study 
populations. Systolic and diastolic blood pressure, body mass, and body fat were 
significantly higher in older men. Maximum oxygen uptake in older men was 
significantly lower than in young men. 
 
 
Table 2. Supine resting characteristics.  
 
 Young (n=10)  Older (n=8) 
Variable Baseline Exercise CPT Baseline Exercise CPT 
MAP, mmHg 86 ± 6 86 ± 4 88 ± 7 101 ± 10 98 ± 8 98 ± 8 
Heart rate, bpm 61 ± 8 61 ± 9 61 ± 5 66 ± 9 66 ± 7 66 ± 8 
Femoral BF, ml⋅min-1 95 ± 57 91 ± 34 74 ± 26 87 ± 40 129 ± 63 94 ± 42 
Femoral D, mm 7.4 ± 0.3 7.6 ± 0.4*† 7.4 ± 0.4 8.5 ± 0.6 8.5 ± 0.6 8.5 ± 0.7 
Values are means ± SD. * Significantly different from Baseline at P<0.05 (Student’s t-test). † 
Significantly different from CPT at P<0.05 (Student’s t-test) (CPT; cold pressor test, MAP; mean 
arterial pressure, BF; blood flow, D; diameter).    
 
 
 
Young men (Day 1-3) 
In young men, the resting diameter of the superficial femoral artery prior to the 
exercise bout was significantly higher compared to the resting diameters prior to 
measurement of the baseline (P=0.01) and CPT-FMD (P=0.002). Resting blood flow, 
heart rate, and mean arterial pressure were not different among the 3 days (table 2).  
The baseline FMD of the superficial femoral artery in young men was not different 
from the FMD during the CPT or from the post-exercise FMD (table 3). Also after 
correction for the eliciting stimulus (ΔMWSR), the FMD was not different among 
baseline condition, during the CPT, and post-exercise (figure 3). Due to nausea, post-
exercise nitroglycerin (NTG) response in one subject was not measured. The NTG 
response was not different among the 3 conditions (table 3). 
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Table 3. Flow mediated dilation and nitroglycerine-response in young men (n=10).  
 
 FMD  NTG  
Parameter Baseline Exercise CPT Baseline Exercise CPT 
Peak femoral BF, ml⋅min-1 1004 ± 251 1157 ± 154 1202 ± 242  -   -   -  
Peak femoral MWSR, s-1 205 ± 55 220 ± 34 247 ± 54  -   -   -  
Peak femoral D, mm 8.0 ± 0.4 8.0 ± 0.5 8.0 ± 0.4 8.3 ± 0.3 8.4 ± 0.5 8.4 ± 0.4 
Absolute change D, mm 0.55 ± 0.17 0.50 ± 0.20 0.63 ± 0.17 0.85 ± 0.71 0.80 ± 0.31 0.93 ± 0.21 
Relative change D, % 7.5 ± 2.4 6.6 ± 2.6 8.5 ± 2.5 10.9 ± 1.6* 10.5 ± 4.1 12.0 ± 2.7 
Maximal absolute (in mm) and relative (in %) change in diameter after occlusion and after 
nitroglycerine, values are means ± SD. *Different from Baseline FMD at P=0.002 (BF; blood 
flow, MWSR; mean wall shear rate, D; diameter, CPT; cold pressor test). 
 
 
 
Older men (Day 1-3) 
Resting characteristics of the superficial femoral artery prior to the FMD were not 
different among the 3 conditions (table 2). The uncorrected and shear rate-corrected 
FMD and NTG-response in older men was significantly lower compared with the 
young men (t-test; P=0.001, P=0.04, and P=0.02, respectively). 
The FMD-response of the superficial femoral artery showed significant differences 
among the three conditions (baseline, CPT, and post-exercise) (table 4). Post-hoc 
analysis revealed that the post-exercise FMD was significantly higher compared with 
baseline FMD and CPT FMD (table 4). Correction for the eliciting stimulus (ΔMWSR) 
showed similar results (figure 3). The NTG response was not different among the 
three conditions (table 4).  
 
 
Table 4. Flow mediated dilation and nitroglycerine-response in older men (n=8).  
 
 FMD  NTG 
Parameter Baseline Exercise CPT Baseline Exercise CPT 
Peak femoral BF, ml⋅min-11160 ± 165 1039 ± 126 1193 ± 177  -   -    -  
Peak femoral MWSR, s-1 157 ± 31 145 ± 35 167 ± 51  -   -    -  
Peak femoral D, mm 8.8 ± 0.8 8.9 ± 0.8 8.8 ± 0.7 9.1 ± 0.8 9.2 ± 0.8 9.1 ± 0.9 
Absolute change D, mm 0.30 ± 0.18 0.42 ± 0.25 0.22 ± 0.11 0.74 ± 0.18 0.67 ± 0.21 0.70 ± 0.26 
Relative change D, % 3.4 ± 1.8 4.8 ± 2.5*† 2.5 ± 1.3 8.8 ± 1.9‡ 7.9 ± 2.2 8.3 ± 2.8 
Maximal absolute (in mm) and relative (in %) change in diameter is indicated during the post-
occlusive period and after administration of nitroglycerine, values are means ± SD. * 
Significantly different from Baseline at P=0.004 (t-test), † Significantly different from CPT at 
P=0.03 (t-test), ‡ Significantly different from Baseline FMD at P<0.001 (t-test). (BF; blood flow, 
MWSR; mean wall shear rate, D; diameter, CPT; cold pressor test) 
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Figure 2. Vascular responses to the cold pressor test (CPT) and to the post-exercise CPT 
(Exercise + CPT) in young (open circles) and older men (solid circles). Values are mean ± SE. * 
P<0.05 between pre- and post-CPT. † P<0.001 between pre- and post-CPT. ‡ P<0.05 between 
pre-training and post-exercise.  
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Maximal cycling test (Day 4): After cessation of the exercise bout, arterial pressure in 
young men was significantly decreased, whereas older men showed no change in 
arterial pressure compared with pre-exercise values (figure 2). The post-exercise CPT 
showed no change in vascular resistance, heart rate, and mean arterial pressure in 
both groups (figure 2). This suggests a post-exercise local attenuation of the 
sympathetic responsiveness in the leg.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Flow-mediated dilation of the superficial femoral artery in young and older men 
after correction for the eliciting stimulus (FMD/ΔMWSR). Results are presented for baseline 
(‘baseline’), after an exercise bout (‘exercise’), and during the cold pressor test (‘CPT’). Values 
are mean ± SE. Differences in FMD-responses to the 3 different conditions between young and 
older men were assessed using a 2-way RM ANOVA. Differences within each group were 
analyzed using a 1-way RM-ANOVA with post-hoc analysis. * Post-hoc significantly different 
from baseline (P=0.02), † Post-hoc significantly different from CPT (P=0.02). 
 
 
 
Cold pressor test (Day 4): Due to technical problems, one subject from the older 
group was not included in the analysis. Leg vascular resistance increased 
significantly during the CPT in young (P<0.001), as well as in older men (P=0.01, 
figure 2A). Heart rate did not change, whereas mean arterial pressure significantly 
increased, suggesting sympathetic stimulation in both groups (figure 2B,C). 
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Superficial femoral arterial diameter did not change during the CPT in young as well 
as older men (ANOVA: P=0.38 and 0.27, respectively). Also in the sub-group of 2 
healthy young men, the CPT-induced increase in leg vascular resistance was 
attenuated after exercise (preexercise: 130 ± 63%, postexercise: 11 ± 1%). 
Interestingly, these subjects demonstrate a similar relative change in forearm vascular 
resistance between pre- and post-exercise CPT (preexercise: 211 ± 82%, 
postexercise: 261 ± 63%). In addition, the other 2 subjects showed a markedly lower 
leg vascular resistance during the FMD time-window (6-8 AU) compared with 
baseline (16 ± 4 AU). This suggests that the exercise bout attenuates the constrictor 
response in the leg but not in the (non-active) forearm during the time-window in 
which we examine the FMD-response. 
 
 
 
Discussion   
 
This study examined the effects of acute stimulation and attenuation of the 
sympathetic responses on the superficial femoral artery FMD in young and older 
men. Our results demonstrate an impaired FMD of the superficial femoral artery with 
advancing age. Interestingly, local exercise-induced attenuation of the sympathetic 
responsiveness in older men was able to restore the post-exercise FMD-response, 
whereas activation of the sympathetic nervous system by a CPT had no effect on the 
FMD in older men. This suggests that the age-related decrease in FMD of the 
superficial femoral artery can at least in part be explained by an increase in 
sympathetic nerve activity, and does not necessarily reflect an attenuated NO 
bioavailability. In healthy young men, acute changes in the sympathetic activity do 
not influence the FMD-response of the superficial femoral artery.  
 
Unique in this study is the application of the CPT and the maximal exercise test, 
which stimulates or reduces, respectively, the responsiveness of the sympathetic 
nervous system to examine the effect on the FMD. The non-invasive nature of these 
interventions is an important advantage. Since these interventions have not been 
used before in this setting, some aspects of our approach should be discussed. First, 
plasma norepinephrine or muscle sympathetic nerve activity were not assessed in the 
current study. Yet, we are confident that the CPT effectively increased sympathetic 
activity, since this has been described in previous studies (22, 24) and because the 
CPT markedly elevated arterial blood pressure in both groups, comparable with 
previous studies (9, 23). This pressor effect is primarily induced by a sympathetic 
vasoconstriction response as demonstrated by the elevated leg vascular tone.  
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Second, to assess whether the maximal exercise bout successfully reduced local 
sympathetic responsiveness in the legs during assessment of the FMD, we quantified 
the post-exercise CPT-response in the time-window of the FMD. In contrast to the 
marked increase in leg peripheral resistance during the pre-exercise CPT, no change 
in leg vascular resistance was observed after maximal exercise. The lack of changes 
in leg vascular tone suggests successful attenuation of the sympathetic responsiveness 
in the legs after maximal cycling exercise. Regarding the physiological underlying 
mechanism, one may hypothesize that a part of this mechanism is in accordance 
with the mechanism as suggested for the exercise-induced hypotension. Halliwill et 
al. (14) demonstrated that the post-exercise hypotension is partly mediated through a 
vascular component (less vasoconstriction with any increase in sympathetic activity). 
Third, the dramatically elevated post-exercise oxygen demand of the leg muscles 
could alter post-occlusive shear rate stimulus, which is the primary trigger for the 
flow-mediated dilation response (21). As such, we adjusted the duration of the post-
exercise leg arterial occlusion (using 5 min instead of 10 min occlusion) and 
achieved a similar shear rate stimulus after exercise compared to baseline FMD or 
CPT-FMD in both groups (table 3-4). Nevertheless, FMD responses were also 
analyzed after correction for the main vasodilating stimulus, i.e. mean wall shear rate 
(21). 
Finally, changes in responsiveness or bioavailability of NO may lead to changes in 
FMD responses during acute stimulation or reduction. The response to exogenous 
NO of the superficial femoral artery in young and older men does not differ among 
baseline, post-exercise, or CPT conditions. Although post-exercise timing of the FMD 
and NTG-responses was not similar, our results suggest that the response of the 
superficial femoral artery to exogenous NO is independent of sympathetic nerve 
activity, which is in agreement with a previous study of Hijmering et al. (2002) 
reporting no effect of sympathetic stimulation on brachial dilation to exogenous NO. 
 
FMD after local attenuation of sympathetic responsiveness  
Our results demonstrate a significantly lower FMD of the superficial femoral artery in 
older men compared with healthy young men. This difference between young and 
older men may be explained by an attenuated NO-bioavailability with aging or by 
the age-related changes in the regulation of the sympathetic nervous system in the 
legs. Dinneno et al. (7) indicated in an elegant study that the reduction in basal limb 
blood flow with human aging is mediated largely by an augmented sympathetic α-
adrenergic vasoconstriction. The age-related increase in sympathetic nerve activity 
(29) may also attenuate the FMD-response in older men. Parallel to our hypothesis, 
local blunting of the sympathetic responsiveness through exercise in older men 
increased the corrected FMD-response towards normal values in healthy controls 
(%FMD/ΔMWSR) (figure 3). Moreover, a significant negative correlation is reported 
                       Sympathetic nervous system contributes to age-related change in FMD 
 69 
between the 3 different conditions of sympathetic nerve activity (exercise, baseline, 
and CPT) and the FMD-response in older men (figure 4B). These results suggest that 
the impaired FMD of the superficial femoral artery in older men may partly be 
explained by age-related elevation of the sympathetic nerve activity. Our findings are 
in agreement with Harvey et al. (16). They reported a significant increase in the post-
exercise FMD of the brachial artery in post-menopausal women, while young pre-
menopausal women showed no change after exercise.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Individual results of the flow-mediated dilation (FMD) of the superficial femoral 
artery in young (A) and older men (B). The FMD response is represented during baseline 
(‘baseline’), after an exercise bout (‘exercise’), and during the cold pressor test (‘CPT’). Data of 
the 3 different conditions are presented with an increasing level of sympathetic stimulation. 
Spearman’s Rho correlation is presented for the level of sympathetic stimulation and FMD-
response in both groups.  
 
 
 
Strenuous exercise does not singularly lead to local sympatholysis, several other 
mechanisms occur, such as the release of vasoactive substances (18). One may argue 
that synthesis of these substances explains the enhanced post-exercise FMD in older 
men. However, this exercise-induced release of vasoactive substances is present in 
young as well as older men, while only older men showed a significant increase in 
FMD. In addition, post-exercise blood lactate levels, one of the vasoactive substances 
released during exercise, in young men were nearly doubled compared with older 
men (table 1). This may suggest that the release of vasoactive substances in young 
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men is at least equal compared to older men. However, since we did not examine 
changes in vasoactive substances, we cannot exclude the possibility that a difference 
in bioavailability of vasoactive substances between young and older men explain our 
results. 
Whereas local sympatholysis in older men restored the FMD-response, young men 
report no change. One may speculate about a possible ‘ceiling effect’ of the FMD in 
healthy young men; the higher FMD-response would be difficult to increase any 
further. However, we compared a subpopulation of the older men with the highest 
FMD-values (n=4) with a subset of the young men (n=4) with matched FMD-values. 
The older men showed an increase in FMD-response during the post-exercise FMD. 
In contrast, 2 young men demonstrated a decreased FMD-response, while the other 2 
showed an increased FMD-response. As such, this argues against a possible ‘ceiling 
effect’ in young men in our study.  
 
FMD after sympathetic stimulation 
In contrast with previous studies in the brachial artery (9, 15, 17, 23), we reported 
that acute stimulation of the sympathetic nervous system, using the CPT, did not alter 
the FMD response of the superficial femoral artery in the young as well as older men. 
To date, evidence is increasing that forearm and leg vasculature show different 
responses to similar stimuli (27, 28, 30, 31). Whether a limb difference may explain 
our findings can be questioned. Therefore, in a subpopulation of the young men from 
our study (n=6) we measured the FMD of the brachial artery with and without the 
CPT. Similar to previous studies in the brachial artery (9, 17, 23), we found that the 
brachial artery FMD decreased significantly during sympathetic stimulation 
(FMD/ΔMWSR 0.024 ± 0.003, CPT: FMD/ΔMWSR 0.014 ± 0.003, t-test: P=0.03). 
These results suggest that limb differences (either in the response to the CPT or in the 
sensitivity of the FMD for sympathetic stimulation) may account for different FMD 
responses of the brachial and femoral artery during acute sympathetic stimulation in 
the subgroup of young men. This interesting finding should be extended by future 
research. 
Whereas local sympatholysis in older men restores the FMD-response, stimulation 
did not significantly decrease the FMD. However, a negative correlation is present 
between the level of sympathetic nerve stimulation and FMD-response. In addition, 
sub-analysis of the older men with the highest baseline FMD all showed a decrease 
of the FMD-response during the CPT. Apparently, the already impaired FMD, which 
makes a further decrease more difficult, may explain why the decrease in FMD after 
CPT in older men did not reach statistical significance. Although our data may 
suggest that baseline FMD is a determinant of the increase in post-exercise FMD. 
However, when we correct for age-effects, we did not find a significant correlation 
(r=0.40, P=0.11). 
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Limitations. The timing of the CPT related to the FMD and NTG may be an important 
determinant of the overall effect on the FMD. In previous studies, the CPT started 7 
(9) or 4 min before (23) cessation of the arterial occlusion cuff. Because maximal 
sympathetic activity is present during the first minutes of the CPT (40), we started the 
test 1 min before cuff release. This ensured that the peak sympathetic activity 
coincides with the maximal post-occlusive diameter.  
A second possible limitation of the study is the difference in resting diameters in the 
young men. Variation of this diameter, while the maximal diameter is unaltered, 
leads to different FMD-values. Prior to the exercise FMD, we found a pre-dilated 
diameter of the superficial femoral artery in young men compared to the resting 
diameters for baseline and CPT FMD. Although the absolute and relative diameter 
increase during the post-exercise FMD in young men was lower than baseline and 
CPT FMD, this was not statistically significant. Moreover, the maximal absolute 
diameters during FMD were not different among the 3 days (table 3). Therefore, the 
larger resting diameter in young men prior to the exercise test did not alter the major 
outcomes of our study. 
A CPT normally provides a strong general sympathetic stimulus leading to a 
generalized increase in vascular tone. Our additional experiments showed that a 
post-exercise CPT leads to a local attenuated vascular response in the thigh, but not 
the forearm in young men. We were not able to proof that these responses are 
sympathetically mediated and/or age-dependent, although there is no compelling 
reason to suspect otherwise. In addition, one of our subjects may be diagnosed as 
borderline hypertensive (resting systolic blood pressure varied between 140-145 
mmHg). This may have some implications for our findings, since we were interested 
in physiological aging. Based on the minimal increase in systolic blood pressure, we 
argue that this has not importantly influenced our results.  
 
Clinical relevance. In a recent interesting point-counterpoint, it was argued whether 
the brachial artery FMD represents NO-mediated endothelial function (12) or if also 
the sympathetic nervous system influences the FMD-response (38). The results of our 
study indicate that decreased FMD-response of the superficial femoral artery in older 
men does not necessarily reflect an impaired NO bioavailability, but might in part be 
explained by an increase in sympathetic nerve activity. This indicates that the 
sympathetic nervous system also influences the superficial femoral artery FMD, at 
least in older men. Parallel to our findings, a recent paper of Harvey et al. (16) 
demonstrated an increased post-exercise FMD in the brachial artery in older women. 
These findings should be kept in mind interpreting the FMD, especially in subjects 
with an elevated activity of the sympathetic nervous system.  
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In conclusion, we have demonstrated that older men had an impaired FMD-response 
of the superficial femoral artery, which increased by local blunting of the 
sympathetic responsiveness, but remained unaltered during sympathetic activation. 
These data suggest that the lower FMD of the superficial femoral artery in older men 
can, at least in part, be explained by an elevated sympathetic nerve activity. In 
addition, in healthy young men the sympathetic nerve activity does not alter the 
FMD of the superficial femoral artery, whereas sympathetic activation using the CPT 
decreases the FMD of the brachial artery. Limb differences in vascular control may 
underlie these findings. 
 
 
Acknowledgements 
We would like to thank Thijs Eijsvogels, Marcia Tummers, Krista Franchimon, Linda 
Ooms, and Jos Evers for their help during the experiments. Furthermore, we would 
like to acknowledge Bregina Kersten for her excellent echo-Doppler measurements 
and analysis. 
 
 
 
References 
1. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, 
and Yeung AC. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 
26: 1235-1241, 1995. 
2. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, and Deanfield JE. Non-
invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340: 1111-1115., 1992. 
3. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, and Deanfield JE. Aging is associated 
with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 24: 471-476, 
1994. 
4. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, 
Gerhard-Herman M, Herrington D, Vallance P, Vita J, and Vogel R. Guidelines for the ultrasound assessment of 
endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery 
Reactivity Task Force. J Am Coll Cardiol 39: 257-265, 2002. 
5. de Groot PC, Poelkens F, Kooijman M, and Hopman MT. Preserved flow-mediated dilation in the inactive legs of spinal 
cord-injured individuals. Am J Physiol Heart Circ Physiol 287: H374-380, 2004. 
6. DeSouza CA, Shapiro LF, Clevenger CM, Dinenno FA, Monahan KD, Tanaka H, and Seals DR. Regular aerobic 
exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation 102: 
1351-1357., 2000. 
7. Dinenno FA, Tanaka H, Stauffer BL, and Seals DR. Reductions in basal limb blood flow and vascular conductance with 
human ageing: role for augmented alpha-adrenergic vasoconstriction. J Physiol 536: 977-983., 2001. 
8. Drexler H, Hayoz D, Munzel T, Hornig B, Just H, Brunner HR, and Zelis R. Endothelial function in chronic congestive 
heart failure. Am J Cardiol 69: 1596-1601, 1992. 
9. Dyson KS, Shoemaker JK, and Hughson RL. Effect of Acute Sympathetic Nervous System Activation on Flow-Mediated 
Dilation of the Brachial Artery. Am J Physiol Heart Circ Physiol, 2005. 
10. Fagius J, Karhuvaara S, and Sundlof G. The cold pressor test: effects on sympathetic nerve activity in human muscle and 
skin nerve fascicles. Acta Physiol Scand 137: 325-334, 1989. 
11. Ferguson DW, Berg WJ, and Sanders JS. Clinical and hemodynamic correlates of sympathetic nerve activity in normal 
humans and patients with heart failure: evidence from direct microneurographic recordings. J Am Coll Cardiol 16: 1125-
1134, 1990. 
12. Green D. Point: Flow-mediated dilation does reflect nitric oxide-mediated endothelial function. J Appl Physiol 99: 1233-
1234; discussion 1237-1238, 2005. 
                       Sympathetic nervous system contributes to age-related change in FMD 
 73 
13. Groothuis JT, van Vliet L, Kooijman M, and Hopman MT. Venous cuff pressures from 30 mmHg to diastolic pressure are 
recommended to measure arterial inflow by plethysmography. J Appl Physiol 95: 342-347, 2003. 
14. Halliwill JR, Taylor JA, and Eckberg DL. Impaired sympathetic vascular regulation in humans after acute dynamic 
exercise. J Physiol 495 ( Pt 1): 279-288, 1996. 
15. Harris CW, Edwards JL, Baruch A, Riley WA, Pusser BE, Rejeski WJ, and Herrington DM. Effects of mental stress on 
brachial artery flow-mediated vasodilation in healthy normal individuals. Am Heart J 139: 405-411, 2000. 
16. Harvey PJ, Morris BL, Kubo T, Picton PE, Su WS, Notarius CF, and Floras JS. Hemodynamic after-effects of acute 
dynamic exercise in sedentary normotensive postmenopausal women. J Hypertens 23: 285-292, 2005. 
17. Hijmering ML, Stroes ES, Olijhoek J, Hutten BA, Blankestijn PJ, and Rabelink TJ. Sympathetic activation markedly 
reduces endothelium-dependent, flow-mediated vasodilation. J Am Coll Cardiol 39: 683-688, 2002. 
18. Keller DM, Ogoh S, Greene S, Olivencia-Yurvati A, and Raven PB. Inhibition of KATP channel activity augments 
baroreflex-mediated vasoconstriction in exercising human skeletal muscle. J Physiol 561: 273-282, 2004. 
19. Koch DW, Leuenberger UA, and Proctor DN. Augmented leg vasoconstriction in dynamically exercising older men 
during acute sympathetic stimulation. J Physiol 551: 337-344, 2003. 
20. Kooijman M, Rongen GA, Smits P, and Hopman MT. Preserved alpha-adrenergic tone in the leg vascular bed of spinal 
cord-injured individuals. Circulation 108: 2361-2367, 2003. 
21. Levenson J, Pessana F, Gariepy J, Armentano R, and Simon A. Gender differences in wall shear-mediated brachial 
artery vasoconstriction and vasodilation. J Am Coll Cardiol 38: 1668-1674, 2001. 
22. Ligtenberg G, Blankestijn PJ, Oey PL, Wieneke GH, van Huffelen AC, and Koomans HA. Cold stress provokes 
sympathoinhibitory presyncope in healthy subjects and hemodialysis patients with low cardiac output. Circulation 95: 2271-
2276, 1997. 
23. Lind L, Johansson K, and Hall J. The effects of mental stress and the cold pressure test on flow-mediated vasodilation. 
Blood Press 11: 22-27, 2002. 
24. Mizushima T, Tajima F, Nakamura T, Yamamoto M, Lee KH, and Ogata H. Muscle sympathetic nerve activity during 
cold pressor test in patients with cerebrovascular accidents. Stroke 29: 607-612, 1998. 
25. Muller-Delp JM, Spier SA, Ramsey MW, and Delp MD. Aging impairs endothelium-dependent vasodilation in rat 
skeletal muscle arterioles. Am J Physiol Heart Circ Physiol 283: H1662-1672, 2002. 
26. Neunteufl T, Katzenschlager R, Hassan A, Klaar U, Schwarzacher S, Glogar D, Bauer P, and Weidinger F. Systemic 
endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis 129: 111-118, 1997. 
27. Newcomer SC, Leuenberger UA, Hogeman CS, Handly BD, and Proctor DN. Different vasodilator responses of human 
arms and legs. J Physiol 556: 1001-1011, 2004. 
28. Newcomer SC, Leuenberger UA, Hogeman CS, and Proctor DN. Heterogeneous vasodilator responses of human limbs: 
influence of age and habitual endurance training. Am J Physiol Heart Circ Physiol 289: H308-315, 2005. 
29. Ng AV, Callister R, Johnson DG, and Seals DR. Age and gender influence muscle sympathetic nerve activity at rest in 
healthy humans. Hypertension 21: 498-503, 1993. 
30. Pawelczyk JA and Levine BD. Heterogeneous responses of human limbs to infused adrenergic agonists: a gravitational 
effect? J Appl Physiol 92: 2105-2113, 2002. 
31. Proctor DN, Le KU, and Ridout SJ. Age and regional specificity of peak limb vascular conductance in men. J Appl Physiol 
98: 193-202, 2005. 
32. Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 22 Suppl 4: S1-
14, 1993. 
33. Seals DR and Dinenno FA. Collateral damage: cardiovascular consequences of chronic sympathetic activation with 
human aging. Am J Physiol Heart Circ Physiol 287: H1895-1905, 2004. 
34. Steinberg HO, Bayazeed B, Hook G, Johnson A, Cronin J, and Baron AD. Endothelial dysfunction is associated with 
cholesterol levels in the high normal range in humans. Circulation 96: 3287-3293, 1997. 
35. Taddei S, Galetta F, Virdis A, Ghiadoni L, Salvetti G, Franzoni F, Giusti C, and Salvetti A. Physical activity prevents 
age-related impairment in nitric oxide availability in elderly athletes. Circulation 101: 2896-2901, 2000. 
36. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo CB, Sudano I, and Salvetti A. Aging and endothelial 
function in normotensive subjects and patients with essential hypertension. Circulation 91: 1981-1987., 1995. 
37. Thijssen DH, Bleeker MW, Smits P, and Hopman MT. Reproducibility of blood flow and post-occlusive reactive 
hyperaemia as measured by venous occlusion plethysmography. Clin Sci (Lond) 108: 151-157, 2005. 
38. Tschakovsky ME and Pyke KE. Counterpoint: Flow-mediated dilation does not reflect nitric oxide-mediated endothelial 
function. J Appl Physiol 99: 1235-1237; discussion 1237-1238, 2005. 
39. Victor RG, Leimbach WN, Jr., Seals DR, Wallin BG, and Mark AL. Effects of the cold pressor test on muscle 
sympathetic nerve activity in humans. Hypertension 9: 429-436, 1987. 
40. Wolf SH, J.D. Studies on pain. Observations on pain due to local cooling and on factors involved in the cold pressor effect. 
J Clin Invest 20: 521-533, 1941. 
 
 
 
Chapter 3 
74 
 
 
Chapter 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4
 
Local vascular adaptations after
hybrid training in spinal cord-
injured subjects
 
 
 
Dick H.J. Thijssen
Petra Heesterbeek
Dirk J.M. van Kuppevelt
Jacques Duysens
Maria T.E. Hopman
 
 
 
 
 
Medicine & Science in Sports & Exercise, 2005, 37(7):1112-1118  
Chapter 4 
76 
 
 
 
 
 
 
 
 
 
 
Abstract 
 
Studies investigating vascular adaptations in non-exercised areas during whole body 
exercise training show conflicting results. Individuals with spinal cord injury (SCI) 
provide a unique model to examine vascular adaptations in active tissue versus 
adjacent inactive areas.  
Purpose. To assess the effects of 4 week voluntary arm and electrically stimulated leg 
exercise (8-12 sessions) on vascular adaptations in active areas (thigh and arms) and 
inactive areas (calf).  
Methods. Vascular characteristics were measured by plethysmography (blood flow 
and vascular resistance) and echo Doppler (diameter and flow-mediated dilation 
(FMD) after 13 min of ischemia). 
Results. After training, increased thigh baseline and peak blood flow, decreased 
thigh baseline vascular resistance, and increased diameter of the common femoral 
artery were found in the stimulated thigh tissue. Forearm and calf arterial parameters 
and FMD, in both superficial femoral artery and brachial artery, did not change. The 
lack of activity in the calf and concomitant insufficient elevation of blood flow during 
training, and the high initial training status of the arms are suggested to explain the 
absence of vascular adaptations in these areas. 
Conclusion. The presence of vascular adaptations after only 4 weeks of FES cycling 
indicates that adaptations occur in an early phase. In addition, 4 weeks of whole 
body exercise training in SCI individuals leads to vascular adaptations in the 
exercised tissues (thigh) but not in non-stimulated passive tissue (calf).  
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Introduction 
 
Spinal cord-injured (SCI) individuals suffer from dramatic vascular (3, 17, 28) and 
muscular (10) adaptations, which occur as a result of the lack of innervation below 
the level of the lesion. Several studies have shown that functional electrical 
stimulation (FES) results in adaptations in the stimulated area such as increased 
muscle mass (16, 26) and oxidative capacity (26), enhanced capillary supply (3), 
increased femoral artery diameter (28), and improved blood flow (11, 18). Whether 
adjacent areas can profit from such changes as well has been studied in control 
subjects and some type of patients, but results are conflicting. 
In healthy subjects as well as in heart failure patients, vascular adaptations have been 
found in non-exercised muscles after large muscle training. Marked forearm vascular 
and endothelial adaptations after leg exercise training were reported (4, 23, 25, 33), 
which seems to be mainly driven by systemic nitric oxide production (13). In 
contrast, 4 week daily unilateral handgrip training in patients with heart failure (19) 
or 10 weeks of aerobic leg exercise in patients with coronary artery disease (12) 
resulted in an improved endothelial function of the trained, but not of the non-
exercised tissue.  
In SCI individuals, no adaptations in the vascular bed of the non-exercised leg 
muscles were found after arm crank exercise training (27). One may argue that arm 
exercise does not elicit sufficient load to induce systemic effects, and therefore 
adding FES exercise of the legs to the arms is of particular interest. Previous studies 
assessed only vascular adaptations of the directly stimulated and not of the non-
stimulated areas (3, 11, 28). It is hypothesized that arterial vascular adaptations occur 
in active (arm and thigh) areas but not in the non-stimulated calf of SCI individuals. 
The purpose of this study, therefore, is to examine the effects of a 4 week whole body 
training program (arm and leg exercise) on arterial vascular adaptations in active 
(arm and thigh) and non-active (calf) areas in SCI individuals. This study may provide 
novel information about the localization of vascular adaptations after whole body 
exercise training. 
 
 
 
Methods 
 
Subjects 
Ten non-smoking spinal cord-injured (SCI) individuals, 9 men and 1 woman (age 39 
± 9 years, height 183 ± 5 cm), with no centrally mediated motor and sensor control 
of the legs participated in this study. All, except one subject (American Spinal Injury 
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Association (ASIA): C) had complete spinal cord lesion (ASIA: A). All lesions were of 
traumatic origin and existed for at least 1 year (table 1). All SCI individuals 
underwent a medical examination, which included a detailed physical and medical 
history, sensory-motor neurological examination, ECG, blood pressure 
measurements, and cardiac and pulmonary auscultation. None of the subjects had 
any cardiovascular diseases or used medication known to interfere with the 
cardiovascular system. The hospital ethics committee approved the study. All 
subjects gave their written informed consent before participation. Studies were 
performed according to the Declaration of Helsinki. 
 
 
Table 1. Characteristics of spinal cord-injured individuals  
 
Subject Gender Age,   
years 
Level of 
Injury
ASIA-
score
TSI, 
years
Exercise 
h/wk 
Medication 
1 M 43 T1 A 14 4 furadantin 
2 M 41 T9 A 19 0.5 omeprazo, ventolin, detrusitol, 
metamucil 
3 M 53 T10 A 13 5  
4 F 33 T6 A 11 6  
5 M 50 T6 A 20 4.5  
6 M 35 T6 A 12 10  
7 M 23 T5 A 3 4  
8 M 36 T4 A 8 5 microlax 
9 M 36 T2 A 7 4 detrusitol, lioresal 
10 M 42 T12 C 1 2 sirdalud, oxyputinine, baclofen
impostal 
(ASIA = American Spinal Injury Association, T = Thoracic, TSI = Time Since Injury) 
 
 
Hybrid training 
A stationary computer-controlled FES ergometer (BerkelBike BV, Nijmegen, The 
Netherlands) was used for hybrid FES cycling exercise; including stimulated 
asynchronous leg cycling and voluntary synchronous arm cranking. The FES 
ergometer provides stimulation via surface electrodes (5x8 cm, Farmadomo, Nuland, 
The Netherlands) placed bilaterally over the hamstring, gluteal, and quadriceps 
muscles. Each training session started with a warming-up of 5 min with arm activity 
only. Thereafter, stimulation of the thigh and gluteal muscles started with 50 mA. 
Intensity of stimulation was manually increased with steps of 10 mA to a maximum 
of 150 mA. Stimulation was increased based on a decrease in power output, which 
indicates fatigue of the stimulated muscle groups. SCI individuals trained ~30 min 
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with stimulation. All subjects trained 2-3 times a week under supervision of a 
researcher for 4 weeks.  
 
Protocol and testing procedure 
Subjects were tested before and directly after the training period. After a 12 h 
overnight fast, experiments were performed in the morning. Subjects refrained from 
caffeine, nicotine, chocolate, kiwi, vitamin C supplements, and alcohol for at least 
18 h before the test. Room temperature was controlled at 23 ± 1°C. Subjects emptied 
their bladder in the last 1.5 h before the test to minimize the possibility of any 
sympathetic activity from bladder filling on the peripheral vascular tone. Subjects 
were positioned comfortably on a bed in the supine position with a slight elevation 
of the head. During an acclimatization period of 30 min supine rest, strain gauges 
and venous occlusion cuffs were positioned. The right arm was positioned ~5 cm 
above heart level. A cuff (10 cm) was placed around the right upper arm and was 
connected to a rapid cuff inflator (Hokanson Inc., Bellevue, WA, USA). A mercury-
in-silastic strain gauge (Hokanson Inc., Bellevue, WA, USA) was placed at the widest 
girth of the forearm. To minimize the contribution of hand skin blood flow, one 
minute before as well as during baseline blood flow measurement the hand 
circulation was excluded by inflating a pediatric cuff around the wrist to 220 mmHg. 
To measure thigh characteristics, a cuff (12 cm) was placed proximally around the 
upper leg, ~5 cm below the inguinal ligament (35). Both legs were elevated and the 
lower legs rested on a 14 cm high platform. The strain gauges were placed at mid-
thigh, at least 10 cm above the patella and at least 4 cm below the cuff. Calf 
properties were assessed with both heels resting on a 20 cm high platform and legs 
were supported at the level of the lateral thigh in order to relax the calf muscles. A 
cuff (12 cm) was placed distally around the upper leg, ~3 cm above the patella. 
Strain gauges were applied to the widest girth of the calf (35). 
Physical and muscular training effects. Physical fitness was assessed by an 
incremental maximal exercise-test on an arm ergometer (Lode, Angio300, 
Groningen, the Netherlands) using a multistage protocol (workload increased by 10 
W per minute, starting at 10 W, until exhaustion). Muscular training effects were 
measured as resistance to fatigue of the quadriceps muscle by activating this muscle 
repetitively for 2 min using 30 Hz stimulation trains of 1 s duration every 2 s at an 
intensity of 125 mA (10). Isometric contractions of the (right) knee extensors were 
obtained while subjects were seated upright with the knee angle fixed at 120°. 
Contractions were generated using a high voltage constant current stimulator (model 
DS7A, Digitimer Limited, Hertfordshire, UK), delivering electrical pulses to surface 
electrodes (8x13 cm, Schwa-Medico, Ehringshausen, Germany) positioned at fixed 
places over the anterior thigh. Forces were recorded using a force transducer 
connected 26 cm below the patella.  
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Vascular parameters. Baseline blood flow of the forearm, calf, and thigh were 
measured unilateral (at the right side) for 5 min using venous occlusion 
plethysmography. A cuff was inflated, ECG-triggered and within one heart beat, to a 
cuff pressure of 50 mmHg (15). This pressure was sustained for 9 heart beats after 
which the cuff was instantaneously deflated (for 10 heart beats). Before each blood 
flow measurement, blood pressure was measured auscultatory at the left brachial 
artery using a sphygmomanometer, and mean arterial pressure (MAP) was calculated. 
MAP was used for calculation of the baseline vascular resistance (MAP/blood flow, in 
mmHg⋅ml⋅min-1⋅dl-1; arbitrary units (AU)) and vascular conductance (blood 
flow/MAP, in ml⋅min-1⋅dl-1⋅mmHg; arbitrary units (AU)). 
Post-occlusive reactive hyperemia was produced by 13 min of unilateral (right side) 
arterial occlusion, achieved by a suprasystolic cuff pressure of 220 mmHg (32). The 
highest value of the blood flow measurements was accepted as the peak flow. Before 
cessation of the occlusion cuff, blood pressure was measured auscultatory at the left 
brachial artery. MAP was used to calculate the post-ischemic minimal vascular 
resistance and peak vascular conductance (35).  
Diameter and Flow Mediated Dilation. Systolic and diastolic vessel diameter of each 
artery was measured with an echo Doppler device (Megas, ESAOTE, Firenze, Italy) 
with a 5 to 7.5 MHz broadband linear array transducer. For the common femoral 
artery images were made 2 cm proximal of the bifurcation. Superficial femoral artery 
images were made 3 cm distal of the bifurcation and brachial images were obtained 
3 cm proximal of the olecranon process. The flow-mediated dilation (FMD) of the 
brachial and superficial femoral artery, representing endothelial function (2), was 
assessed after 13 min of ischemia. This protocol results in maximal reactive 
hyperemia (32); the eliciting stimulus for FMD (22). After cuff deflation, diameter was 
videotaped for 4 min to assess the maximal endothelium dependent dilation of the 
artery off-line. In addition, a single spray of sublingual nitroglycerin (400 μg), a nitric 
oxide donor, was administered to determine the maximal endothelium independent 
vasodilation of the superficial femoral artery (5), which is indicative for smooth 
muscle function. 
 
Data analysis 
Physical and muscular training effects. Maximal (VO2max) and resting (VO2rest) 
oxygen consumption were measured with a gas-analyzer (Jaeger Benelux BV, Breda, 
the Netherlands) and averaged over 30 s intervals. VO2rest was assessed prior to the 
test and VO2max was determined as the mean of the last minute of the maximal 
exercise test. Local muscle fatigue after repetitive electrical stimulation was analyzed 
as the remaining force at 1 and 2 min expressed as a percentage of the pre-test force-
value (100%).  
Training and detraining in spinal cord injury 
   81 
Vascular parameters. Plethysmographic data were digitalized with a sample 
frequency of 100 Hz (MIDAC, Instrumentation Department, Radboud University 
Nijmegen Medical Centre, The Netherlands) and analyzed by a customized 
computer program (Matlab, Mathworks Inc., USA). Blood flow (in ml⋅min-1⋅dl-1) was 
calculated as the slope of the volume change over a 4 s interval, starting directly after 
the inflation-induced cuff artefact (calf, forearm; 1 s, thigh; 2 s). 
Peak blood flow after occlusion (in ml⋅min-1⋅dl-1) was calculated from the slope of 
the volume change over a 1 s interval. Analysis started after the cuff inflation artefact 
(forearm and calf; 0.5 s, thigh; 1.5 s). The highest value after release of the cuff 
pressure was accepted as the peak blood flow. Post-ischemic minimal vascular 
resistance was calculated from the highest blood flow and the corresponding MAP. 
Diameter and Flow-mediated Dilation. To measure resting diameter, two consecutive 
images in the longitudinal view were frozen at the peak systolic and end-diastolic 
phase. Off-line, 3 measurements were performed per diameter image, and the mean 
diameter (D) was calculated by using the formula: 1/3⋅systolic diameter + 
2/3⋅diastolic diameter. Vessel diameters of the brachial and superficial femoral artery 
during the FMD were measured off-line from videotape at 50, 60, 70, 90, 120, 180, 
and 240 s after cuff release and at 120, 180, 200, 220, 240, and 300 s after 
sublingual nitroglycerine administration. FMD and the nitroglycerin-response were 
expressed as the maximal absolute (mm) and relative (%) diameter change in end-
diastolic baseline diameter. The ratio between the relative FMD response (%FMD) 
and the primary stimulus for vessel dilation (mean wall shear rate; MWSR) was 
calculated. Regional MWSR was calculated as (4⋅Vmean/D)(s–1). Delta MWSR 
(ΔMWSR) was defined as the difference between rest and peak response and was 
used to calculate the amount of vasodilation per stimulus during the FMD (22). 
 
Statistical analysis 
Statistical analyses were performed using SPSS 12.0 computer software (SPSS Inc., 
Chicago, Illinois, USA). A Student’s t-test for dependent groups was used to assess 
differences before and after 4 weeks of training. Data are presented as means ± SD. 
The level of statistical significance was set at α=0.05. 
 
 
 
Results  
 
Four weeks of hybrid FES training did not result in changes in body mass, blood 
pressure, forearm circumference, and lower leg volume (table 2). Thigh (pre; 24.9 ± 
0.6 °C, post; 24.9 ± 0.6 °C, P=0.36), calf (pre; 24.6 ± 0.6 °C, post; 24.5 ± 0.8 °C, 
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P=0.37), and forearm (pre; 25.3 ± 0.6 °C, post; 25.3 ± 0.8 °C, P=0.79) resting 
temperature were not different pre versus post-training. Thigh volume was increased 
after the training period (P=0.047). The incomplete motor and sensor lesion (ASIA C) 
in subject 10 did not lead to deviating results. 
 
General and muscular training parameters. Maximal workload (P=0.01) and VO2max 
(P=0.02) were significantly higher after 4 weeks of training. VO2rest did not change by 
training (table 2). Pre-training, relative force declined to 26 ± 11% at the end of the 2 
min of quadriceps stimulation. After training, relative force decreased significantly 
less to 36 ± 10% after 2 min of stimulation (P=0.002, table 2).  
 
Vascular parameters. Baseline thigh blood flow increased from 2.3 ± 0.8 to 3.3 ± 1.2 
ml⋅min-1⋅dl-1 (P=0.004) and thigh baseline vascular resistance and vascular 
conductance changed significantly after 4 weeks of training (table 3). No differences 
in baseline blood flow, vascular resistance, and vascular conductance of the forearm 
and calf were found between pre- and post-training (table 3). 
 
 
Table 2. Anthropometry and physical fitness from pre- and post-training (4 weeks training).  
 
 Pre-training (n=10) Post-training (n=10) P-value 
Body mass, kg 73 ± 13 73 ± 12 0.77 
Diastolic blood pressure, mmHg 73 ± 14 68 ± 12 0.23 
Systolic blood pressure, mmHg 123 ± 18 119 ± 17 0.17 
Forearm circumference, cm 28.3 ± 1.9 28.4 ± 2.2 0.26 
Thigh volume right, l* 4.7 ± 0.6 5.1 ± 0.7 0.047 
Lower leg volume right, l* 2.8 ± 0.5 2.7 ± 0.5 0.31 
 
Incremental maximum test 
   
  VO2rest, l⋅min-1 0.31 ± 0.06 0.32 ± 0.05 0.51 
  VO2max, l⋅min-1 1.47 ± 0.55 1.56 ± 0.55 0.02 
  Maximal workload, W 95 ± 38 101.5 ± 38 0.01 
 
Resistance-to-Fatigue 
   
  Remaining force after 1 min, % 63 ± 13 72 ± 10 0.002 
  Remaining force after 2 min, % 26 ± 10 36 ± 10 0.002 
Data are presented as means ± SD (VO2rest=resting oxygen consumption, VO2max=maximal 
oxygen consumption). *Measurement according to Jones et al. (20). 
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Thigh peak blood flow and vascular conductance were significantly higher post-
training (P=0.049 and 0.02, respectively). Thigh minimal vascular resistance, as well 
as calf and forearm minimal vascular resistance, vascular conductance, and peak 
blood flow were not different between pre- and post-training (table 3). 
 
 
Table 3. Vascular data of the thigh, calf, and forearm before and after 4 weeks training.  
 
 Pre-training (n=10) Post-training (n=10) P-value 
Thigh  
Baseline BF, ml⋅min-1⋅dl-1 2.3 ±
 
0.8 3.3 ±
 
1.2 
 
0.004 
Baseline VR, AU 44 ± 19 30 ± 10 0.01 
Baseline VC, AU 0.027 ± 0.011 0.039 ± 0.014 0.002 
PORH, ml⋅min-1⋅dl-1 14.6 ± 2.0 17.1 ± 3.8 0.049 
Post-Ischemic VR, AU 6.9 ± 1.2 5.8 ± 1.6 0.06 
Post-Ischemic VC, AU 0.15 ± 0.03 0.19 ± 0.06 0.02 
 
Calf 
   
Baseline BF, ml⋅min-1⋅dl-1 3.1 ± 1.6 3.4 ± 1.5 0.58 
Baseline VR, AU 37 ± 17 28 ± 10 0.13 
Baseline VC, AU 0.037 ± 0.021 0.042 ± 0.016 0.30 
PORH, ml⋅min-1⋅dl-1 21.2 ± 5.0 20.4 ± 4.4 0.63 
Post-Ischemic VR, AU 5.2 ± 1.8 4.5 ± 1.0 0.47 
Post-Ischemic VC, AU 0.22 ± 0.06 0.24 ± 0.06 0.78 
 
Forearm 
   
Baseline BF, ml⋅min-1⋅dl-1 2.1 ± 0.8 2.7 ± 1.2 0.10 
Baseline VR, AU 51 ± 25 37 ± 17 0.11 
Baseline VC, AU 0.023 ± 0.012 0.033 ± 0.014 0.06 
PORH, ml⋅min-1⋅dl-1 22.0 ± 8.8 20.9 ± 6.0 0.71 
Post-Ischemic VR, AU 4.1 ± 1.7 5.0 ± 1.6 0.14 
Post-Ischemic VC, AU 0.26 ± 0.08 0.24 ± 0.07 0.13 
P-values represents the Student’s t-test. Data are presented as means ± SD (AU; arbitrary units, 
BF; blood flow, VR; vascular resistance, VC; vascular conductance, PORH; post-occlusive 
reactive hyperemia) 
 
 
 
Diameter and Flow Mediated Dilation. The resting diameter of the common femoral 
artery was significantly increased by training (P=0.02). No differences in resting 
diameter were found for the superficial femoral artery (P=0.08) and brachial artery 
(P=0.57) between pre- and post-training (figure 1). 
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Figure 1. Resting diameter (mm) of the common femoral artery (CFA), superficial femoral 
artery (SFA) and brachial artery (BA) before (pre-training) and after 4 weeks (post-training) of 
training. Error bars represent the SE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Maximal absolute (A; in mm) and relative (B; in %) change during the flow-mediated 
dilation (FMD) of the superficial femoral artery (SFA) and brachial artery (BA) and the 
nitroglycerine (NTG)-response of the SFA are represented. Error bars represent the SE. 
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The absolute (figure 2A) and relative (figure 2B) FMD in the superficial femoral artery 
(P=0.06 and 0.10, respectively) and brachial artery (P=0.48 and 0.68, respectively) 
were not altered by training. The absolute and relative nitroglycerine-response 
showed no change post- versus pre-training (P=0.53 and 0.99, respectively). In 
addition, after correction for the dilating stimulus of the hyperemic response 
(%FMD/ΔMWSR) in the superficial femoral artery, results were not changed pre 
versus post-training (pre; 0.070 ± 0.046, post; 0.083 ± 0.031, P=0.44). Due to 
technical problems, the hyperemic response of the brachial artery was not measured 
in 5 subjects. Therefore, no correction of FMD for the stimulus in the brachial artery 
was performed. 
 
 
 
Discussion 
 
The main finding of the present study is that 4 weeks whole body exercise training in 
SCI individuals results in local vascular adaptations in the stimulated areas (thigh) but 
not in the non-stimulated, adjacent passive areas (calf) or tissues with a high initial 
training status (forearm).  
 
The improved VO2max and increased muscular resistance to fatigue of the quadriceps 
muscle indicate the effectiveness of our 4 weeks hybrid training in SCI individuals. 
The relatively small increase in VO2max in the present study most likely results from 
the high pre-training activity level of the SCI individuals, indicated by a high pre-
training VO2max (1.47 l⋅min-1) compared with most previous studies (1.20-1.35 l⋅min-
1) (16, 26). In addition, the improvement of quadriceps muscle fatigability (+38%) 
after only 4 weeks of training is in line with earlier studies using 6 weeks of FES 
training (10).  
 
Vascular parameters 
Pre-training values of the vascular parameters correspond with results of previous 
studies on SCI individuals (11, 18, 34). Studies assessing leg blood flow after FES 
cycling, using plethysmography (18) or echo-Doppler (11, 34), found an increase in 
resting blood flow of 30-50% after 6 weeks to 7 years of training. The present study 
demonstrated a 46% increase in blood flow already after 4 weeks. In addition, the 
increase in thigh peak blood flow, which represents structural peripheral vascular 
adaptations (21), is comparable to previous studies using 6 weeks of FES (11, 18). 
Moreover, the enlargement of the common femoral artery diameter represents a 
substantial part of the adaptation found after 6 weeks FES training (11). These 
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findings indicate that vascular adaptations to FES training occur in the early phase, 
regardless of the duration of the lesion (1-20 years). Recently, Olive et al. (29) 
showed that the femoral diameter and maximal hyperemic flow response are closely 
linked to unit muscle volume. No differences between SCI and healthy subjects were 
present when diameter or hyperemic flow was normalized for units of muscle mass 
(29). Since upper leg volume (9 ± 12%), hyperemic flow (17 ± 23%) and femoral 
diameter (5 ± 6%) show increases in the same range, it may be suggested that 
vascular and muscular adaptations to FES training are correlated. Since this study did 
not measure units of muscle mass, this may be subject for future research.  
Our main finding is that the common femoral arterial diameter, the baseline and 
peak thigh blood flow, and the vascular conductance are significantly increased after 
4 weeks of hybrid training, while no changes in the passive, non-stimulated calf nor 
in the voluntary active forearm were found. The vascular changes in the thigh suggest 
adaptations at the level of resistance vessels as well as conduit arteries. These 
changes result in an improved supply of blood, and thus oxygen and fuel, to the 
exercising thigh muscles and, consequently, in a better homeostasis. Mechanisms 
responsible for exercise training-induced vascular adaptations seem to differ among 
the different vascular territories. Exercise training induces structural enlargement of 
conduit vessels (arteriogenesis), which primarily depends on high shear stress forces 
during repeated exercise bouts (8, 14). In contrast, microvascular adaptations 
(angiogenesis) occur primarily in response to hypoxia rather than shear stress (24).  
In contrast to the thigh, the calf did not show any significant vascular adaptations. 
Lack of activity of the calf muscles, and therefore insufficient elevation of shear stress 
and hypoxia, most likely explains these findings. It has been suggested that during 
FES cycling calf muscles may be activated by reflex-activity, initiated by a spinally 
located central pattern generator (9). However, the reflex activity of calf muscles 
appears to be too low to induce vascular remodelling after 4 weeks of training. 
Recently, it was demonstrated (30, 31) in SCI subjects that electrical stimulation of 
the quadriceps muscle leads to an increase in blood flow of the superficial femoral 
artery. Therefore, elevated levels of blood flow and shear stress in this conduit artery 
are most likely present in our study during exercise. Apparently, the stimulus is not 
sufficient to induce vascular adaptations within 4 weeks. The findings of the present 
study, demonstrate that vascular adaptations to whole body exercise training are 
limited to the activated areas. In other words, vascular adaptations seem to be a truly 
local phenomenon, which do not irradiate into other vascular beds. In contrast, 
previous studies found vascular adaptations in non-exercised tissue after isolated leg 
or arm exercise training (4, 23, 25, 33). However, voluntary contractions in ‘non-
exercising’ muscles are unavoidably present in healthy subjects during whole body 
exercise. For example, arm muscle contractions for stabilization during leg cycling or 
extensive arm movements during running cannot be avoided. Our model with SCI 
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individuals, who have their legs paralyzed, represents an ideal model to investigate 
whether truly inactive adjacent areas of active muscles can profit from heavy 
exercise.  
The fact that no vascular adaptations were found in the forearm after 4 weeks of 
hybrid training may be explained by the initially high training status of the arms of 
those wheelchair bound SCI individuals. The high training status of the arms is 
illustrated by the regular participation in wheelchair-bound exercise (average of 4.5 h 
per week) and the high VO2max before the training started.  
 
Flow mediated dilation 
Endothelium-dependent (FMD) and –independent (nitroglycerine-response) dilation 
of the superficial femoral artery in SCI were relatively high compared to healthy 
subjects (12, 14). Also after correction for the eliciting stimulus (mean wall shear rate) 
(22), the ratio %FMD/ΔMWSR was still rather high. These findings are in agreement 
with a previous study reporting the FMD of chronic SCI individuals (14.1%) using a 
comparable protocol (7). Since the duration of ischemia in our protocol (13 min) was 
even longer compared to previous studies (5-10 min) (5), we suggest that maximal 
nitric oxide release was achieved with concomitant vasodilation, based on the 
presence of a maximal eliciting stimulus i.e., maximal reactive hyperemia (32). After 
4 weeks of training no changes in the FMD of the superficial femoral artery were 
found. In contrast, 4 weeks of daily electrical stimulation of the tibial anterior muscle 
in SCI individuals resulted in a decrease of the FMD of the superficial femoral artery 
(unpublished data). The discrepancy may be explained by the fact that the superficial 
femoral artery mainly supplies the calf, a non-stimulated and passive area during 
hybrid training in the present study, but a highly active area during FES exercise of 
the tibial anterior muscle. In healthy subjects, exercise training such as leg-cycling 
causes a change in FMD in exercised as well as non-exercised muscles (4, 23, 25). 
However as previously discussed, one should consider that voluntary contractions in 
‘non-exercising’ muscles are unavoidably present in healthy subjects during whole 
body exercise. Our results suggest that endothelial adaptations are based largely on 
local rather than on systemic processes. Consequently, caution should be taken 
when using measurements of one conduit vessel to represent systemic endothelial 
function in humans.  
 
Clinical relevance. Previous studies (6, 36) suggested FES cycle training to be a 
suitable method to improve lower leg circulation and decrease the risk for decubitus 
and poor wound healing, predominantly present at the heels, foot, and calf. The 
present study shows that vascular adaptations are present at the stimulated thigh 
muscles only. Therefore, to aim at decreasing risk factors for ulcers, decubitus or 
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poor wound healing at the foot or calf, we suggest to include stimulation of the calf 
muscles in the FES training or to choose for isolated stimulation of lower leg muscles.   
 
Limitations. It may be suggested that the hybrid FES exercise in the present study did 
not elicit sufficient load to induce systemic effects. However, FES cycling and arm 
cranking exercise activate a large muscle mass and resulted in an increase in 
VO2max. Moreover, the training was performed at an intensity of 65-85% of the 
maximal heart rate, which is comparable to previous studies that demonstrated 
endothelial adaptations in non-exercised muscles after 4 (23) or 8 weeks (25) of 
exercise training. In addition, it can be suggested that the duration of training or 
sample size explains the lack of vascular adaptations in the calf of the SCI 
individuals. Previous studies, in 12 and 14 subjects respectively, found already after 
4 weeks (19) or 4 days (1) significant improvement of arterial function. It is, therefore, 
unlikely that a larger sample size or longer training duration would have altered the 
basic results of this study.  
 
In conclusion, hybrid training in SCI individuals results in vascular adaptations in the 
activated muscles (thigh), already within 4 weeks, but not in passive areas not 
directly involved in the exercise (calf). This suggests that vascular adaptations are not 
the result of systemic processes but rather locally mediated. 
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Abstract 
 
Functional electric stimulation (FES)-training is a widely accepted and effective 
method to exercise the paralyzed legs of people with a spinal cord injury (SCI). It is 
not clear whether the benefits are proportional to the time and effort the patients 
must invest in FES training.  
Purpose. To assess the time course of arterial adaptations during 6 weeks of 
functional electric stimulation (FES)-training and 6 weeks of detraining in subjects 
with SCI. 
Methods. A volunteer sample of 9 SCI individuals performed a 6 week FES training 
(2 sessions per week). Vascular characteristics were measured by plethysmography 
(baseline and peak blood flow of the thigh) and echo Doppler (diameter of the 
femoral artery and flow-mediated dilation (FMD)). Subjects were measured at 0, 2 
and 6 weeks of training and 1 and 6 weeks after cessation of the training. 
Results. After 2 weeks of FES training, arterial characteristics changed significantly: 
there was an increase in baseline and peak blood flow, an increase in femoral artery 
diameter, and a decrease in FMD of the femoral artery. Detraining reversed baseline 
and peak thigh blood flow, vascular resistance, and femoral diameter toward 
pretraining values within 1 week. However, detraining did not restore the FMD of the 
femoral artery, even not after 6 weeks. 
Conclusions. Two weeks of hybrid functional electrostimulation training (4 exercise 
bouts) is sufficient to improve peak leg blood flow, arterial diameter, and normalizes 
flow-mediated dilation. In addition, detraining results in rapidly reversed vascular 
characteristics within 1 week.   
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Introduction 
 
Exercise training results in various physiologic adaptations that enhance athletic 
performance, but the cessation of training leads to a partial or complete reversal of 
these adaptations (27, 28). Accordingly, enforced inactivity or paralysis leading to 
extreme inactivity, as in people with spinal cord injury (SCI), results in marked 
adaptations of the vascular tissue such as, decreased baseline and peak blood flow, 
decreased diameter, and diminished capillarization (18, 19, 29, 31, 36). The only 
method to effectively exercise the paralyzed legs of people with SCI is functional 
electric stimulation (FES)-training. Although this method has frequently been 
evaluated for muscular (17, 26, 34) and vascular characteristics (6, 13, 18, 29, 30), it 
is not clear whether the benefits are proportional to the time and effort the patients 
must invest in FES training.  
Previous studies reported that at least 4 weeks of dynamic (38) or 4 weeks of daily 
static (9) FES exercise results in arterial adaptations in subjects with SCI. The 
magnitude of these changes are comparable to studies using 6 or 8 weeks of 
stimulation (13, 18, 28, 36). Although this suggests rapid vascular adaptation, little is 
known about the time course of these adaptations during FES training. In addition, 
the effects of detraining on vascular parameters in people with SCI are unknown. 
Recently, vascular adaptations were studied after onset of SCI. Adaptations were 
largely completed within 3 to 6 weeks post-injury (11). Whether detraining leads to a 
similar time course is debatable. Moreover, knowledge on detraining provides insight 
into the preservation of the benefits of FES training. 
The purpose of this study was to assess the time course of arterial vascular 
adaptations to training and detraining in subjects with SCI. The paralyzed legs of 
people with SCI provide a unique human model to examine the time course of 
training and, especially, detraining. A period of FES training, which improves 
vascular and muscular characteristics, is followed by the cessation of the stimulus for 
the exercise-induced adaptations. Consequently, this restores the situation of extreme 
inactivity. To assess the time course, vascular adaptations were measured before, and 
at 2 and 6 weeks of hybrid FES cycling exercise, and at 1 and 6 weeks after cycling.  
 
 
 
Methods 
 
Subjects 
Nine subjects with SCI (8 men, 1 woman, age 39 ± 3 years, height 180 ± 3 cm; table 
1) volunteered to participate in this study after verbal and written information about 
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the content and intent of the study. Eight subjects had a traumatic complete motor 
and sensory spinal cord lesion (American Spinal Injury Association (ASIA) grade A), 
while 1 participant had a motor and sensory incomplete lesion (ASIA grade C). The 
level of injury varied from C5 to T12. No abnormalities were reported from physical 
examination, which included medical history, a 12-lead resting electrocardiogram 
(ECG), and cardiac and pulmonary auscultation. Analysis of concentrations of blood 
cholesterol (5.7± 0.7 mmol⋅l-1), triglycerides (1.68 ± 0.96 mmol⋅l-1), low-density 
lipoprotein (3.82 ± 0.79 mmol⋅l-1), and high-density lipoprotein (1.18 ± 0.25 mmol⋅l-
1) showed no abnormalities (compared with the normative range). None of the 
subjects had any cardiovascular diseases or used medication known to interfere with 
the cardiovascular system. Two subjects stopped smoking, starting at least 2 weeks 
prior to the first measurement. Prior to testing, all subjects gave their written informed 
consent. The study is approved by the ethics committee of the Radboud University 
Nijmegen Medical Centre. 
 
 
Table 1. Characteristics of Subjects With SCI.  
 
Subject Age, 
years
Height, 
m 
Weight, 
kg 
Level of 
lesion
ASIA-
score 
TSL, 
years
Medication 
1 52 1.87 80 T7 A 20 metanamine, furadantine 
2 45 1.96 109 T5 A 25  
3 36 1.67 48 T12 C 3 cibutine, antibiotics, microlax 
4 38 1.82 84 C7 A 13 dantrium, oxybutinine, baclofen
5 46 1.78 78 T8 A 10  
6 25 1.75 62 T4 A 2 methylphenadate, imipramine 
7 43 1.70 65 C5 A 24 bisacodyl, baclofen 
8 43 1.84 88 T11 A 1  
9 24 1.80 71 T6 A 4  
TSL; time since lesion. ASIA-score is used to classify the completeness of the lesion: A, sensory 
and motor complete; B, sensory incomplete but motor complete; C, sensory and motor 
incomplete but no functional motor activity. 
 
 
Protocol 
Subjects were tested before and after 2 and 6 weeks of training to assess the time 
course of arterial adaptations to FES exercise. Subjects trained for a period of 6 weeks 
with a frequency of 2 times a week under supervision of a researcher with at least 1 
day between subsequent sessions. In addition, arterial characteristics were measured 
1 and 6 weeks after cessation of the training to assess the time course of detraining.  
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Hybrid Training 
A stationary computer-controlled FES ergometer (BerkelBike BV, Nijmegen, The 
Netherlands) was used for hybrid FES cycling exercise; including stimulated 
asynchronous leg cycling and voluntary synchronous arm cranking. The FES 
ergometer provides stimulation via surface electrodes (5x8cm, Farmadomo BV, 
Nuland, The Netherlands) placed bilaterally over the hamstring, gluteal, and 
quadriceps muscles. Each training session started with a warming-up of 5 min with 
arm activity only. Thereafter, stimulation of the thigh and gluteal muscles started with 
50 mA. Intensity of stimulation was manually increased with steps of 10 mA to a 
maximum of 150 mA. Stimulation was increased based on a decrease in power 
output, which indicates fatigue of the stimulated muscle groups. Subjects with SCI 
trained for ~25 min with stimulation (38). 
 
Testing Procedure 
After a 12 h overnight fast, evaluation measurements were started between 8:30 and 
9:30 AM. Subjects refrained from caffeine, chocolate, kiwi, vitamin C supplements, 
and alcohol for at least 18 h before the test. Room temperature was controlled at 23 
± 1 °C. Subjects emptied their bladder in the last 1.5 h before the test to minimize the 
possibility of any sympathetic activity from bladder filling on the peripheral vascular 
tone. Subjects were positioned comfortably on a bed in the supine position with a 
slight elevation of the head. During an acclimatization period of 30 min, strain 
gauges and venous occlusion cuffs were positioned. The right arm was positioned 
about 5 cm above heart level. A cuff (10 cm) was placed proximally around the right 
upper arm and was connected to a rapid cuff inflator (DE Hokanson Inc., Bellevue, 
WA, USA). A mercury-in-silastic strain gauge (Hokanson Inc., Bellevue, WA, USA) 
was placed at the widest girth of the forearm. To minimize the contribution of hand 
skin blood flow, 1 min before as well as during baseline blood flow measurement the 
hand circulation was excluded by inflating a pediatric cuff around the wrist to 220 
mmHg (21). To measure thigh characteristics, a cuff (12 cm) was placed proximally 
around the upper leg. Both legs were elevated and the lower legs rested on a 14 cm 
high platform. The strain gauges were placed at mid-thigh, at least 10 cm above the 
patella and at least 4 cm below the cuff (37). 
Resistance vessels. Baseline blood flow and vascular resistance of the forearm and 
thigh were measured unilateral (at the right side) for 5 min using venous occlusion 
plethysmography. A cuff was inflated, ECG triggered and within 1 heart beat, to a 
cuff pressure of 50 mmHg (15). This pressure was sustained for 9 heart beats after 
which the cuff was instantaneously deflated (for 10 heart beats). Before each blood 
flow measurement, blood pressure was measured auscultatory at the left brachial 
artery using a sphygmomanometer, and mean arterial pressure (MAP) was calculated.  
Conduit arteries. Systolic and diastolic vessel diameters of each artery were measured 
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with an echo Doppler device (Megas; ESAOTE, Firenze, Italy) with a 5 to 7.5 MHz 
broadband linear array transducer. For the femoral artery, images were made 2 cm 
proximal of its bifurcation into the deep and superficial femoral artery. Carotid artery 
resting diameter and resting flow was measured 3 cm proximal of the bifurcation of 
the left carotid artery into the external and internal carotid artery. Brachial artery 
images were obtained 3 cm proximal of the olecranon process. The flow-mediated 
dilation (FMD) of the brachial and femoral artery, representing endothelial function 
(5, 8), were assessed after 5 and 10 min of ischemia, respectively. After cuff deflation, 
hyperemic flow was recorded during the first 25 s. Diameter images were videotaped 
for 4 min to assess the maximal dilation of the artery offline.  
Training effects. Leg cycling performance was assessed before and after the training 
using a computer controlled leg cycling ergometer (Ergys2, Therapeutic Alliances 
Inc, Fairborn, OH, USA) Stimulation was increased to achieve a pedaling rate of 
50rpm. When maximal stimulation (140 mA) was achieved and pedaling rate 
dropped below 35 rpm, the test was terminated (13).  
 
Data Analysis  
Resistance vessels. Plethysmographic data were digitalized with a sample frequency 
of 100Hz (MIDAC; Radboud University Nijmegen, The Netherlands) and analyzed 
by a customized computer program (Matlab; The MathWorks Inc, Natick, MA, USA). 
Blood flow (in ml⋅min−1⋅dl−1) was calculated as the slope of the volume change over 
a 4 s interval, starting directly after the inflation-induced cuff artifact (calf and 
forearm, 1 s; thigh, 2 s). Vascular resistance is calculated as blood flow divided by 
auscultatory MAP in mmHg⋅ml⋅min−1⋅dl−1; arbitrary units (AU) (37).  
Conduit arteries. To measure resting diameter, 3 consecutive images in the 
longitudinal view were frozen at the peak systolic and end-diastolic phase. Offline, 3 
measurements were performed per diameter image, and the mean diameter (D) was 
calculated by using the formula: 1/3⋅systolic diameter + 2/3⋅diastolic diameter. Vessel 
diameters of the brachial and femoral artery during the FMD were measured offline 
from videotape at 50, 60, 70, 90, 120, 180, and 240 s after cuff release. FMD was 
expressed as the maximal absolute (in millimeters) and relative (in percentage) 
diameter change in end-diastolic baseline diameter. The ratio between the relative 
FMD response (%FMD) and the primary stimulus for vessel dilation (mean wall shear 
rate (MWSR)) was calculated. Regional MWSR was calculated as (4⋅Vmean/D) (s–1). 
Delta MWSR (ΔMWSR) was defined as the difference between rest and peak 
response and was used to calculate the amount of vasodilation per stimulus during 
the FMD (22). During the initial 25 s after cuff release the hyperemic flow was 
measured. The 2 highest flow profiles were accepted as the peak flow, peak MWSR, 
and peak PWSR. 
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Statistical Analysis 
Statistical analyses were performed using SPSS (Version 12.0; SPSS Inc, Chicago, IL, 
USA). A paired t-test was used to assess differences between pre- (0 wk) and post-
training (6 wk) in body mass, blood pressure, leg volume. Leg cycling performance 
data of 3 subjects were missing, therefore the non-parametric Wilcoxon signed-rank 
test was used. A repeated-measures analysis of variance (ANOVA) (dependent 
variable ‘time’) was used to assess vascular changes during training and detraining at 
5 time points; 0, 2, 6, 7 (6+1: 1 wk detraining), and 12 (6+6: 6 wk detraining) weeks. 
Post hoc analysis was used to assess significant changes between the different time 
points. Power analysis for the 3 main parameters of the study to detect a moderate 
effect (baseline blood flow 0.5 ml⋅min−1⋅dl−1; baseline diameter 0.7 mm; FMD 3.0%), 
resulted in a group size of 9 subjects. Data are presented as means ± standard 
deviation. The level of statistical significance is set at 5%. 
 
 
 
Results 
 
One subject did not finish the training period and was therefore excluded from the 
analysis. In 1 subject, data from 2 week training and 1 week detraining were missing. 
These data were intrapolated in order to maintain power of the statistical analysis. 
FES training did not result in changes in body mass (pre, 74 ±18 kg; post, 75 ±18 kg; 
t-test, P=0.52) or MAP (pre, 92 ±7 mmHg; post, 92 ±12 mmHg; t-test, P=0.86). Leg 
volume was increased after the training period (pre, 7.5 ±0.5 l; post, 7.9 ±0.5 l; t-
test, P=0.02). The workload during the Ergys leg cycling performance test increased 
after training (pre 1.5 ±1.9 kJ, post 4.2 ±4.1 kJ; Wilcoxon, P=0.03). 
 
 
Resistance Vessels 
Thigh baseline blood flow and vascular resistance tended to change (ANOVA, 
P=0.078 and P=0.057) during the period of training and detraining (figure 1A, C). 
Post hoc analysis revealed that vascular resistance decreased significantly after 2 (0 
vs. 2, P=0.01) and 6 weeks (0 vs. 6, P=0.04) of training. During detraining, thigh 
vascular resistance returned to pre-training values within 1 week of detraining (post 
hoc 0 vs. 6+1, P=0.51). Thigh baseline blood flow significantly increased within 2 
weeks (post hoc 0 vs. 2, P=0.03) and tended to increase after 6 weeks of FES cycling 
(post hoc 0 vs. 6, P=0.08). Forearm baseline blood flow and vascular resistance did 
not change during the study (figure 1B, D).  
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Figure 1. Results of plethysmography (n=9). Baseline (A) thigh and (B) forearm blood flow and 
baseline (C) thigh and (D) forearm vascular resistance. All parameters were analyzed using a 1-
way ANOVA (dependent variable, time) with the P value reported in the figure. Values are 
mean ± SE (BF, blood flow; VR, vascular resistance). *Post hoc significant from 0 week. 
 
 
Post occlusive peak blood flow of the femoral artery was significantly altered during 
training and detraining (figure 2A, ANOVA, P=0.04). Peak femoral blood flow tended 
to increase after 2 and 6 weeks of training (post hoc 0 vs. 2 and 0 vs. 6, P=0.059). In 
addition, the peak blood flow returned to pre-training values within 1 week of 
detraining (post hoc 0 vs. 6+1, P=0.76; 6 vs. 6+1, P=0.04). Brachial artery reactive 
hyperemia did not change (figure 2B). 
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Figure 2. Peak blood flow during the post-occlusive reactive hyperemia (PORH) of the (A) 
femoral and (B) brachial artery (n=9). Parameters were analyzed using a 1-way ANOVA 
(‘dependent variable, time) with the P value reported in the figure. Values are mean ± SE. *Post 
hoc significant from 0 week. †Post hoc significant from 6 weeks 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Diameter change of the femoral artery (n=9). Diameter was analyzed using a 1-way 
ANOVA with the P value reported in the figure. Values are mean ± SE. *Post hoc significant 
from 0 week. †Post hoc significant from 6 weeks. 
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Table 2. Results of echo-Doppler in carotid, brachial, and femoral artery (n=8).  
 
 0 Week 2 Weeks 6 Weeks 6+1 Weeks 6+6 Weeks P value 
Carotid artery  
  Diameter, mm 
 
7.0 
 
± 
 
0.2 7.3 ±
 
0.1 7.3 ±
 
0.2 7.1 ±
 
0.1 7.1
 
± 
 
0.1 
 
0.49 
  Flow, mL⋅min-1 387 ± 16 365 ± 18 398 ± 46 348 ± 25 319 ± 16 0.08 
  MWSR, s-1 90 ± 4 82 ± 4 88 ± 11 86 ± 9 76 ± 7 0.42 
  PWSR, s-1 397 ± 30 380 ± 18 381 ± 41 384 ± 39 352 ± 41 0.68 
 
Brachial artery 
         
  Diameter, mm 4.6 ± 0.4 4.7 ± 0.3 4.7 ± 0.3 4.5 ± 0.3 4.5 ± 0.3 0.08 
  Flow, mL⋅min-1 56 ± 27 52 ± 16 76 ± 36 71 ± 38 48 ± 22 0.27 
  MWSR, s-1 42 ± 14 41 ± 9 52 ± 16 55 ± 17 39 ± 11 0.18 
  PWSR, s-1 590 ± 46 574 ± 49 585 ± 46 636 ± 54 586 ± 40 0.63 
 
Femoral artery 
         
  Diameter, mm 7.0 ± 0.3 7.6 ± 0.2† 7.7 ± 0.3† 7.6 ± 0.3 7.4 ± 0.2 0.002 
  Flow, mL⋅min-1 211 ± 49 268 ± 53 253 ± 47 248 ± 47 265 ± 42 0.48 
  MWSR, s-1 48 ± 9 60 ± 11 49 ± 9 56 ± 11 60 ± 11 0.39 
  PWSR, s-1 477 ± 30 568 ± 51 551 ± 65 531 ± 47 595 ± 50 0.24 
Values are mean ± SE. P-values represents repeated-measures ANOVA (dependent variable, 
time). †Post hoc significant from 0 week. 
 
 
Conduit Arteries  
The diameter of the femoral artery changed during the training. Post hoc analysis 
revealed that the diameter increased within 2 weeks by 6% (0 vs. 2, P=0.02), with no 
additional increase after 6 weeks (2 vs. 6, P=0.28) (figure 3). After cessation of the 
training, diameter of the femoral artery reversed toward pretraining values within 1 
week (post hoc 0 vs. 6+1, P=0.053; post hoc 6 vs. 6+1, P=0.069). Carotid and 
brachial resting diameter did not change during training (2 and 6wk) and detraining 
(6+1wk and 6+6wk) (table 2). Carotid, brachial, and femoral artery baseline flow and 
mean and peak wall shear rate did not change during the study. 
The FMD of the femoral artery showed a significant decrease (ANOVA, P=0.002) 
within 2 weeks of training (post hoc 0 vs. 2, P=0.01) with no further decrease 
thereafter (2 vs. 6, P=0.15; figure 4A). During detraining, post hoc analysis 
demonstrated an increase in FMD already within 1 week (6 vs. 6+1, P=0.046). 
However, FMD of the femoral artery was still significantly lower compared with 
pretraining values after 1 week (0 vs. 6+1, P=0.04) and 6 weeks (0 vs. 6+6, P=0.049) 
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of detraining. FMD was corrected for the eliciting stimulus (8, 22), and results show a 
similar pattern to the uncorrected FMD (ANOVA, P=0.026; figure 4C). Brachial FMD 
(figure 4B, D) did not change during the study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Results of the FMD (n=9). Relative change of the FMD and corrected FMD 
(ΔMWSR/FMD, MWSR; mean wall shear rate) of the femoral (A+C) and brachial (B+D) artery 
are presented. Parameters were analyzed using a 1-way ANOVA (dependent variable, time) 
with the P value reported in the figure. Values are mean ± SE. *Post hoc significant from 0 
week. †Post hoc significant from 6 weeks. 
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Discussion 
 
The main findings of the present study are that FES training in subjects with SCI 
provides a strong exercise stimulus leading to rapid vascular adaptations in the 
exercised area within 2 weeks after onset of exercise training. After cessation of the 
FES training, the state of extreme inactivity in the paralyzed legs of subjects with SCI 
is restored. The paralyzed legs of subjects with SCI, therefore, offer a unique model to 
examine the effects of detraining in human vascular tissue. Interestingly, cessation of 
FES cycling rapidly reversed vascular characteristics toward pretraining values within 
only 1 week. Therefore, a principle finding of this study is that the vascular 
adaptations to training or detraining have a different time course, suggesting that 
detraining is not simply the reverse process of training. 
 
Time Course During Training 
Two weeks of FES cycling (including 4 exercise bouts only) resulted in a significant 
increase in peak leg blood flow and diameter of the femoral artery, and decrease in 
leg vascular resistance and FMD. After these initial adaptations, no significant 
additional changes could be demonstrated, which may indicate that the largest part 
of the potential vascular adaptations to FES exercise is reached after a few exercise 
bouts. Moreover, the exercise-induced changes of baseline blood flow, resting 
diameter, and FMD within 2 weeks of training are comparable to adaptations 
reported after longer and more intensive periods of FES training (9, 13, 18, 29, 38). 
For example, the present study indicated a 6% increase in femoral diameter after 2 
weeks, while previous studies reported a 5 to 8% enhancement after 4 to 6 weeks of 
training (9, 13, 18, 29, 38). Also the 30% increase in leg baseline blood flow after 2 
weeks FES cycling is in range with the 30 to 50% increase in resting blood flow after 
6 weeks to 7 years of training, using plethysmography (18) or echo Doppler (13, 36). 
Finally, the 48% decrease of the corrected FMD is comparable to the 40% decrease 
after 4 weeks daily electric stimulation (9). These findings indicate a rapid onset of 
FES exercise-induced vascular changes within 2 weeks followed by minimal 
adaptations thereafter. The possibility exists that the initial exercise bouts provide a 
significant stimulus to the onset of gene expression (2), which could have led to the 
observed vascular adaptations. Further, because angiogenesis-related gene 
expression rapidly attenuates during training (33), this could have accounted for the 
failure to observe continued adaptations in vascular changes with continued training 
(i.e., 2−6wk) in the present study. To achieve additional vascular adaptations, 
training intensity has to increase dramatically.  
Interestingly, the 25% increase in peak femoral blood flow, which represents 
structural peripheral adaptations (22), found after 2 and 6 weeks of FES cycling is 
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lower compared with previous studies using a longer or more frequent training 
design. For example, 6 weeks of FES training (3 times a week) showed an increase of 
44% (13) and 8 weeks of training (4 times a week) increased peak blood flow even 
with 80% (29). Because exercise-induced structural vascular adaptations occur more 
gradually, it appears that adaptation in peak blood flow is dependent on the duration 
of the exercise period. Time course of vascular adaptations may differ between 
different vascular beds (ie, conduit vs resistance vessels), as has been indicated in 
exercise training studies in animals (32) and humans (14).   
Olive et al. (31) reported a close relationship between the peak hyperemic flow and 
muscle volume with no differences present in a cross-sectional study between long-
term SCI and healthy subjects after correcting hyperemic flow for units of muscle 
mass. Based on this, one may question whether peak blood flow and muscle mass 
are also linked during training. Interestingly, in line with vascular adaptations, 
adaptations in muscle mass to FES training seem to depend on the duration of the 
exercise period. The 9% increase in thigh volume in the present study is lower than 
the 21% and 22 to 39% increase found after 8 weeks of daily FES cycling (17) or 98 
bouts of FES cycling in about 38 weeks (35).  
It is well known that aerobic exercise training in healthy subjects or in disease (7, 12) 
leads to an enhanced FMD of the brachial artery. Adaptations in the FMD response 
have even been reported to occur after 4 days of aerobic training (1). In contrast, 
extreme inactivity (such as present in the paralyzed legs of persons with SCI) seems to 
have strikingly different effects. A relatively high FMD of the superficial femoral 
artery in long-term SCI has been reported previously (10). In addition, this high FMD 
was reported to decrease toward normative values after 4 weeks of daily FES training 
in SCI (38). Our findings are in agreement with these previous SCI studies (10, 38). In 
addition, 7 (4) or 52 (3) days of bed rest, another model of inactivity, in healthy 
subjects resulted in an increase of the FMD. Clearly, the results of the present study 
indicate that inactivity is not just the opposite of exercise training. It is hypothesized 
that the bioavailability of nitric oxide (NO) or the sensitivity of the smooth muscles to 
NO, an important endothelium-derived relaxing factor, plays a possible role in the 
inactivity-related elevation of FMD. Future research is necessary to unravel the 
mechanism behind the adaptations during (de)training of the FMD. 
 
Time Course During Detraining 
The present study indicates that baseline and peak leg blood flow, femoral diameter, 
and femoral artery FMD reversed toward pretraining values within 1 week after 
cessation of the training (table 3). Previous studies did not examine the time course of 
vascular adaptations during the first weeks of detraining but only reported vascular 
characteristics after 6 or 8 weeks of detraining in healthy subjects (25, 39), diabetes 
(23), and patients with chronic heart failure (16, 20, 24). In healthy subjects, cross-
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sectional area of the femoral artery (25) and forearm skin blood flow (39) returned to 
pretraining values after 6 and 8 weeks detraining, respectively. Detraining in patients 
with chronic heart failure or diabetes showed FMD to decrease to pretraining values 
after 6 (20) or 8 weeks (16, 23, 24). Collectively, the effects observed after 6 to 8 
weeks of detraining in health and disease (16, 20, 23-25, 39) are in line with the 
findings of the present study after only 1 week of detraining in SCI. This may suggest 
that these previous studies that examined detraining after 6 to 8 weeks may have 
underestimated the rapid time course of this process. However, because exercise 
training improves physical fitness in healthy subjects and patients, many of these 
subjects stay physically active after cessation of the training, inhibiting the process of 
detraining. In contrast, in persons with SCI the state of extreme inactivity in the 
paralyzed legs is completely restored after cessation of training. The paralyzed legs of 
people with SCI, therefore, offer a unique model to examine the effects of detraining 
in human vascular tissue.  
 
 
Table 3: Structural and Functional Changes During Training and Detraining (n=9)  
 
Training Detraining   
2 Weeks 6 Weeks 
 
6+1 Weeks 6+6 Weeks 
 
Baseline BF ↑ ↑ (0.06) = = 
Baseline VR ↓ ↓ = = 
Peak BF    ↑ (0.06) ↑ (0.06) = = 
Diameter ↑ ↑ = = 
FMD (%) ↓ ↓ ↓ ↓ 
FMD (%/ΔMWSR) ↓ ↓ = ↓ 
Post hoc significant increase (↑), decrease (↓), or no change (=) versus pretraining value is 
represented for all vascular characteristics. (BF, blood flow; VR, vascular resistance). 
 
 
Remarkably, after 6 weeks detraining in subjects with SCI, the normalized FMD after 
training was still not reversed to pretraining values. Previous studies investigating the 
FMD response in able-bodied subjects (16, 20, 23, 24) indicated that the enhanced 
FMD after training was decreased to pretraining values after 6 to 8 weeks. This 
unexpected finding may be explained by the fact that the FMD response in the 
paralyzed legs of subjects with SCI (decreases by training) represents a different 
physiologic mechanism than that in healthy subjects (improves by training).   
 
Clinical Relevance. Previous longitudinal studies in subjects with SCI with FES 
cycling used intensive exercise training (6, 13, 36) for extended periods of at least 6 
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weeks. Based on the findings of the previous study, we suggest that only minimal 
training effort (4 training sessions of ~25 min stimulation) is sufficient to initiate rapid 
vascular adaptations. Moreover, this study advocates the increase in training duration 
or intensity after the initial period, since the adaptations after 2 weeks of FES cycling 
reported in the present study are in line with adaptations found after longer and more 
intensive training periods. In addition, this study indicates that detraining rapidly 
reverses the exercise-induced vascular adaptations, and, therefore an exercise 
program is necessary to maintain the vascular benefits of exercise in subjects with 
SCI.  
 
Our findings demonstrate that only 2 weeks of hybrid FES training (4 exercise bouts) 
markedly improves baseline and peak leg blood flow, arterial diameter, and 
normalizes FMD. In addition, detraining resulted in a rapid reversion of the vascular 
characteristics, that is, within 1 week after cessation of training.  
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Abstract 
 
Endothelin-1 (ET-1) contributes to the increased peripheral resistance in heart failure 
and hypertension. Physical inactivity is associated with cardiovascular disease and 
characterized by increased vascular tone.  
Purpose. To assess the contribution of ET-1 to the increased vascular tone in the 
extremely deconditioned legs of spinal cord-injured (SCI) individuals before and after 
6 weeks of exercise.  
Methods. In 8 controls and 8 SCI individuals, bilateral thigh blood flow was 
measured by plethysmography before and during the administration of an ETA/B-
receptor blocker into the femoral artery. In SCI, this procedure was repeated after 6 
weeks of electro-stimulated training. In a subset of SCI (n=4), selective ETA-receptor 
blockade was performed to determine the role of the ETA-receptors. 
Results. In controls, dual ET-receptor blockade increased leg blood flow at the 
infused side (10%, P<0.05), indicating a small contribution of ET-1 to leg vascular 
tone. In SCI, baseline blood flow was lower compared with controls (P=0.05). In SCI, 
dual ET-receptor blockade increased blood flow (41%, P<0.001). This vasodilator 
response was significantly larger in SCI compared with controls (P<0.001). The 
response to selective ETA-receptor blockade in the subset of SCI individuals was 
similar to the effect of dual blockade. Electro-stimulated training normalized baseline 
blood flow in SCI, and reduced the response to dual ET-receptor blockade in the 
infused leg (29%, P=0.04). 
Conclusions. ET-1 mediates the increased vascular tone of extremely inactive legs of 
SCI individuals by increased activation of ETA-receptors. Physical training reverses 
the ET-1-pathway, which normalizes basal leg vascular tone.  
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Introduction 
 
The endothelium plays an important role in the regulation of vascular tone via the 
release of vasodilator and vasoconstrictor substances. Endothelin-1 (ET-1) (36) is one 
of the most potent endothelium-derived constricting factors, and contributes to the 
regulation of peripheral vascular tone (11, 34) by interacting with ETA- (1) and ETB-
receptors (10) on smooth muscle and endothelial cells (5, 33).  
In several pathological conditions, such as pulmonary (28) and systemic essential 
hypertension (9), heart failure (15, 24), atherosclerosis and obesity (2), ET-1 plasma 
levels are elevated and contribute to the increased vascular tone observed in these 
disease states. In models of skeletal muscle deconditioning, such as unilateral limb 
suspension (3) and bed rest (13), vascular tone is also increased. In the present study, 
we hypothesize that the elevated vascular tone in deconditioned muscles can be 
explained by an augmented contribution of ET-1. 
Individuals with a spinal cord injury offer a unique model of nature to assess 
peripheral vascular adaptations to inactivity since the skeletal muscles below the 
level of the lesion are paralyzed and, therefore, extremely inactive. Previous research 
demonstrated that extensive vascular adaptations, such as an increased leg vascular 
tone, occur in the inactive and paralyzed legs of spinal cord-injured individuals (14). 
These adaptations cannot be explained by a reduced availability of nitric oxide (4) or 
adaptations in the α-adrenergic tone (18). According to our hypothesis, the increased 
vascular tone in the deconditioned legs of spinal cord-injured individuals is caused 
by an augmented contribution of ET-1. To address this hypothesis we investigated the 
vasodilator response to combined ETA- and ETB-receptor blockade in SCI individuals 
as well as in matched controls. To further explore the causal role of inactivity in 
alterations in the ET pathway, we repeated the experiments in SCI individuals after 
training of the paralyzed legs. 
Since a sedentary life style is an independent risk factor for the development of 
cardiovascular disease and atherosclerosis (19), insight into the cause and the 
reversibility of vascular changes as a result of inactivity is highly relevant. 
 
 
 
Methods 
 
Subjects  
Eight spinal cord-injured (SCI) individuals (7 men and 1 woman, age: 38 ± 12 years, 
table 1) and 8 healthy, non-smoking control subjects (7 men and 1 woman, age: 
34±± 12 years) participated in the study. The SCI individuals continued their 
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medication throughout the study (table 1). Two SCI individuals stopped smoking 2-4 
weeks prior to the initial experiment. All SCI individuals except one (incomplete 
motor lesion from L3: American Spinal Injury Association (23); ASIA C) had complete 
motor and sensor spinal cord lesions of traumatic origin varying from Cervical 5 to 
Thoracic 12 (ASIA A). The subjects had no history of cardiovascular disease, were 
normotensive, had no hypercholesterolemia, and used no medication known to 
interfere with the cardiovascular system. The study was approved by the hospital 
ethics committee. All subjects gave their written informed consent before 
participation. 
 
 
Table 1. Characteristics of spinal cord-injured individuals  
 
 Sex Age, years Level of lesion TSI, years Medication 
1 M 45 T5 25  
2 M 52 T7 20 metanamine, furadantine 
3 F 36 T12 3 cibutine, antibiotic, microlax 
4 M 46 T8 10  
5 M 43 C5 24 bisacodyl, baclofen 
6 M 25 T4 2 ritalin, imipramine 
7 M 38 C7 13 dantrium, baclofen, oxybutinine 
8 M 24 T6 4  
(TSI: time since injury) 
 
 
Experimental design  
Control subjects and SCI individuals were studied to quantify the vasodilator 
response to blockade of ET-receptors in the leg. Subsequently, at least two weeks 
thereafter, SCI individuals started with a 6 week functional electro-stimulated training 
of the paralyzed legs to assess whether the observed alterations were reversible upon 
training So, exactly the same experimental protocol was repeated after the final 
training session. In SCI individuals, the role of the ETA- and ETB-receptor was further 
explored with selective blockade of the ETA-receptors. 
 
Protocol 
Experiments for both control subjects and SCI individuals started at 8:30 AM after a 
12 h overnight fast. Subjects refrained from caffeine-containing food and beverages, 
alcohol, and vitamin C for at least 18 h and did not perform any strenuous activities 
for at least 48 h before testing. At least 1.5 h before the test, subjects emptied their 
bladder to minimize the influence of any reflex sympathetic activation on peripheral 
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vascular tone. The tests were performed in a quiet, temperature-controlled room 
(23.3 ± 0.6 °C), with the subjects in the supine position.  
A modified Seldinger technique was used to introduce an intra-arterial cannula 
(Angiocath 16 gauge, Becton Dickinson, Sandy, Utah, USA) into the right femoral 
artery at the level of the inguinal ligament under local anesthesia (0.4 ml lidocaine 
20 mg⋅ml-1). This cannula was used for the intra-arterial administration of ET-receptor 
antagonists by an automatic syringe infusion pump (Type P4000, Welmed Ltd, 
Hampshire, UK) (4, 18) and for blood pressure measurement (Type PX600, Edwards 
Lifesciences Services GmbH, Unterschleissheim, Germany). Heart rate was recorded 
from the ECG. After complete instrumentation and at least 30 min after cannulation 
of the femoral artery, an arterial blood sample was taken from the right femoral artery 
using a non-heparinized container to determine baseline plasma ET-1 levels using a 
chemo-luminescent immunoassay (QuantiGlo, R&D Systems, Abingdon, UK; 
sensitivity for ET-1 <0.16 pg⋅ml-1). Subsequently, a 30 min measurement of baseline 
leg blood flow during saline infusion into the femoral artery was performed. Bilateral 
leg blood flow was measured 3-4 times per minute, using ECG-triggered venous 
occlusion plethysmography. For this purpose, an occlusion cuff (12 cm) was placed 
proximally around the upper leg and was connected to a rapid cuff inflator 
(Hokanson Inc., Bellevue, WA, USA), which inflated the cuff to a pressure of 50 
mmHg for 9 heart cycles, with 10 heart cycles between the occlusions (7). A 
mercury-in-silastic strain gauge (Hokanson Inc., Bellevue, WA, USA) was placed at 
mid-thigh, at least 10 cm above the patella and at least 4 cm below the cuff (30). The 
lower legs were supported ~10 cm above heart level to facilitate venous outflow 
between the venous occlusion periods.  
After the baseline measurements, dual infusion of a selective ETA- and ETB-receptor 
antagonist (BQ-123 and BQ-788, respectively, Clinalfa, Calbiochem-Novabiochem 
AG, Läufelfingen, Switzerland) was started to block the ET-receptors of the right leg. 
BQ-123 and BQ-788 were infused at 10 and 1 nmol⋅min-1⋅l-1 leg volume, 
respectively, and the infusion was continued for 75 min (6, 34). Leg-volume was 
determined by anthropometry as described and validated by Jones et al. (17). 
Previous studies showed that a 60 min co-infusion of BQ-123 and BQ-788 (10 and 1 
nmol⋅min-1⋅l-1 tissue into the brachial artery, respectively) resulted in maximal 
forearm vasodilation in healthy subjects without triggering systemic blood pressure 
effects (6, 12). 
 
Selective ETA-receptor blockade 
To determine the contribution of the ETA-receptor in the observed effect of dual 
ETA/B-receptor blockade in SCI individuals, we infused the selective ETA-receptor 
antagonist BQ-123 (10 nmol⋅min-1⋅l-1 leg volume), while the syringe with BQ-788 
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was replaced by saline. These experiments were performed at least 21 months after 
cessation of the FES cycling, which is sufficient to exclude any possible chronic 
training effect (31). The combined ETA/B-blockade was compared with the selective 
ETA-receptor blockade to explore the role of the ETA-receptor in the observed effects 
in SCI individuals.  
 
Drugs and solutions 
BQ-123 (10 nmol⋅min-1⋅l-1 leg volume) and BQ-788 (1 nmol⋅min-1⋅l-1 leg volume) 
were dissolved in saline at the beginning of the experiment. During the whole 
protocol, infusion rate was kept constant at 0.1 ml⋅min-1⋅l-1 tissue. 
 
Hybrid exercise training 
A stationary computer-controlled functional electro-stimulation (FES)-ergometer 
(BerkelBike BV, Nijmegen, the Netherlands) was used for hybrid FES cycling 
exercise; including stimulated leg-cycling and voluntary arm cranking. The FES 
ergometer provides stimulation via surface electrodes (5x8 cm, Farmadomo, Nuland, 
The Netherlands) to the hamstring, gluteal, and quadriceps muscles. Details 
regarding this training are described elsewhere (32). SCI individuals trained twice a 
week for 6 weeks. Compliance with the training sessions was 100%.  
 
Data analysis  
Plethysmographic data of both legs were digitalized with a sample frequency of 100 
Hz (MIDAC, Instrumentation Department, Radboud University Nijmegen Medical 
Centre) and analyzed off-line by a customized computer program (Matlab, 
Mathworks Inc., USA). Leg blood flow (in ml⋅min-1 per dl of leg tissue) was 
calculated as the slope of the volume change curve over a 4 s interval, starting 
directly after the inflation-induced cuff artifact (2 s) (30). Thigh vascular resistance 
was calculated as the mean arterial pressure (mmHg) divided by thigh blood flow (in 
ml⋅min-1⋅dl-1) and expressed in arbitrary units (AU; mmHg⋅ml-1⋅min-1⋅dl-1).  
Because of the differences in baseline vascular characteristics between SCI and 
control subjects, analysis of absolute values could affect the comparison between 
both groups. Therefore, data were expressed as percentage changes from baseline. 
Baseline blood flow and vascular resistance were calculated by averaging values 
over a 10 min interval prior to the infusion of the ET-receptor blockers. In addition, 
leg blood flow was expressed as the ratio between the infused and control (contra-
lateral) leg to correct for possible random systemic changes (26). An increase of the 
flow ratio during ET-receptor blockade indicates vasodilation in the leg vascular bed, 
suggesting a role for endogenous ET-1 in the regulation of baseline vascular tone. 
Blood flow, vascular resistance, and blood flow ratio were analyzed over the last 10 
min, where ET-receptor blockade reached its maximal effect (figure 1) (29, 35) 
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Figure 1. Percentage increase in blood flow ratio during the ET-receptor blockade in controls 
(C, •, n=8) and spinal cord-injured individuals (n=8), both before (SCI, ■) and after the training 
procedure (SCI-training, □). Each symbol represents the change in blood flow ratio over 15 
min, with the error bars representing the SE. The black square indicates the maximal effect 
during the final 10 min of the ET-receptor blockade. This effect was used for statistical analysis 
(see figure 2) 
 
 
 
Statistical analysis 
The primary end point of this study is the vasodilator response to ET-receptor 
blockade in the leg. We decided that with an estimated SD of 20% of the baseline 
value, a mean relevant effect of the ET-receptor blockade should be at least 25% (for 
the control versus SCI comparison) or 17.5% (for the before versus after training 
comparison) and calculated that with an alpha of 0.05, 8 subjects per group would 
be needed to achieve a power of 80%. Kolmogorov-Smirnov test indicated a normal 
(Gaussian) distribution of data. Results are expressed as mean ± SE. To assess 
differences between SCI individuals and controls (unpaired) and between the pre- 
and post- FES training measurement (paired), the maximal effect of ET-receptor 
blockade (defined as the average of the final 10 min of infusion) was compared using 
a Student’s t-test. Differences were considered to be statistically significant at a 2-
sided probability value of 0.05. 
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Results  
 
Baseline characteristics 
Because of muscle spasms in one SCI subject and of technical problems in one 
control subject, the data of the non-infused leg were not available for analysis in 
these 2 subjects. Baseline leg blood flow was significantly lower in SCI individuals as 
compared with controls (table 2, Student’s t-test: P=0.05). The training procedure 
increased baseline leg blood flow in SCI individuals (table 2). Leg volume of SCI 
individuals was lower as compared with control subjects, but increased in response 
to the training procedure (table 2). Baseline mean arterial pressure, heart rate, and 
plasma ET-1 levels were not different between SCI individuals and controls, and did 
not change by training in SCI individuals (table 2). 
 
 
Table 2. Results of ET-receptor blockade in controls and spinal cord-injured individuals.  
 
 Controls (n=8) SCI pre-training (n=8) SCI post-training (n=8) 
 Baseline ET-block P Baseline ET-block P Baseline ET-block P 
Leg volume, l 9.3 ± 0.3   7.5 ± 0.5*   7.9 ± 0.5†   
ET-1, pg/ml 0.91 ± 0.20   0.55 ± 0.05   0.61 ± 0.14   
HR, bpm 57 ± 4 59 ± 4 0.10 57 ± 2 59 ± 3 0.30 57 ± 2 58 ± 3 0.54 
MAP, mmHg 84 ± 3 84 ± 4 0.77 93 ± 3 84 ± 4* 0.006 90 ± 4 81 ± 4 0.01 
 
Infused leg 
              
 BF, ml/min/dl 3.6 ± 0.4 3.9 ± 0.5 0.06 2.4 ± 0.4* 3.4 ± 0.5 0.0001 3.2 ± 0.5† 4.1 ± 0.7 0.0004 
 BF, % 100 ± 0 110 ± 4 0.03 100 ± 0 141 ± 5* 0.0001 100 ± 0 129 ± 3† 0.0001 
 VR, AU 27 ± 4 24 ± 4 0.01 44 ± 6* 29 ± 5 0.0001 33 ± 4† 23 ± 4 0.0001 
 VR, % 100 ± 0 90 ± 4 0.02 100 ± 0 65 ± 2* 0.0001 100 ± 0 69 ± 2 0.0001 
 
Non-infused leg 
  
 BF, ml/min/dl 3.5 ± 0.4 3.7 ± 0.5 0.22 2.1 ± 0.2* 2.5 ± 0.3 0.02 2.3 ± 0.3 2.8 ± 0.4 0.005 
 BF, % 100 ± 0 104 ± 4 0.34 100 ± 0 117 ± 6 0.02 100 ± 0 124 ± 6 0.003 
 VR, AU 28 ± 3 27 ± 4 0.38 46 ± 4* 38 ± 6 0.01 44 ± 4 33 ± 5 0.002 
 VR, % 100 ± 0 95 ± 4 0.18 100 ± 0 81 ± 5* 0.01 100 ± 0 71 ± 5 0.001 
 
Infused and non-infused leg 
  
 Flow ratio, % 100 ± 0 109 ± 4 0.04 100 ± 0 122 ± 5* 0.002 100 ± 0 105 ± 4† 0.24 
Vascular characteristics are presented for controls (n=8) and spinal cord-injured (SCI) 
individuals (n=8) before the start of the infusion (‘Baseline’) and at the end of the infusion of 
ET-receptor antagonists (last 10 min, ‘ET-block’). Due to technical problems, values from 
controls for endothelin-1 levels represents 6 subjects. The P-values refer to a paired t-test 
between ‘Baseline’ and ‘ET-block’. Data are presented as mean ± SE. * P≤0.05 from controls (t-
test), † P≤0.05 from SCI pre-training (t-test). 
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Dual ET-receptor blockade in controls and SCI individuals 
Controls. Blockade of the ET-receptors did not affect mean arterial pressure, heart 
rate, or blood flow and vascular resistance in the non-infused leg in the control 
subjects (table 2). The ET-receptor blockade induced a small, but significant change 
in blood flow (10±± 4%) and vascular resistance (-10 ± 4%) of the infused leg. As 
such, the blood flow ratio between both legs increased by 9 ± 4% (figure 1-2). 
SCI individuals. During the ET-receptor blockade in SCI individuals, heart rate did 
not change while mean arterial pressure significantly decreased (table 2). After ET-
receptor blockade, blood flow clearly increased in the infused leg of the SCI 
individuals (41 ± 5%, figure 2). In the non-infused leg, a slight but significant increase 
in blood flow was observed (17 ± 6%, table 2). Blockade of the ET-receptors induced 
a significant increase in the blood flow ratio (22 ± 5%, figure 1-2). 
Controls versus SCI individuals. In contrast to controls, blockade of the ET-receptors 
induced a significant decrease in mean arterial pressure in the SCI individuals (table 
2). The change in blood flow and vascular resistance of the infused leg during ET-
receptor blockade in SCI was larger than in the controls. Likewise, the increase in 
blood flow ratio in response to the ET-receptor blockade was significantly larger in 
SCI individuals (figure 1-2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. The mean (± SE) percentage increase in blood flow ratio or blood flow, induced by 
the ET-receptor blockade in controls (C, n=8) and spinal cord-injured individuals (n=8), both 
before (SCI) and after the training procedure (SCI-training). * indicates a significant relative 
increase from baseline. 
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Dual ET-receptor blockade in SCI individuals after FES cycling  
SCI individuals after FES cycling. ET-receptor blockade did not change heart rate, but 
decreased mean arterial pressure. After training, blood flow of the infused and non-
infused leg both increased during the infusion protocol (29 ±±3 and 24±± 6%, 
respectively, table 2). Vascular resistance of both legs decreased during ET-receptor 
blockade (-31 ± 2 and –29 ± 5%, respectively, table 2). The blood flow ratio did not 
change during blockade of the ET-receptors (figure 1-2).  
Pre-training versus Post-training. The response of heart rate and mean arterial 
pressure to ET-receptor blockade did not differ between pre- and post-training 
measurements. The increase in leg blood flow in the infused leg as well as the flow 
ratio during ET-receptor blockade were significantly lower after training than before 
(figure 2), while the difference between the pre- and post-training fall in vascular 
resistance did not reach statistical significance (table 2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The mean (± SE) percentage increase in blood flow ratio or blood flow (BF) in the 
infused leg in spinal cord-injured individuals (n=4) during infusion of the combined ETA/B- 
(black bars) and selective ETA-receptor antagonists (open bars). Error bars represent SE. 
 
 
 
Selective ETA-receptor blockade 
Due to medical problems (n=2) and withdrawal (n=2), we examined a subset of the 
SCI individuals (n=4, male, 36 ± 12 years). At least 21 months after cessation of the 
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exercise training, baseline characteristics did not differ between both situations (table 
3). During selective ETA-receptor blockade in SCI individuals, heart rate did not 
change. Mean arterial pressure showed a decrease, but did not reach statistical 
significance (table 3). After ETA-receptor blockade, blood flow increased in the 
infused leg (figure 3), but did not change significantly in the non-infused leg (table 3). 
Blockade of the ETA-receptor induced an increase in the blood flow ratio, but did not 
reach statistical significance (figure 3). The hemodynamic responses did not differ 
between selective ETA- and combined ETA/B-receptor blockade (table 3, figure 3). 
 
 
 
Table 3. Dual ETA/B- and selective ETA-receptor blockade in a subset of spinal cord-injured 
individuals.  
 
 Dual ET-receptor blockade  Selective ETA-receptor blockade 
 Baseline End-infusion Baseline End-infusion 
HR, bpm 58 ± 3 59 ± 4 57 ± 6 62 ± 7 
MAP, mmHg 90 ± 2 81 ± 3 * 89 ± 2 83 ± 3 
 
Infused leg 
    
 BF, ml⋅min-1⋅dl-1 2.3 ± 0.3 3.3 ± 0.5 * 3.1 ± 0.5 4.6 ± 0.3 * 
 BF, % 100 ± 0 143 ± 7 * 100 ± 0 153 ± 18 * 
 VR, AU 42 ± 7 27 ± 5 * 30 ± 4 18 ± 1 * 
 VR, % 100 ± 0 64 ± 3 * 100 ± 0 63 ± 7 * 
 
Non-infused leg 
   
 BF, ml⋅min-1⋅dl-1 2.0 ± 0.2 2.4 ± 0.3 3.4 ± 1.0 4.0 ± 0.8 
 BF, % 100 ± 0 119 ± 8 100 ± 0 135 ± 18 
 VR, AU 46 ± 5 36 ± 7 * 35 ± 10 23 ± 4 
 VR, % 100 ± 0 76 ± 8 * 100 ± 0 73 ± 10 
 
Infused and non-infused leg 
   
 Flow ratio, % 100 ± 0 117 ± 8 100 ± 0 117 ± 8 
Vascular characteristics are presented for a subset of spinal cord-injured (SCI) individuals 
(n=4), before the start of the infusion (‘Baseline’) and at the end of the infusion of the dual 
ETA/B- and selective ETA-receptor antagonists (last 10-min, ‘End-infusion’). Data are presented 
as mean ± SE. * P≤0.05 from baseline (Student’s t-test).  
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Discussion 
 
The present study provides three interesting and clinically important new findings: 1) 
endogenous ET-1 hardly contributes to baseline vascular tone in the leg of healthy 
control subjects, 2) in contrast, in SCI individuals endogenous ET-1 has a prominent 
role in the regulation of vascular tone in the deconditioned leg, and 3) exercise 
training in SCI individuals reverses the ET-1-pathway, which normalizes basal leg 
vascular tone. Based on the fact that ET-1 plasma levels did not change, our findings 
in SCI may be explained by an up-regulation of the ET-receptor sensitivity or 
signaling. Thus, our results indicate that intensive long-term inactivity in humans 
results in a significant, though reversible, ET-1-mediated vasoconstrictor state in the 
skeletal muscle vascular bed.  
 
In contrast to previous studies, using the perfused forearm model, we only observed a 
slight vasodilator effect of ET-1 blockade (9% increase in blood flow) in the leg of 
healthy subjects, whereas forearm blood flow increased by 35-60% during infusion 
of the ET-receptor antagonists BQ-123 and BQ-788 (11, 34, 35). The difference in 
response to ET-receptor blockade between forearm and leg vascular bed suggests that 
ET-1 has a different physiological effect on the lower limbs than on the upper limbs 
in healthy subjects. Recently, Newcomer et al. (25) reported significantly different 
responses for human forearm and leg vascular beds to endothelium-dependent 
(acetylcholine and substance P) and –independent (sodium nitroprusside) stimuli. 
Moreover, infusion of ET-1 in the rat hindquarters skeletal muscle bed results in a 
significantly lower vasoconstrictor response as compared with the mesenteric bed (8). 
It may be hypothesized that the level of activity may partly explain the differences in 
contribution of ET-1 to vascular tone between both limbs. The average level of 
skeletal muscle activity varies markedly between the upper and lower extremities. As 
bipeds, the legs are far more active during daily life (i.e. locomotion, standing) and 
during sports activities (i.e. running, cycling) than the human forearm.  
 
The larger vasodilator response to ET-receptor blockade in SCI individuals compared 
with controls indicates that ET-1 importantly contributes to the elevated baseline leg 
vascular tone in SCI. Moreover, since ET-receptor blockade eliminates the difference 
in leg blood flow between SCI and control subjects, ET-1 may even be primarily 
responsible for the increased basal leg vascular tone in SCI. This agrees with previous 
studies from our department which excluded a role for nitric oxide (4) or for α-
adrenergic receptor-mediated effects (18) in the elevated leg vascular tone in SCI 
individuals. Apart from the sympathetic denervation the main difference between SCI 
individuals and controls is the paralysis of the legs, resulting in an extreme inactivity 
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of the legs. This suggests a functional link between the contribution of ET-1 to 
vascular tone and inactivity, which is supported by the second part of our study 
demonstrating that exercise training in SCI individuals attenuates the contribution of 
ET-1 to leg vascular tone. This observation is in line with recent animal studies that 
report exercise training in healthy animals to result in a down-regulation of the ET 
pathway. For example, a decrease in receptor sensitivity to ET-1 in pig coronary 
arteries (16) and rat aortic and cerebellar vessels (20) is reported after exercise 
training. However, the reversal of the contribution of ET-1 to leg vascular tone in our 
study was not complete, suggesting that ET-1 may not be the only factor in vascular 
adaptation to SCI or, alternatively, that the training period didn’t last long enough.  
The mechanism behind the adaptation of the ET pathway to (in)activity remains to be 
solved. In the present study, ET-1 plasma levels were not different before and after 
training in SCI individuals, nor between controls and SCI individuals. This indicates 
that different ET-1 plasma levels cannot explain the changes in the contribution of 
ET-1 to leg vascular tone with (in)activity. As such, changes in sensitivity (and/or 
density) of the ETA- and ETB-receptors or changes in endothelin receptor signaling are 
more likely to explain the inactivity-induced up-regulation of the ET pathway. The 
magnitude of the response to selective ETA-receptor blockade in the subset of SCI 
individuals is similar to the vascular response observed during dual blockade of the 
ETA/B-receptors. In combination with the marked increase in blood flow during ET-
blockade in the SCI subjects, these results indicate that the ETA-receptor mediates the 
increased contribution of ET-1 to leg vascular tone in SCI subjects. A strong argument 
against a role of the ETB-receptor is related to the fact that these receptors mediate 
vasodilation by endothelial generation of nitric oxide (NO) (34). We recently 
demonstrated that the contribution of NO to baseline leg vascular tone is preserved 
in SCI subjects as examined with infusion of L-NMMA in the femoral artery (4). Since 
the vasodilator properties induced by agonism of the ETB-receptors are mediated by 
NO, the ETB-receptor cannot account for the increased ET-1-mediated 
vasoconstriction observed in the legs of SCI subjects. 
Because both groups were sex-matched, each population consisted of 7 males and 1 
female. Interestingly, there was no gender difference noted in any of the measured 
parameters. Excluding the female subjects did not change the magnitude of the data 
outcome measures. 
 
Clinical relevance. SCI individuals are prone to develop decubitus and have poor 
wound healing, which may be caused by the increased leg vascular tone. Based on 
the constrictor action of ET-1 in SCI, pharmacological interventions that block the ET-
1 activity may improve or prevent these pathologic conditions. Prolonged 
administration may even improve general cardiovascular function, but at present, no 
data is available. Increasing evidence supports a pathophysiological role for ET-1 in 
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the modulation of vascular tone in cardiovascular disease (21, 28). Based on our 
findings one should realize that the negative effects of ET-1 in cardiovascular disease 
may be confounded by the level of inactivity. Therefore, inactivity, rather than the 
pathology of these specific cardiovascular diseases, is emerging as a strong candidate 
to explain the ET-1-mediated elevated vascular tone in cardiovascular disease.  
 
Limitations. In this study we used local infusions of drugs into the femoral artery. 
Since the leg represents an ~8-fold larger vascular bed as compared with the 
forearm, higher dosages were necessary, and therefore systemic spill-over effects may 
have occurred. Control subjects, however, showed no change in mean arterial 
pressure or heart rate during ET-receptor blockade. In SCI individuals, although the 
same protocol was used, a significant decrease in mean arterial pressure was found. 
This change in arterial pressure is most likely mediated through the ET-receptor 
blockade-induced vasodilation, without the concomitant contra-regulation via 
baroreflex-mediated sympathetic vasoconstriction in SCI. The non-infused leg 
showed a vasodilator response, indicating a systemic vascular effect, which may be 
caused by a minor spillover of the ET-antagonists. Differences in body composition 
between controls and SCI individuals (e.g. less fat-free mass in SCI (22)) may have 
contributed to the spillover. As a consequence of the vasodilation in the control limb 
in SCI, flow ratios underestimate unilateral vascular changes in the infused leg (27). 
The contribution of ET-1 to leg vascular tone in SCI may, therefore, be even more 
pronounced than indicated by the flow ratio. Although in this study design it was not 
possible to avoid systemic actions of the ET-receptor antagonists, these issues will not 
alter the major outcome of the study.  
 
In conclusion, compared to the minor effect of ET-1 on leg vascular tone in healthy 
subjects, ET-1 is a key mediator in the increased leg vascular tone in SCI individuals. 
In addition, data of this study indicate that exercise training can reverse the 
contribution of ET-1 to vascular tone in SCI. These adaptations in the ET pathway 
may be the result of changes in ET-receptor sensitivity or signaling, rather than 
changes in plasma levels of ET-1. Thus, inactivity appears to up-regulate the ET 
pathway in the human skeletal muscle vascular bed. 
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Abstract 
 
Because age-related changes in the large conduit arteries (increased wall thickness, 
and attenuated arterial compliance and endothelial function) are associated with 
cardiovascular pathology, prevention is of paramount importance. The effects of 
endurance training (i.e., walking or cycling) in older humans are assessed in cross-
sectional studies, examining the brachial and carotid arteries (supplying non-trained 
areas).  
Purpose. To assess the effects of 8 week endurance training in older men on conduit 
artery characteristics in the trained and non-trained vascular beds.  
Methods. In 8 healthy sedentary older men (70 ± 3 years), characteristics of the large 
conduit arteries (common femoral (CFA), superficial femoral (SFA), carotid (CA), and 
brachial artery (BA)) were measured before and after 8 week cycling training. 
Functional (arterial compliance and flow-mediated dilation (FMD)) and structural 
(diameter and intima-media thickness) conduit artery properties were measured using 
echo-Doppler. Peak blood flow, representing structural peripheral adaptations, was 
measured using venous occlusion plethysmography.  
Results. After training, peak leg blood flow was increased (P<0.01) and baseline 
diameter and flow were increased in the CFA (P<0.05). Cycling training enhanced 
arterial compliance of the SFA (P<0.05), but did not affect the FMD or the intima-
media thickness of the SFA. Exercise training did not alter characteristics of the BA 
nor CA.  
Conclusion. Eight weeks of endurance training in older men altered functional and 
structural characteristics of the lower extremity vasculature, whereas no changes are 
reported for the conduit arteries in the non-trained areas (BA or in the CA).  
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Introduction 
 
The conduit arterial wall and the inner surrounding, the endothelium, are essential to 
support the cardiovascular system to optimally meet the requirements of the human 
body (13). The arterial wall expands and recoils during the cardiac cycle, thereby 
damping down the fluctuation of blood flow (1). The absolute change in arterial 
volume for a change in pressure is commonly referred to as the arterial compliance. 
In addition, the endothelium can alter vascular function by the production of 
vasorelaxants (i.e. nitric oxide and prostaglandins) or vasoconstrictors (i.e. 
endothelin). Attenuation of arterial compliance (1, 15) and endothelial function (4, 
18) are associated with an increased risk of cardiovascular disease. 
Advancing age is reported to impair endothelial function (9, 25), decrease arterial 
compliance (22, 23, 26), and increase the intima-media thickness (17, 27, 28). 
Prevention of these adverse adaptations in conduit arteries is of paramount 
importance. Based on the repetitive intervals of increased shear stress and hypoxia 
(20), exercise seems to be a non-pharmacological intervention to improve 
cardiovascular function. However, current knowledge about the effects of exercise 
training in older men is primarily based on cross-sectional studies, suggesting that 
exercise correlates with an increased brachial endothelial function (9, 25) and a 
decreased carotid arterial stiffness (23, 26). To date, only one study (9) examined the 
restorative capacity of exercise training on vascular properties in older/middle-aged 
men and reported an increased brachial artery endothelial function.  
Recently, we reported that exercise-induced vascular adaptations occur in active 
tissues, rather than in non-trained areas (31). Nevertheless, previous studies that 
examined the effects of endurance training (i.e. walking or cycling) examined carotid 
or brachial artery function, but not the large conduit arteries of the legs supplying the 
active trained areas. As such, the aim of the present study is to examine the effects of 
an 8 week cycling training on the large conduit arteries (legs and arm) in a group of 
healthy sedentary older men. We hypothesize that exercise training leads to 
adaptations in the leg conduit arteries, but not in the brachial or carotid artery. 
 
 
Methods 
 
Subjects 
Eight healthy older men (age 70 ± 1 years, table 1), who were classified as sedentary 
(not participating in regular exercise), were included in the study. Subjects never 
smoked or they stopped smoking at least 15 years ago. All subjects were 
normotensive (blood pressure <140/90), had no hypercholesterolemia (triglycerides 
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<1.7 mmol⋅l-1 and HDL-cholesterol >0.9 mmol⋅l-1, total cholesterol <6.0 mmol⋅l-1), 
and were free of overt chronic cardiovascular disease as assessed by medical history 
and physical examination. None of the subjects used medication known to interfere 
with the cardiovascular system. Individuals with ankle-brachial pressure index <0.90 
and/or abnormal 12-lead resting ECG were excluded. The research has been carried 
out in accordance with the Declaration of Helsinki and the ethics committee of the 
Radboud University Nijmegen Medical Centre approved the study. All subjects gave 
their written informed consent before participation. 
 
 
Table 1. Subject characteristics in sedentary older men (n=8) before and after training.  
 
 Before training After training 
Cholesterol, mmol⋅l-1 4.83 ± 0.38 4.58 ± 0.11 
Triglycerides, mmol⋅l-1 1.01 ± 0.27 0.97 ± 0.15 
HDL, mmol⋅l-1 1.16 ± 0.20 1.15 ± 0.06 
LDL, mmol⋅l-1 3.23 ± 0.26 3.01 ± 0.10 
 
Incremental exercise test 
  HR max, bpm 165 ± 7 166 ± 8 
  VO2max, ml⋅kg-1⋅min-1 30.8 ± 4.8 33.3 ± 5.5 
  Workload max, W 171 ± 32 201 ± 39 * 
  Lactate max, mmol⋅l-1 7.7 ± 2.1 7.6 ± 1.2 
  RER 1.20 ± 0.13 1.17 ± 0.06 
Data are presented as means ± SD. (HDL; high-density lipoprotein, LDL; low-density 
lipoprotein, HR; heart rate, VO2max; maximal oxygen consumption, W; watts, RER; respiratory 
exchange ratio). * P<0.01 before versus after training (Student’s t-test). 
 
 
Protocol  
Before and after an 8 week cycling training, vascular characteristics (arterial 
compliance, intima-media thickness, flow-mediated dilation, diameter and blood 
flow) were measured in the large conduit arteries (common femoral artery (CFA), 
superficial femoral artery (SFA), carotid artery (CA), and brachial artery (BA)). On a 
separate day, maximal oxygen consumption was measured during an incremental 
cycling test. 
 
Measurements 
After a 12 h overnight fast, vascular measurements were performed in the morning. 
Subjects refrained from caffeine, nicotine, chocolate, kiwi, vitamin C supplements, 
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and alcohol for at least 18 h before the test. Room temperature was controlled at 23 
± 1 °C. Measurements started after a 30 min acclimatization period in the supine 
position. 
 
Peripheral vascular parameters 
Resting heart rate was recorded using a 3-lead ECG and calculated as the average 
heart rate over a 5 min period. Baseline blood flow and vascular resistance of the 
forearm, calf, and thigh were measured unilateral (at the right side) for 5 min using 
venous occlusion plethysmography in the supine position. Positioning of the cuffs 
and mercury-in-silastic strain gauges (Hokanson Inc., Bellevue, WA, USA) are 
described in detail in a previous study (29). The venous occlusion cuff was inflated, 
ECG-triggered and within one heart beat, to a cuff pressure of 50 mmHg (14). This 
pressure was produced by a rapid cuff inflator (Hokanson Inc., Bellevue, WA, USA) 
and sustained for 9 heart beats after which the cuff was instantaneously deflated (for 
10 heart beats). Before each measurement, blood pressure was measured at the left 
brachial artery using a sphygmomanometer, and mean arterial pressure (MAP) was 
calculated. The MAP was used for calculation of the baseline vascular resistance 
(MAP/blood flow, in mmHg⋅ml-1⋅min-1⋅dl-1; arbitrary units (AU)). Peak thigh blood 
flow was measured during the post-occlusive reactive hyperemia, which was 
achieved by 5 min of arterial occlusion (220 mmHg). 
Plethysmographic data were digitalized with a sample frequency of 100 Hz (MIDAC, 
Instrumentation Department, Radboud University Nijmegen Medical Centre, The 
Netherlands) and analyzed by a customized computer program (Matlab, Mathworks 
Inc., USA). Baseline and peak blood flow were calculated as the slope of the volume 
change over a 4 and 1 s interval, respectively. Measurement started directly after the 
inflation-induced cuff artefact, as previously described (29). For the peak thigh blood 
flow, the highest value after release of the cuff was accepted as the peak blood flow. 
In our laboratory, this technique has a good day-to-day reproducibility for forearm, 
calf, and thigh baseline blood flow (CV of 16.9, 14.0, and 5.9%, respectively) and 
thigh peak blood flow (CV of 6.4%) in a group of healthy men (29). 
 
Conduit artery characteristics  
An experienced echographist performed and analyzed all echo Doppler data. 
Diameter. Systolic and diastolic vessel diameter was measured with an echo Doppler 
device (Megas, ESAOTE, Firenze, Italy) with a 5 to 7.5 MHz broadband linear array 
transducer. Images for the CA (left) were made at the proximal 1.5 cm straight portion 
of this artery. Brachial images were obtained 3 cm proximal of the olecranon 
process. For the CFA images were made 2 cm proximal of the bifurcation. SFA 
images were made 3 cm distal of the bifurcation. Two consecutive images in the 
longitudinal view were frozen at the peak systolic and end-diastolic phase. Off-line, 
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3 measurements were performed per diameter image, and the mean diameter (D) 
was calculated by using the formula: 1/3⋅systolic diameter + 2/3⋅diastolic diameter.  
Arterial compliance. The combination of ultrasound imaging of an artery with 
simultaneous assessment of the arterial pressure permits determination of arterial 
compliance. CA and SFA arterial diameters were measured in the supine position 
with an echo Doppler device (Megas, ESAOTE, Firenze, Italy) with a 5 to 7.5 MHz 
broadband linear array transducer. Three consecutive images at end-diastolic and 
systolic pressure were recorded and analyzed off-line. The pressure waveform and 
amplitude were obtained invasively from the contra-lateral femoral artery. A 
modified Seldinger technique was used to introduce an intra-arterial cannula 
(Angiocath 16 gauge, Becton Dickinson) into the right femoral artery at the level of 
the inguinal ligament for blood pressure measurement (Hewlett Packard monitor type 
78353 B, Hewlett Packard GmbH). The measurement of pulse pressure and changes 
in diameter were synchronized and used to calculate the arterial cross-sectional 
compliance as the changes in cross sectional area relative to the pulse pressure 
according to the formula (ΔD/Dmean)/(2⋅ΔP)⋅π⋅Dmean2 (mm2⋅mmHg-1) (26) (ΔD is the 
difference between systolic and diastolic diameter, Dmean is 1/3⋅systolic diameter + 
2/3⋅diastolic diameter, ΔP is the difference between systolic and diastolic pressure). 
In our laboratory, this technique has an excellent day-to-day reproducibility for the 
Dsystolic (n=5, CV of 2.6%) and Ddiastolic (CV of 2.3%) in a group of healthy men. 
Flow Mediated Dilation (FMD). The FMD of the BA and SFA, representing 
endothelial function (6), was assessed after 5 min of arterial occlusion. The occlusion 
cuff (10 cm) for the brachial artery was placed around the forearm. For superficial 
femoral artery occlusion, a large cuff (12 cm) was placed around the upper thigh, 
~10 cm distally from the greater trochanter (8). Release of the occlusion cuff results 
in a marked increase in wall shear stress; the eliciting stimulus for FMD (6). The 
diameter was videotaped for 4 min to assess the maximal endothelium dependent 
dilation off-line. In addition, a single spray of sublingual nitroglycerin (NTG; 400 μg), 
a nitric oxide donor, was administered to determine the maximal endothelium 
independent dilation of the SFA (6), which is indicative of smooth muscle function. 
Vessel diameters during the FMD were measured off-line from videotape at 50, 60, 
70, 90, 120, 180, and 240 s after cuff release and every 30 s after administration of 
NTG. FMD and the NTG-response were expressed as the maximal relative (%) 
diameter change in end-diastolic baseline diameter. The ratio between the FMD 
response (%FMD) and the primary dilating stimulus (mean wall shear rate; MWSR) 
was calculated. Regional MWSR was calculated as (4⋅Vmean/D) (s–1). Delta MWSR 
(ΔMWSR) was defined as the difference between rest and peak response and was 
used to calculate the amount of vasodilation per stimulus during the FMD. In a group 
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of healthy men, this technique has a day-to-day reproducibility (CV) of 16 and 15% 
for BA and SFA FMD, respectively (8). 
Intima-media thickness (IMT). IMT of the CA and SFA were measured with an echo 
Doppler device (Logiq book, GE Healthcare, United Kingdom) equipped with a high-
resolution linear array transducer. Two consecutive ultrasound carotid and 
superficial femoral images were recorded at end-diastolic pressure and were 
analyzed off-line. The spatial resolution of the ultrasound machine used in the 
present study is 0.1 mm. IMT was defined as the distance from the leading edge of 
the lumen-intima interface to the leading edge of the media-adventitia interface (10). 
Lumen diameter was defined as the distance between the far wall boundary, i.e. 
lumen-intima interface, and the near wall boundary corresponding to the media-
adventitia interface. At least 10 measurements of IMT and lumen diameter were 
taken at each segment and used for analysis. IMT/lumen diameter ratio was used as a 
measure of wall thickness normalized for lumen size (10). In our laboratory, this 
technique has excellent day-to-day reproducibility for the carotid and superficial 
femoral artery IMT (n=5, CV 3.6 and 5.5%, respectively), in a group of healthy men. 
 
Maximal oxygen consumption  
Physical fitness before and after the training period in older men was assessed by an 
incremental maximal exercise-test on a cycling ergometer (Lode, Angio300, 
Groningen, the Netherlands) using a multistage protocol (workload increased by 10 
W per minute, starting at 10 W, until exhaustion). Oxygen consumption was 
measured continuously with a gas-analyzer (Jaeger Benelux BV, Breda, the 
Netherlands). Maximal oxygen consumption (VO2max) was calculated as the mean of 
the last minute of the test. Subjects were verbally encouraged to continue for as long 
as possible. Heart rate was recorded using a 3-lead ECG. The criterion used to assess 
the quality of the VO2max-test included 1) a heart rate in excess of 90% of age 
predicted maximum (220–age); 2) a respiratory exchange ratio ≥1.10; and 3) 
identification of a plateau (≤150 ml increase) in oxygen consumption despite a 
further increase in workload. 
 
Exercise Intervention 
The elderly trained for 8 weeks (3 sessions per week) under the supervision of a 
researcher with at least 1 day between subsequent exercise bouts. A cycling 
ergometer (Lode, Angio300, Groningen, the Netherlands) was used for leg cycling 
exercise. Each session started with a 10 min warming-up. After muscle stretching, the 
exercise protocol was followed with 20 min cycling exercise at 65% of the individual 
HRR. As their exercise tolerance improved, the intensity of the training was increased 
by 5% HRR to a maximum of 85% of the HRR. In the 1st training session the average 
workload was 157 ± 48 kJ; in the 24th training session 234 ± 50 kJ. Control of the 
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exercise prescription was documented through the use of heart rate monitors (Polar 
heart rate recorder). 
 
Statistical analysis 
The primary end points of this study are the FMD-response and arterial compliance. 
With an estimated SD of 50%, a relevant effect of intervention of 45%, and an alpha 
of 0.05, we calculated that at least 8 subjects per group would be needed to achieve 
a power of 80%. Statistical analyses were performed using SPSS 12.0 computer 
software (SPSS Inc., Chicago, Illinois, USA). Based on the Kolmogorov-Smirnov test 
for normality, all parameters were normally distributed and analysed with a Student’s 
t-test. Data are presented as means ± SD. The level of statistical significance was set 
at α=0.05. 
 
 
 
Table 2. Peripheral vascular characteristics of the thigh, calf, and forearm in sedentary older 
men (n=8) before and after the training.  
 
 Before training After training 
Thigh   
 Baseline BF, ml⋅min-1⋅dl-1 3.1 ± 1.1 3.7 ± 1.0 * 
 Baseline VR, AU 37 ± 17 27 ± 7 * 
 Peak BF, ml⋅min-1⋅dl-1 19.1 ± 5.9 24.6 ± 6.6 † 
 Minimal VR, AU 6.0 ± 1.8 4.6 ± 1.0 * 
 
Calf 
    
 Baseline BF, ml⋅min-1⋅dl-1 3.7 ± 1.5 4.1 ± 1.8 
 Baseline VR, AU 32 ± 16 26 ± 10 
 
Forearm 
    
 Baseline BF, ml⋅min-1⋅dl-1 3.2 ± 0.7 3.0 ± 1.0 
 Baseline VR, AU 33 ± 11 34 ± 11 
Data are presented as means ± SD. (BF; blood flow, VR; vascular resistance, AU; Arbitrary 
Units in mmHg⋅ml-1⋅min-1⋅dl-1). * P<0.05 before versus after training. † P<0.01 before versus 
after training. 
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Results 
 
Baseline physical characteristics 
All older men successfully completed the training with a compliance with the 
training sessions of 100%. Eight weeks of cycling training did not alter body mass 
(pre: 76 ±±7 kg, post: 75±± 6 kg), systolic (pre: 129 ± 9 mmHg, post: 127±± 8 
mmHg) and diastolic blood pressure (pre: 77±± 6 mmHg, post: 75±± 6 mmHg), but 
significantly decreased resting heart rate (pre: 60±± 4 bpm, post: 52±± 3 bpm, t-test: 
P<0.05). Cholesterol levels did not change after training (table 1).  
Maximal power output during the incremental cycling test was significantly 
increased after training (table 1). Although not significant, maximal oxygen 
consumption tended to increase (P=0.09).  
 
 
Table 3. Characteristics of the conduit arteries (femoral artery, superficial femoral artery, 
carotid artery, brachial artery) in sedentary older men (n=8) before and after the training.  
 
Data are presented as means ± SD (MWSR; mean wall shear rate). * P<0.05 before versus after 
training. † P<0.01 before versus after training. 
 
 Before training After training 
Femoral artery   
Diameter, mm 9.7 ± 0.9 10.3 ± 0.9 † 
Flow, ml⋅min-1 147 ± 74 194 ± 83 * 
MWSR, s-1 14 ± 7 15 ± 5 
 
Superficial femoral artery 
     
Diameter, mm 8.2 ± 0.4 8.3 ± 0.3 
Flow, ml⋅min-1 53 ± 27 80 ± 28 * 
MWSR, s-1 8 ± 4 12 ± 5 
 
Carotid artery 
     
Diameter, mm 7.7 ± 0.5 7.8 ± 0.6 
Flow, ml⋅min-1 443 ± 123 392 ± 102 
MWSR, s-1 81 ± 17 73 ± 22 
 
Brachial artery 
     
Diameter, mm 5.1 ± 0.3 5.1 ± 0.4 
Flow, ml⋅min-1 54 ± 22 55 ± 12 
MWSR, s-1 36 ± 16 38 ± 17 
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Peripheral vascular parameters 
Eight weeks cycling training significantly increased thigh baseline and peak blood 
flow and decreased thigh baseline and minimal vascular resistance. Baseline forearm 
and calf blood flow and vascular resistance did not change after training (table 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Arterial cross-sectional compliance (SCS in mm2⋅mmHg-1) of the carotid artery (CA) 
and superficial femoral artery (SFA) before (black bars) and after (white bars) 8 weeks of 
cycling training in older men (n=8). A paired Student’s t-test was used to assess differences 
before and after the training intervention. Error bars represent SE. 
 
 
 
Conduit artery structural and functional characteristics 
Diameter. Resting diameter of the CFA, but not of the SFA, was significantly 
increased after training. Flow of the CFA and SFA were significantly increased after 
training (table 3). Cycling training did not change diameter and flow of CA and BA. 
Arterial compliance. Cross-sectional arterial compliance of the SFA increased by 
40% after 8 weeks of exercise training. CA arterial compliance did not change with 
training (figure 1). 
Flow Mediated Dilation (FMD). The uncorrected and corrected (for mean wall shear 
rate) FMD of the BA and SFA did not change after training (figure 2A-B). The 
nitroglycerine response of the SFA was not changed with training (figure 2A). 
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Intima-media thickness (IMT). Due to technical problems prior to training, the 
baseline IMT in one subject could not be analyzed. The IMT of the SFA (pre: 0.55 ± 
0.03 mm, post: 0.59 ± 0.02 mm) and CA (pre: 0.77 ± 0.04 mm, post: 0.77 ± 0.05 
mm) showed no change after the training period (table 2). Also the corrected IMT 
(IMT/lumen) did not change after training in the SFA (pre: 0.064 ± 0.002, post: 0.070 
± 0.002) or CA (pre: 0.098 ± 0.006, post: 0.099 ± 0.006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Flow-mediated dilation (FMD, in % from baseline, A) and corrected flow-mediated 
dilation (%FMD/ΔMWSR, B) of the brachial (BA) and superficial femoral artery (SFA) before 
(black bars) and after (white bars) 8 weeks of cycling training in older men (n=8). Also the 
nitroglycerine response of the SFA is represented (SFA-NTG, A). P-values represent the paired 
Student’s t-test to assess differences before and after the training. Error bars represent SE. 
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Discussion 
 
This study examined the effects of 8 week cycling exercise on the characteristics of 
the large conduit arteries in healthy older men. Interestingly, our results demonstrate 
exercise-induced adaptations in the conduit arteries of the legs in older men (CFA 
and SFA), but not of the BA and CA. These results suggest that 8 weeks of cycling 
training in older men leads to vascular adaptations in the trained, but not in the non-
trained areas. 
 
General adaptations 
The maximal oxygen consumption of the sedentary older men before training (23, 
26, 28) is comparable with previous studies. Although the cycling training in older 
men did not significantly improve maximal oxygen consumption, 7 out of 8 subjects 
increased their maximal oxygen consumption and all men completed a higher 
maximal workload during the post-training cycling test. Moreover, the ~8% increase 
in oxygen consumption is larger than reported in previous studies in which older 
men were trained for 12 weeks (9, 26, 28). 
The unchanged vascular function in non-trained areas (CA and BA) after cycling 
training in older men is in agreement with previous studies in healthy middle-aged 
subjects (28), while others report improvement in BA endothelial function after leg 
exercise in young men (5, 9). An important difference is that we used cycling 
training, while others used walking (9) or whole body exercise (5). While cycling 
mainly exercises the thigh muscles, the other exercise modalities activate the upper 
and lower extremity muscle groups. Although leg exercise increases blood flow in 
the non-trained vascular beds during exercise (12), this change may be insufficient to 
induce adaptations in the non-trained BA and CA within 8 weeks in older men.  
 
Leg vascular adaptations 
This study demonstrates that 8 weeks of cycling in older men induces an increase in 
CFA diameter (structural change) and an increase in thigh peak blood flow (structural 
adaptation peripheral vasculature (16)). These structural adaptations of conduit 
arteries and resistance arteries to exercise are consistent with previous longitudinal 
studies that examined the effects of 12 week training in middle-aged subjects (10, 
21). 
Arterial compliance. The arterial compliance of the CA in older men is well below 
values of younger controls (~0.20 mm2·mmHg-1) (23, 26). SFA compliance has not 
been measured before in older men. Compliance of the SFA in our study is lower 
than reported previously in young men (~0.08 mm2⋅mmHg-1) (7, 22). Apart from 
cross-sectional data (23, 26), only Tanaka et al. (26) examined the effect of 
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endurance training on arterial compliance in sedentary men. They found an increase 
in CA arterial compliance, while we demonstrated no change in arterial compliance 
after training. Differences in training stimulus (12 week walking versus 8 week 
cycling) and population (middle-aged versus elderly) may contribute to the different 
outcomes. The longitudinal effect of endurance training on the arterial compliance of 
the SFA in older men has not been examined before. We found a ~40% increase in 
SFA compliance after 8 weeks of cycling exercise in older men, which represents a 
substantial reversion of the age-related decrease in SFA compliance. Our results are 
therefore consistent with a recent training study (7), which demonstrated an 
increased arterial compliance of the femoral artery over a relatively short time period 
in spinal cord-injured individuals.  
The major determinants of arterial compliance are the distensibility of the artery in 
relation to the differences between the diastolic and systolic pulse pressure within the 
artery. Although the pulse pressure in the older men was relatively high (~71 mmHg), 
the age-related increase in arterial compliance is caused through adaptations of the 
arterial wall itself. This is nicely demonstrated by the post-training arterial 
compliance in the older men. The post-training pulse pressure has changed 
minimally, while distensibility of the SFA increased by ~42% in the older men. The 
physiological mechanism for the change in arterial distensibility is not clear. Potential 
mechanisms may include the formation of elastic fibres or decrease of collagen cross-
linking and glycation of end products. In addition, exercise training is reported to 
decrease resting muscle sympathetic nerve activity (11). Since the sympathetic 
nervous system is a determinant of arterial wall vascular tone, a decreased post-
training sympathetic vasoconstrictor tone (3) may contribute to the increased arterial 
compliance.  
Flow-mediated dilation (FMD). Parallel to previous studies (9, 25), we report 
relatively low BA FMD values in older men compared with healthy young men in 
our lab (2, 8). To date, little is known about the effects of aging on the SFA 
endothelial function. Here, we demonstrate that the corrected (for the MWSR) and 
uncorrected SFA FMD in healthy older men are well below values previously 
reported in our lab in young men (2, 8, 30). Our findings, while consistent with 
earlier studies in the BA (9, 25), suggest that advancing age is associated with 
impaired systemic endothelial function. This leaves open the question whether a 
decreased physical activity contributes to this lower FMD in the SFA. In contrast to 
our hypothesis, the FMD of the SFA was not increased after 8 weeks of training. 
Although this suggests that exercise training does not influence the endothelial 
function in the SFA in older men, it should be noted that the MSWR-corrected FMD 
increased 57%, but not significantly. Possibly, 8 weeks is insufficient to induce a 
relevant increase in superficial femoral artery FMD in older men. 
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IMT (intima-media thickness). Previous studies reported positive correlations between 
age and IMT of the CA (28) and CFA (10). In parallel, the wall thickness of the CA 
and SFA in this study is well above values reported previously for young subjects 
(CA: ~0.48 mm (28), SFA: ~0.46 mm (19)). The unaltered CA IMT after endurance 
training in the older men is in agreement with previous training studies (12 weeks) in 
middle- and older aged men (28) and post-menopausal women (24). However, 
Dinenno et al. (10) demonstrated a decrease in CFA IMT after 3 months of walking 
exercise. In contrast, we report no change in the wall thickness in the SFA after 
training. Methodological differences between both studies may contribute to the 
discrepancies in findings; we trained a significantly older population (70±± 1 years 
versus 51 ± 2 years), while also the exercise stimulus in the present study was lower 
(8 wk, 3 sessions p/wk versus 12 wk, 5.3 sessions p/wk).  
 
Clinical relevance. This study provides rationale that training improves arterial 
compliance and decreases leg vascular resistance in healthy older men. In addition, 
based on the absent vascular adaptations in the non-trained areas (BA and CA), we 
advocate the use of whole-body exercise to improve general vascular function in 
older men.  
 
In conclusion, eight weeks of cycling training in older men results in functional and 
structural adaptations of the large conduit arteries of the legs, but not in conduit 
arteries of the non-trained vascular beds (brachial and carotid artery). This indicates 
that endurance training in older men rapidly induces vascular adaptations, which 
may contribute to the beneficial effects of physical exercise in this population.  
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Abstract 
 
Previous reports demonstrated that advanced age is associated with a decrease in leg 
blood flow and reduced physical activity. Based on the vasoconstrictor properties of 
endothelin (ET-1), it may play a role in the increased leg vascular tone in older men. 
Recent observations indicate that the level of physical (in)activity affects the ET 
pathway in humans.  
Purpose. To assess the contribution of ET-1 to the increased vascular tone in the legs 
of healthy sedentary older men, both before and after 8 weeks of exercise training. 
Methods. In 8 young subjects (7 male, 1 female, 19-50 years) and 8 older men (67-
76 years) bilateral thigh blood flow was measured using venous occlusion 
plethysmography before and after complete blockade of ET-1. Blockade was 
achieved by the combined infusion of selective ETA- and ETB-receptor antagonists 
into the femoral artery. In the older men, reversibility of the observations was 
assessed after 8 weeks of cycling.  
Results. ET-receptor blockade increased leg blood flow significantly more in the 
older men compared with the young individuals (29 ± 9% and 10 ± 4%, respectively, 
P<0.05). Eight weeks of cycling training normalized baseline blood flow in older 
men. The blood flow response to ET-receptor blockade in older men was not affected 
by the training program (25 ± 8%, P>0.05 for comparison with pre-training). The 
response in flow ratio (blood flow infused leg/blood flow non-infused leg) decreased 
significantly by training from 26 ± 8% to 7 ± 3% (P<0.05). 
Conclusions. The increased baseline vascular tone in aging is at least in part 
mediated by the endothelin pathway. These alterations may partially be explained by 
an age-related decrease in physical activity. 
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Introduction  
 
A common feature in older men is an increased baseline vascular tone (8, 9). This 
age-related increase in vascular tone is partly mediated by a chronically elevated 
sympathetic α-adrenergic vasoconstriction (11). However, also other factors may 
contribute. The endothelium plays an important role in the regulation of vascular 
tone via the release of dilator and constrictor substances. Endothelin-1 (ET-1) (42) is 
the most potent endothelium-derived constricting factor and contributes to the 
regulation of peripheral vascular tone (16, 18, 31, 40) by interacting with ETA- (1) 
and ETB-receptors (17) on smooth muscle and endothelial cells (7, 39). 
Recently, animal studies demonstrated that aging leads to an augmented 
vasoconstrictor response to ET-1 in rat gastrocnemius (12) and coronary (22) vascular 
bed. Although some previous studies in humans reported increased ET-1 plasma 
levels in older humans (3, 24, 25), this provides no information about the functional 
contribution of endogenous ET-1 to vascular tone. In the present study, we 
hypothesize that the age-related elevated vascular tone can be explained by an 
augmented contribution of ET-1. To address this hypothesis we examined the 
vasodilator response to combined ETA- and ETB-receptor blockade in older men as 
well as in younger controls. 
Aging is often associated with physical inactivity (36). Parallel to this, exercise 
training in older men improves vascular function (10), reduces plasma levels of ET-1 
(24), and decreases vascular tone (8). To further explore the causal role of inactivity 
in age-related changes of the ET pathway, we repeated the experiments in the older 
men after 8 weeks of cycling training. 
 
 
 
Methods 
 
Subjects 
Eight healthy older men (67-76 years, table 1), who were classified as sedentary (no 
regular exercise), and 8 healthy control subjects (7 male and 1 female, 19-50 years, 
table 1), participated in the study. Subjects never smoked or stopped smoking at least 
15 years ago. Subjects were included when they fulfilled the inclusion criteria: 
normotensive (blood pressure <140/90, auscultatory measurement after at least 5 min 
seated rest), no hypercholesterolemia (cholesterol <6.0 mmol⋅l-1), and free of overt 
cardiovascular disease as assessed by medical history, physical examination, ankle-
brachial pressure index, and a 12-lead ECG at rest. None of the subjects used 
medication known to interfere with the cardiovascular system. The study was 
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approved by the hospital ethics committee. All subjects gave their written informed 
consent before participation. 
 
 
Table 1. Physical characteristics and the incremental maximal test of controls (n=8) and older 
men (n=8) before and after 8 weeks of exercise training.  
 
Values from controls for lipid profile represents 7 subjects and endothelin-1 levels represent 6 
subjects. Blood pressure values are derived from the screening procedure. Data are presented 
as means ± SD. * Indicates a significant difference between before and after training (paired 
Student’s t-test). † Indicates a significant difference between controls and older men (unpaired 
Student’s t-test) (BP; blood pressure, HDL; high density lipoproteins, LDL; low density 
lipoproteins, VO2max; maximal oxygen consumption, RER; respiratory exchange ratio). 
 
 
Experimental design  
The study was designed in two separate parts. First, control subjects and older men 
were studied to quantify the vasodilator response to blockade of ET-receptors in the 
leg. Second, at least two weeks thereafter, the older men started with an 8 week 
cycling training program to examine whether the contribution of ET-1 to leg vascular 
tone is reversible by training. For this purpose, exactly the same experimental 
protocol was repeated 4-5 days after the final training session. 
Characteristics Controls (n=8)  Older men (n=8)  
  0 weeks 8 weeks 
 Body mass, kg 71 ± 7 † 76 ± 7 75 ± 6 
 Body height, cm 177 ± 10 173 ± 8    
 Body mass index, kg⋅m2 22.7 ± 2.3 † 25.4 ± 2.8 25.2 ± 2.6 
 Diastolic BP, mmHg 73 ± 5 77 ± 6 75 ± 6 
 Systolic BP, mmHg 123 ± 9 129 ± 9 127 ± 8 
 Cholesterol, mmol⋅l-1 4.4 ± 1.2 4.8 ± 0.4 4.6 ± 0.1 
 Triglycerides, mmol⋅l-1 1.0 ± 0.6 1.0 ± 0.3 1.0 ± 0.2 
 HDL, mmol⋅l-1 1.3 ± 0.1 1.2 ± 0.2 1.2 ± 0.1 
 LDL, mmol⋅l-1 2.6 ± 1.0 3.2 ± 0.3 3.0 ± 0.1 
 Endothelin-1, pg⋅ml-1 0.91 ± 0.20 0.73 ± 0.14 0.64 ± 0.12 
 
Incremental maximum test 
  VO2max, ml⋅kg-1⋅min-1  30.8 ± 4.8 33.3 ± 5.5 
  Maximal workload, W  171 ± 32 201 ± 39 * 
  Maximal lactate, mmol⋅l-1  7.7 ± 2.1 7.6 ± 1.2 
  Maximal hear rate, bpm  165 ± 7 166 ± 8 
  RER  1.20 ± 0.13 1.17 ± 0.06 
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Protocol 
ET-receptor blockade. Experiments for both control subjects and the older men 
started at 8:30 AM after a 12 h overnight fast. All subjects refrained from caffeine-
containing food and beverages, alcohol, and vitamin C for at least 18 h and did not 
perform any strenuous activities at least 48 h before testing. All tests were performed 
in a quiet, temperature-controlled room (23.5 ± 0.5 °C), with the subjects in the 
supine position.  
A modified Seldinger technique was used to introduce an intra-arterial cannula 
(Angiocath 16 gauge, Becton Dickinson, Sandy, Utah, USA) into the right femoral 
artery at the level of the inguinal ligament under local anesthesia (0.4 ml lidocaine 
20 mg⋅ml-1). This cannula was used for the intra-arterial administration of ET-receptor 
antagonists by an automatic syringe infusion pump (Type P4000, Welmed Ltd, 
Hampshire, UK) (4, 21) and for blood pressure measurement (Monitor: Type 78353B, 
Hewlett-Packard, Houston, Texas, USA; Transducer: Type PX600, Edwards 
Lifesciences Services GmbH, Unterschleissheim, Germany). Heart rate was recorded 
continuously with ECG (lead II). After complete instrumentation and at least 30 min 
after cannulation of the femoral artery, an arterial blood sample was collected in 
non-heparinized tubes and stored at -80°C for later analysis. Plasma ET-1 levels were 
determined using a chemo-luminescent immunoassay with sensitivity for ET-1 of 
<0.16 pg⋅ml-1 (QuantiGlo, R&D Systems, Abingdon, UK). Subsequently, a 30 min 
measurement of baseline leg blood flow was performed, while saline was infused 
into the femoral artery. Bilateral leg blood flow was measured 3-4 times per minute, 
using ECG-triggered venous occlusion strain gauge plethysmography as previously 
described (14, 37). Briefly, an occlusion cuff (12 cm) was placed proximally around 
the upper leg and was connected to a rapid cuff inflator (Hokanson Inc., Bellevue, 
WA, USA), which inflated the cuff to a pressure of 50 mmHg (14). A mercury-in-
silastic strain gauge (Hokanson Inc., Bellevue, WA, USA) was placed at mid-thigh, at 
least 10 cm above the patella and at least 4 cm below the cuff (37). The lower legs 
were supported 10 cm above heart level to facilitate venous outflow between the 
venous occlusion periods.  
After the baseline measurements, the combined infusion of a selective ETA- and ETB-
receptor antagonist (BQ-123 and BQ-788, respectively, Clinalfa, Calbiochem-
Novabiochem AG, Läufelfingen, Switzerland) was started to block the ET-receptors of 
the right leg. BQ-123 (10 nmol⋅min-1⋅l-1 leg volume) and BQ-788 (1 nmol⋅min-1⋅l-1 
leg volume) were dissolved in saline, immediately prior to administration. During the 
whole protocol, infusion rate was kept constant at 0.1 ml⋅min-1⋅l-1 tissue. Infusion 
rate was adjusted to total leg-volume, which was determined by anthropometry as 
described and validated by Jones et al. (20). The ET-receptor blockers were infused 
for 75 min (13, 40). Previous studies showed that a 60 min co-infusion of BQ-123 
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and BQ-788 (at respectively 10 and 1 nmol⋅min-1⋅l-1 tissue into the brachial artery) 
resulted in maximal vasodilation in the forearm of healthy subjects without triggering 
any systemic blood pressure effects (13, 19).  
Physical training program. The older men trained under supervision for 8 week (3 
sessions per week) with at least 1 day between subsequent exercise bouts. A cycling 
ergometer (Lode, Angio300, Groningen, the Netherlands) was used for leg cycling 
exercise. Each session started with a 10 min warming-up at ~55% of the individual 
heart rate reserve (HRR). After muscle stretching, the exercise protocol was followed 
with 20 min cycling exercise at 65% of the individual HRR. As their exercise 
tolerance improved throughout the training period, the intensity of the exercise bouts 
was increased to a maximum of 85% of the HRR. In the 1st training session the 
average workload was 157 ± 48 kJ and in the 24th (i.e. last) training session, 234 ± 50 
kJ. Adherence to the exercise prescription was documented through the use of heart 
rate monitors (s610, Polar, Brooklyn, NY, USA). 
Physical fitness. In older men, physical fitness was assessed before and after the 
training by an incremental maximal exercise-test on a cycling ergometer (Lode, 
Angio300, Groningen, the Netherlands) using a multistage protocol (workload 
increased by 10 W per minute, starting at 10 W, until exhaustion). Oxygen 
consumption was measured continuously by a gas-analyzer (Jaeger Benelux BV, 
Breda, the Netherlands) and averaged over 30 s intervals. Maximal oxygen 
consumption was determined as the mean of the last minute of the cycling test.   
 
Data Analysis 
Plethysmographic data of both legs were digitalized with a sample frequency of 100 
Hz and analyzed off-line by a customized computer program (Matlab, Mathworks 
Inc., USA). Leg blood flow (in ml⋅min-1 per dl of leg tissue) was calculated as the 
slope of the volume change curve over a 4 s interval, starting directly after the 
inflation-induced cuff artifact (37). Thigh vascular resistance was calculated as the 
mean arterial pressure (in mmHg) divided by thigh blood flow (in ml⋅min-1⋅dl-1) and 
expressed in arbitrary units (AU; mmHg⋅ml-1⋅min-1⋅dl-1). In addition, the ratio 
between the infused and control (contra-lateral) leg was calculated to correct for 
possible systemic changes (28). 
Because of the anticipated differences in baseline thigh blood flow and vascular 
resistance between controls and older men, the response to intra-arterial drug 
infusion was expressed as percentage changes from baseline. For this purpose, 
baseline blood flow, vascular resistance and flow ratio were calculated by averaging 
registrations over a 10 min interval prior to the infusion of the ET-receptor blockers. 
Likewise, blood flow, vascular resistance, and blood flow ratio were analyzed over 
the last 10 min of the intra-arterial drug infusion, where ET-receptor blockade 
reached its maximal effect (32, 41) 
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Statistics 
The primary end point of this study is the vasodilator response to ET-receptor 
blockade in the leg in controls versus older men, and before versus after cycling 
training in older men. Based on an estimated SD of 13% of the average vasodilator 
response (for the between group comparison), a SD of 12% for the within group 
comparison (before versus after training), and a mean relevant effect of the ET-
blockade of 20% (control versus older men) or 15% (before versus after training) (38), 
we calculated that with an alpha of 0.05, 6-8 subjects per group would be needed to 
achieve a power of 80%. Therefore, we included 8 individuals per group. Shapiro-
Wilk and Kolmogorov-Smirnov tests indicated a normal distribution of data. Results 
are expressed as mean ± SE. To assess differences between controls and older men 
(unpaired) and between the pre- and post-training measurement (paired), the 
maximal effect of ET-receptor blockade (as defined as the average of the final 10 min 
of infusion) was compared using a Student’s t-test. Differences were considered to be 
statistically significant at a 2-sided probability value of α=0.05.  
 
 
 
Results 
 
Baseline characteristics 
Leg volume, ET-1 plasma levels, resting heart rate, and baseline leg blood flow and 
vascular resistance were not different between controls and healthy older men (table 
2). Diastolic and systolic blood pressure, ET-1 plasma levels, and cholesterol levels 
were not different between controls and healthy older men (table 1). Body weight 
and body mass index were significantly larger in the older men compared with 
controls (table 1).  
 
Dual ET-receptor blockade in controls and older men 
Controls. Blockade of the ET-receptors did not affect mean arterial pressure, heart 
rate, nor blood flow and vascular resistance in the non-infused leg in the control 
subjects (table 2). The ET-receptor blockade induced a small, but significant change 
in blood flow (10 ± 4%) and vascular resistance (-10 ± 4%) of the infused leg. As a 
consequence, the blood flow ratio between both legs increased significantly by 9 ± 
4% (figure 1). 
 
Older men. During ET-receptor blockade, heart rate and mean arterial pressure did 
not change in older men (table 2). However, blood flow increased (29±9%) and 
vascular resistance decreased (-23 ± 7%) in the infused leg of the older men (figure 
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1). In the non-infused leg, no change in blood flow or vascular resistance was 
observed (table 2). Blockade of the ET-receptors induced a significant increase in the 
blood flow ratio (26 ± 8%, figure 1). 
 
Controls versus Older men. In aged men, the increase in blood flow and in blood 
flow ratio in response to ET-receptor blockade was more pronounced than in 
controls (table 2, figure 1). 
 
 
 
Table 2. Results of ET-receptor blockade in controls and older men.  
 
 Controls Older men pre-training Older men post-training 
 Baseline ET-block P Baseline ET-block P Baseline ET-block P 
Leg volume, l 9.3 ± 0.3   8.8 ± 0.2   8.8 ± 0.3   
HR, bpm 57 ± 4 59 ± 4 0.10 60 ± 4 63 ± 4 0.25 52 ± 3 59 ± 4 0.005 
MAP, mmHg 84 ± 3 84 ± 4 0.77 103 ± 4* 99 ± 7 0.32 100 ± 3 102 ± 4 0.18 
 
Infused leg 
  
 BF, ml/min/dl 3.6 ± 0.4 3.9 ± 0.5 0.06 3.1 ± 0.3 4.0 ± 0.5 0.005 3.6 ± 0.4† 4.5 ± 0.5 0.004 
 BF, % 100 ± 0 110 ± 4 0.03 100 ± 0 129 ± 9* 0.008 100 ± 0 125 ± 8 0.01 
 VR, AU 27 ± 4 24 ± 4 0.01 36 ± 3 28 ± 5 0.02 30 ± 3† 25 ± 3 0.02 
 VR, % 100 ± 0 90 ± 4 0.02 100 ± 0 77 ± 7 0.009 100 ± 0 84 ± 5 0.009 
 
Non-infused leg 
  
 BF, ml/min/dl 3.5 ± 0.4 3.7 ± 0.5 0.22 3.1 ± 0.3 3.3 ± 0.5 0.50 3.8 ± 0.3† 4.3 ± 0.3 0.053 
 BF, % 100 ± 0 104 ± 4 0.34 100 ± 0 104 ± 9 0.60 100 ± 0 115 ± 9 0.08 
 VR, AU 28 ± 3 27 ± 4 0.38 34 ± 3 35 ± 6 0.85 28 ± 3† 25 ± 2 0.11 
 VR, % 100 ± 0 95 ± 4 0.18 100 ± 0 100 ± 12 0.97 100 ± 0 90 ± 6 0.09 
 
Infused and non-infused leg 
  
 Flow ratio, % 100 ± 0 109 ± 4 0.04 100 ± 0 126 ± 8* 0.007 100 ± 0 107 ± 3† 0.02 
Vascular characteristics are presented for controls (n=8) and older men (n=8) before the start of 
the infusion (‘Baseline’) and at the end of the infusion of ET-receptor antagonists (last 10 min, 
‘ET-block’). The columns with P-values refer to a paired t-test between ‘Baseline’ and ‘ET-
block’. Data are presented as mean ± SE. * P≤0.05 from controls (t-test), † P≤0.05 from older 
men pre-training (t-test). 
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Effects of cycling training  
In the group of older men, maximal workload during the cycling test was 
significantly increased after training (table 1). Although not significant, maximal 
oxygen consumption tended to increase (P=0.09). Systolic and diastolic blood 
pressure, leg volume, ET-1 plasma levels, and body mass did not change in the older 
men by training. Resting heart rate and baseline leg vascular resistance decreased 
significantly, while baseline leg blood flow increased by training (table 1-2).  
After training, ET-receptor blockade did not change mean arterial pressure, and 
increased heart rate (table 2). Blood flow increased (25 ± 8%) and vascular resistance 
decreased (-16 ± 5%) in the infused leg during the ET-receptor blockade (table 2). 
Blood flow and vascular resistance of the non-infused leg did not change during ET-
receptor blockade (figure 1). The blood flow ratio showed a small, but significant 
increase after blockade of the ET-receptors (7 ± 3%, table 2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 1. The mean (± SE) relative increase in blood flow ratio and blood flow (BF) during ET-
receptor blockade in controls (n=8) and older men (n=8), both before and after the training 
procedure. * indicates a significant relative increase from baseline. 
 
 
Pre-training versus Post-training. The response in heart rate and mean arterial 
pressure to ET-blockade did not differ between pre- and post-training measurements. 
Also the changes in blood flow and vascular resistance in the infused and non-
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infused leg during ET-receptor blockade did not change by training (figure 1). 
However, the increase in blood flow ratio during ET-receptor blockade was 
significantly lower after training (figure 1).  
 
 
 
Discussion 
 
The present study provides several interesting and clinically important new findings: 
1) endogenous ET-1 hardly contributes to baseline vascular tone in the leg of healthy 
young subjects, 2) in contrast, in sedentary older men endogenous ET-1 has a 
prominent role in the regulation of vascular tone in the legs, and 3) exercise training 
in older men improves basal leg vascular tone and partly restores the endothelin 
pathway in these subjects. Thus, our results suggest that in older men the increased 
contribution of ET-1 to baseline leg vascular tone may, at least in part, be reversible 
by endurance training. 
 
Previous studies reported that baseline leg blood flow was ~25% lower in older 
compared with young men (8, 9). The present study, however, could not demonstrate 
such a difference in baseline blood flow between young and older men. 
Nevertheless, the difference between the controls and older men for blood flow (~15) 
and vascular resistance (~25%) in the present paper is similar to previous studies (8, 
9). Important to notice is that this study was not powered to detect differences in 
baseline vascular tone between groups. The maximal oxygen consumption of the 
sedentary older men is comparable with previous studies in this population (9, 26, 
34, 35). The cycling training decreased leg baseline vascular tone, increased 
maximal oxygen-uptake in 7 out of 8 subjects, and increased the maximal workload 
during the cycling test. This emphasizes the effectiveness of an 8 week cycling 
training program in the present study. 
 
In previous studies, using the perfused forearm model, forearm blood flow increased 
by 35-60% during infusion of the ET-receptor antagonists BQ-123 and BQ-788 (18, 
40, 41). In contrast, we observed only a slight vasodilator effect of ET-1 blockade 
(9% increase in blood flow) in the leg of healthy subjects. The difference in response 
to ET-receptor blockade between forearm and leg vascular bed suggests that ET-1 has 
a different physiological effect on the lower limbs than on the upper limbs in healthy 
subjects. Recently, Newcomer et al. (27) reported significantly different responses for 
human forearm and leg vascular beds to endothelium-dependent (acetylcholine and 
substance P) and –independent (sodium nitroprusside) stimuli. Moreover, infusion of 
ET-1 in the rat hindquarters skeletal muscle bed results in a significantly lower 
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vasoconstrictor response as compared with the mesenteric bed (15). It may be 
hypothesized that the level of activity explains the differences in contribution of ET-1 
to vascular tone between both limbs. The average level of skeletal muscle activity 
varies markedly between the upper and lower extremities. As bipeds, the legs are far 
more active during daily life (i.e. locomotion, standing) and during sports activities 
(i.e. running, cycling) than the human forearm.  
We observed in the present study that healthy older men demonstrate a significantly 
larger vasodilator response to ET-receptor blockade compared with younger subjects. 
This indicates that ET-1 importantly contributes to the elevated baseline leg vascular 
tone in older men. This finding agrees with two recent studies in animals (2, 12), that 
reported an enhanced contribution of ET-1 to the increased baseline leg vascular 
tone with advanced age. However, the observation in the present study represents 
the first human study that demonstrates the role of ET-1 to leg vascular tone in older 
men.  
Given the inclusion of healthy sedentary older men, the larger vasoconstrictor 
response to ET-1 in older men can be explained by: 1) a decreased level of physical 
fitness, and/or 2) the physiological aging process. To extend our knowledge about the 
age-related change in regulation of the ET pathway, older men performed an 8 week 
aerobic cycling training. After training, the increase of blood flow of the infused leg 
during ET-receptor blockade in older men was slightly lower than before training, but 
not significant. Expressing the effect of ET-antagonists on vascular tone as flow ratio, 
in order to exclude systemic effects (29), a significantly lower contribution of ET-1 to 
leg vascular tone is observed in older men after training. The response in flow ratio to 
ET-receptor blockade after training should be interpreted with caution, since blood 
flow in the non-infused leg tended to increase (table 2). This may have 
underestimated the vasodilator response in the infused leg after training when 
expressed as flow ratio. Nevertheless, our observations suggest that exercise training 
in older humans may partially reverse the age-related increase in vasodilator 
response during ET-receptor blockade. Recently, Donato et al. (12) examined the 
regulation of the ET pathway in sedentary and 12-week trained older rats. They also 
demonstrated that advanced age in rats leads to an enhanced ET-mediated 
vasoconstriction, but indicated that exercise training in older rats does not alter the 
enhanced ET-mediated vasoconstriction. The different finding of exercise training 
may in part be explained by the different species used (rats versus humans). In 
addition, we examined older men before and after training (longitudinal), while 
Donato studied sedentary and trained older rats (cross-sectional). The latter design is 
less susceptible to detect small differences. These methodological differences may in 
part explain the different findings.  
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Although it was not the primary purpose of our study, our results lead to an 
interesting question regarding the mechanism behind the adaptations of the ET 
pathway in the older men. In the present study, ET-1 plasma levels were not different 
between controls and older men, while ET-1 levels did not differ between pre- and 
post-training in older men as well. This suggests that differences in plasma ET-1 levels 
unlikely explain the changes in the contribution of ET-1 to leg vascular tone with 
aging. In contrast, some studies demonstrated elevated ET-1 plasma levels with 
advanced age (3, 25), which decreased after endurance training (24). Theoretically, 
an increased rate in clearance of ET-1 could explain our results in the older men, 
leading to unchanged ET-1 plasma levels, while the contribution of ET-1 to regulate 
vascular tone is increased. In addition, a change in sensitivity (and/or density) of the 
ETA- and/or ETB-receptors or changes in ET-receptor signaling may explain the age-
related up-regulation of the ET pathway. This hypothesis is in agreement with 
previous studies in animals. For example, Donato et al. (12) recently examined the 
differential contribution of the ETA- and ETB-receptors to the age-related increase in 
vascular tone in older rats. They reported that the augmented constrictor response to 
ET-1 in older rat skeletal muscle arterioles is mediated through an enhanced ETA-
receptor signaling pathway, rather than the ETB-receptors. In contrast, Asai et al. (2) 
examined the contribution of both ET-receptors to the enhanced ET-1-mediated 
vasoconstriction in older monkeys and reported an impairment of the endothelial 
ETB-receptors. Future studies in humans should further elucidate the underlying 
mechanism of the age-related change in the ET pathway. 
Apart from the contribution of ET-1 to the elevated vascular tone in older men, other 
factors are known to contribute as well. For example, a reduced nitric oxide-
mediated vasodilation (33) and elevated sympathetic α-adrenergic vasoconstriction 
(11) partially contribute to the age-related increased vascular tone. 
Although young and older subjects were healthy and free of cardiovascular disease, 
both groups differed regarding body mass index. This difference, however, unlikely 
explains the increased vasodilator response to ET-receptor blockade in the older 
men. In previous studies, it was demonstrated that lean (<27 kg/m2), overweight 
(>27.0 and <29.9 kg/m2), and obese (>30 kg/m2) subjects without hypertension, 
demonstrate similar vasodilator responses to ET-receptor blockade (6). Moreover, in 
our study we could not find a correlation between body mass index and the 
vasodilator response to ET-receptor blockade in young (r=0.19, P=0.66) or older 
subjects (r=-0.39, P=0.39). In addition, the decrease in blood flow ratio after training 
in the older men was not accompanied by a decrease in BMI. 
The post-training measurements were performed 4-5 days after the final training 
session, which may have introduced a detraining effect. Any detraining effect would 
negatively influence the effect of the 8 week cycling training. Nevertheless, we could 
demonstrate a significant increase in baseline leg vascular tone and a diminished 
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contribution of ET-1 to leg vascular tone after training in older men. This emphasizes 
the robustness of exercise training to improve vascular function in healthy older men.  
 
Clinical relevance. Increasing evidence supports a pathophysiological role for ET-1 in 
the modulation of vascular tone in cardiovascular disease (23, 30). Based on the 
constrictor action of ET-1 in older men, an enhanced ET-1 signal transduction 
mechanism may contribute to the elevations in skeletal muscle vascular resistance 
and, consequently, systemic vascular resistance. These changes in the ET pathway 
may partially explain the underlying mechanism for the predisposition of older men 
to cardiovascular pathology such as hypertension. Upregulation of the ET pathway in 
the older men may also result in media hypertrophy (30). This vascular remodeling 
process could further contribute to the development of hypertension. The 
physiological effect of exercise training in older men on the ET pathway potentially 
has beneficial consequences for vascular structure and function, but also for reducing 
the cardiovascular risk. However, future research is necessary to elucidate the 
clinical relevance of our observed physiological effect.   
 
Limitation. In this study we used local infusions of drugs into the femoral artery. 
Since the leg represents an ~8 fold larger vascular bed as compared with the forearm, 
higher dosages were necessary, and therefore systemic spill-over effects may have 
occurred. However, we observed no change in mean arterial pressure or heart rate 
during ET-receptor blockade, except for an increase in heart rate in the post-training 
sessions of the older men. This latter change in heart rate may have been mediated 
by baroreceptor unloading due to a more generalized vasodilator response to ET-
receptor blockade. To exclude the influence of systemic changes in blood pressure 
on the ultimate results (29), we expressed the effects of ET-1 on vascular tone as the 
blood flow ratio.  A second possible limitation is the inclusion of a female subject 
into the control group. Although several studies examined the vasodilator response to 
ET-receptor blockade in men as well as in women (5, 6, 40), no study reported a 
gender difference for this response. Excluding the female subjects did not change the 
magnitude of the data outcome measures. So, gender differences between the groups 
cannot explain the major outcomes of the present study. 
 
In conclusion, the enhanced activity of the endothelin pathway in older men 
compared with young controls, suggests that ET-1 is a key mediator in the increased 
leg vascular tone with advancing age. These adaptations may be the result of a 
change in ET-receptor sensitivity or signaling, rather than changes in plasma levels of 
ET-1. In addition, 8 weeks of exercise training normalizes baseline leg vascular tone, 
and partly restores the endothelin pathway in older men. 
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Abstract 
 
The number of hematopoietic stem cells (HSC) and endothelial progenitor cells (EPC) 
is thought to be a marker for neovascularization and vascular repair. Since physical 
inactivity and aging are risk factors for cardiovascular diseases, these factors may 
influence the numbers of HSCs and EPCs.  
Purpose. To examine baseline and exercise-inducd levels of HSC and EPCs in 
sedentary and trained young and older men. 
Methods. To study the role of aging, in 8 sedentary young (19-28 years) and 8 
sedentary older men (67-76 years), baseline and acute exercise-induced numbers of 
HSCs (CD34+-cells) and EPCs (CD34+/VEGFR-2+-cells) were quantified by 
fluorescence-activated cell sorter (FACS)-analysis. To examine the effect of chronic 
training, 8 age-matched trained young men (18-28 years) were compared with 
sedentary young men, whereas older men performed an 8 week endurance training. 
Results. Older men showed significantly lower baseline and exercise-induced levels 
of HSCs/EPCs than the young men (P<0.05). In young and older men, acute exercise 
significantly increased HSCs (P<0.01), but not EPCs. The absolute increase in 
numbers of HSCs was attenuated in older men (P<0.05). Apart from the lower 
baseline numbers of EPCs after chronic training in older men, training status did not 
alter baseline or exercise-induced levels of HSCs/EPCs in young and older men. 
Conclusions. Advancing age results in lower circulating numbers of HSCs and EPCs 
and attenuates the acute exercise-induced increase in HSCs. Interestingly, in young 
as well as in older men, chronic endurance training does not affect baseline and 
exercise-induced numbers of HSCs and EPCs. 
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Introduction 
 
Recent evidence suggests that vascular morphology and function can be modulated 
by bone-marrow derived hematopoietic stem cells (HSCs, CD34+) and endothelial 
progenitor cells (EPCs, CD34+/VEGFR-2+) (2). In pre-clinical studies it was shown that 
HSCs and EPCs can enhance angiogenesis, promote vascular repair, improve 
endothelial function, and induce neo-vascularization (12, 20, 24, 36). HSCs and 
EPCs may play a role in the vascular responses and adaptations to exercise. A single 
exercise bout acutely mobilizes circulating HSCs in healthy men (15, 19) and in 
subjects with cardiovascular disease (1, 16, 25, 32). Based on the fact that advancing 
age is associated with an impaired vascular function (4, 6), the acute exercise-
induced mobilization of HSCs may be influenced by age. Heiss et al. (11) recently 
reported that advancing age is associated with a functional deficit of stem cells (such 
as proliferation, survival, and migration). The primary aim of the present study is to 
examine the effect of advanced age on the numbers of HSCs and EPCs in young and 
older men before (‘baseline’) and after (‘acute exercise-induced’) a single exercise 
bout. We hypothesise that advancing age reduces baseline and acute exercise-
induced levels of HSCs and EPCs. 
Increased levels of HSCs and EPCs are associated with an enhanced endothelial 
function (12) and a decrease in cardiovascular risk (12, 38). Interestingly, endurance 
training is associated with an improved endothelial function (10) and a decrease in 
cardiovascular risk (22) as well. As such, one may speculate about a possible 
influence of the training status (i.e. trained versus untrained) on the baseline or 
exercise-induced numbers of HSCs and EPCs. Therefore, the second aim of the study 
is to examine baseline and exercise-induced numbers of HSCs and EPCs in an age-
matched population of sedentary and endurance trained young men. We extended 
our observations on the possible link between training status and numbers of HSCs 
and EPCs by training the older men for 8 weeks. We hypothesise that a higher 
training status leads to an elevation in baseline and exercise-induced numbers of 
HSCs and EPCs in young as well as in older men. 
 
 
 
Methods 
 
Subjects 
Twenty-four participants, free of any cardiovascular disease and not on any 
medication known to interfere with the cardiovascular system, were recruited. 
Subjects never smoked or stopped smoking at least 15 years ago. To examine the 
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effect of aging, these healthy participants were parsed into two groups on the basis of 
age: 8 older sedentary men (67-76 years) and 8 young sedentary men (19-28 years, 
table 1). Sedentary was defined as less than 1 h exercise per week for the past year or 
longer. To address the influence of the training status, the group of young sedentary 
men was compared with an age-matched population of endurance-trained young 
men (n=8, 18-28 years, >8 h aerobic exercise per week). In addition, the older men 
performed an 8 week cycling training. Subjects underwent a physical examination, 
whereby subjects with abnormalities in a 12-lead ECG at rest and/or an ankle-
brachial pressure index of <0.90 were excluded. The study was approved by the 
hospital ethics committee and conforms with the principles outlined in the 
Declaration of Helsinki. All subjects gave their written informed consent before 
participation. 
 
 
 
Table 1. Group characteristics of the sedentary and trained young and older men.  
 
Young men  Older men  
Sedentary (n=8) Trained (n=8) Sedentary (n=8) Trained (n=8) 
Activity, h/week 0.8 ± 0.9 10.4 ± 2.6 * 0.5 ± 0.8 2.5 ± 0.8 * 
Body mass index, kg⋅m2 22.4 ± 1.7 22.8 ± 1.2 25.4 ± 2.8 † 25.2 ± 2.6 
Cholesterol, mmol⋅l-1 4.4 ± 1.4 4.2 ± 0.8 4.8 ± 0.4 4.6 ± 0.1 
Triglycerides, mmol⋅l-1 1.5 ± 0.8 0.9 ± 0.4 1.0 ± 0.3 1.0 ± 0.2 
HDL, mmol⋅l-1 1.2 ± 0.3 1.6 ± 0.2 * 1.2 ± 0.2 1.2 ± 0.1 
LDL, mmol⋅l-1 2.5 ± 1.1 2.2 ± 0.7 3.2 ± 0.3 3.0 ± 0.1 
 
Incremental exercise test 
HR rest, bpm 62 ± 6 54 ± 7 * 60 ± 4 52 ± 3 * 
HR max, bpm 194 ± 11 195 ± 8 165 ± 7 166 ± 8 
VO2max, ml⋅kg-1⋅min-1 49.0 ± 4.0 58.5 ± 7.5 * 30.8 ± 4.8 † 33.3 ± 5.5 
Workload max, W 341 ± 41 393 ± 53 * 171 ± 32 † 201 ± 39 * 
Lactate max, mmol⋅ml-1 9.1 ± 1.6 12.0 ± 1.9 * 7.7 ± 2.1 7.6 ± 1.2 
RER 1.24 ± 0.04 1.19 ± 0.04 * 1.20 ± 0.13 1.17 ± 0.06 
 
Resting values stem cells 
HSC, cells⋅ml-1 412 ± 70 355 ± 95 119 ± 21 † 95 ± 17 
EPC, cells⋅ml-1 154 ± 43 185 ± 96 35 ± 12 † 19 ± 8 * 
Data represent mean ± SE. (HDL; high-density lipoprotein, LDL; low-density lipoprotein, HR; 
heart rate, VO2max; maximal oxygen consumption, bpm; beats per minute, RER; Respiratory 
Exchange Ratio, HSC; hematopoietic stem cell, EPC; endothelial progenitor cell). * P<0.05 
(sedentary versus trained). † P<0.05 (sedentary young versus sedentary older men). 
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Design 
All participants performed a single maximal exercise bout on a cycling ergometer. 
Before and directly after the single exercise bout, blood was collected to analyze 
baseline and acute exercise-induced numbers of circulating HSCs and EPCs. The 
older men performed an 8 week endurance training. Subsequently, the same 
experimental protocol was repeated after the final training session (figure 1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic presentation of the experimental protocol. After a 5 min seated rest venous 
blood was taken. Subsequently, 10 min after cessation of the cycling test, a 2nd venous sample 
was taken. The sedentary and trained young men performed this protocol once, while the 
sedentary old men completed the protocol before and after the 8 week endurance training.  
 
 
Measurements  
Single Exercise Bout. Experiments started between 8:30-10:00 AM. Subjects refrained 
from caffeine for at least 18 h and did not perform any strenuous activities at least 24 
h before testing. Subjects were advised to have a light breakfast. All tests were 
performed in a temperature-controlled room (20 ± 1 °C). Before the single exercise 
bout, subjects were seated in the upright position for at least 5 min before the 
baseline blood sample was drawn from an antecubital vein. The single exercise bout 
was performed on an electrically braked leg-cycling ergometer (Lode, Angio300, 
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Groningen, the Netherlands), using a multistage protocol. Young men increased their 
workload by 20 W per min, starting at 20 W, until exhaustion, whereas older men 
used steps of 10 W per min. Oxygen consumption was measured continuously in all 
groups using a gas-analyzer (Jaeger Benelux BV, Breda, the Netherlands). Maximal 
oxygen consumption (VO2max) was analyzed as the mean of the last minute of the 
single exercise bout. In addition, blood lactate level (Roche Diagnostics GmbH, 
Mannheim, Germany) was measured before and 2 min after cessation of the test 
using capillary blood. Heart rate was recorded continuously. Subjects were verbally 
encouraged to continue for as long as possible. The criterion used to assess VO2max 
included: 1) a heart rate in excess of 90% of age predicted maximum (220 – age); 2) 
a respiratory exchange ratio ≥1.10; and 3) identification of a plateau (≤150 ml 
increase) in VO2 despite a further increase in workload (9). In all tests, at least two of 
three criteria were met. Finally, 10 min after cessation of the cycling test, the post-
exercise blood sample was taken (25). 
Enumeration of circulating HSCs and EPCs. For enumeration of circulating HSCs and 
EPCs, flow cytometric analysis was performed using a multi-parametric gating 
strategy based on the International Society of Hematotherapy and Graft Engineering 
(ISHAGE). This lyse/no wash method uses Trucount tubes (Becton Dickinson, 
Franklin Lakes, NJ, USA) that contain a defined number of brightly fluorescent 
microbeads, permitting the acquisition of absolute counts of cells, even at very low 
numbers. Circulating hematopoietic stem cells (HSCs) are defined as cells with low-
expression of CD45, positive for CD34, and located in the lympho-gate on a side- 
and forward-scatter plot. This gating strategy was extended by calculating the 
number of CD34+ cells that also express vascular endothelial growth factor receptor-
2 (VEGFR-2) to define the number of circulating endothelial progenitor cells (EPCs). 
This strategy avoids inclusion of mature endothelial cells, which are also positive for 
CD34 and VEGFR-2, since they are located outside the lympho-gate. 
Within 2 h of blood-withdrawal, 50 μl of EDTA-anticoagulated whole blood was 
added per Trucount tube (two per subject) by reverse pipetting and directly-labeled 
antibodies were added: CD45-PerCP, CD34-FITC (BD Biosciences, Erembodegem, 
Belgium) and VEGFR-2-PE (R&D Systems, Minneapolis, MN, USA). After 30 min 
incubation on ice and in the dark, cells were fixed using FACS-lysing solution (BD 
Biosciences, Erembodegem, Belgium) and the samples were measured within 24 h 
using a fluorescence-activated cell sorter (FACS)-Calibur (BD Biosciences, 
Erembodegem, Belgium). A total of 500,000 CD45+ cells were measured (excluding 
the beads) and the number of HSCs and EPCs per ml blood was calculated. 
VEGF assay. Plasma vascular endothelial growth factor (VEGF) was measured, based 
on its suggested ability to mobilise EPCs into the blood (3). Plasma VEGF levels were 
determined with a customised enzyme-linked immuno sorbent assay (ELISA; 
Department of Chemical Endocrinology, Radboud University Nijmegen, the 
Effect of aging and training on numbers of stem cells 
  161 
Netherlands). The assay measures VEGF165 and VEGF121; the main isoforms of VEGF 
in blood. Details of the assay, including specificity and performance, have been 
described previously (31).  
 
Endurance training 
The older men performed endurance training for 8 week (3 sessions per week 
including cycling exercise) with at least 1 day between subsequent training sessions, 
under the supervision of a researcher. A cycling ergometer (Lode, Angio300, 
Groningen, the Netherlands) was used for endurance training. Each session started 
with a 10 min warming-up at 65% of the individual heart rate reserve (HRR). After 
muscle stretching, the exercise protocol was followed with 20 min cycling exercise 
at 65% of the individual HRR. As their exercise tolerance improved throughout the 
training period, the intensity of the exercise bouts was increased by 5% HRR to a 
maximum of 85% of the HRR. In the 1st training session the average workload was 
157 ± 48 kJ and in the 24th (i.e. last) training session, 234 ± 50 kJ. Adherence to the 
exercise prescription was documented through the use of heart rate monitors (s610, 
Polar, Brooklyn, NY, USA). 
 
Statistical analysis 
The main goal of this study is to compare the exercise-induced change in levels of 
HSCs and EPCs. Based on the average exercise-induced changes from previous 
studies (16, 19, 32) and an alpha of 0.05, we calculated that 8 subjects per group 
would be necessary to achieve a power of 80%. For the circulating numbers of HSCs 
and EPCs, a two-way mixed-plot factorial analysis of variance (‘single exercise bout × 
age’ or ‘single exercise bout × training status’) was used (Statistical Package for Social 
Science (SPSS), version 12.0) (26). Unpaired Student’s t-tests were used to compare 
differences in all other variables between groups (young versus old and trained 
versus sedentary young men), while a paired Student’s t-test was used to assess 
differences before and after endurance training in older men. Multiple linear 
regression was performed to identify relationships between variables. Results are 
expressed as mean ± SE. When data are not distributed normally, data are presented 
as median [lowest value – highest value] and a non-parametric test was used to 
compare differences between (Mann Whitney U-test) or within groups (Wilcoxon’s 
Signed Rank). A 2-sided probability value of ≤0.05 was considered to be statistically 
significant.  
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Results 
 
Effect of aging on HSC and EPC in sedentary healthy men  
Maximal oxygen consumption in sedentary young men was significantly higher than 
in older men, while body-mass index was significantly lower in young than in older 
men (table 1). Lipid profile was not different between both groups.  
Baseline. Numbers of HSCs and EPCs in young men were significantly higher than in 
older men (t-test: P<0.05, table 1). Plasma VEGF concentration in young men was 
significantly lower than in older men (table 2). 
 
 
Table 2. Plasma concentrations VEGF (in pg⋅ml-1).  
 
 Baseline VEGF Post-EX VEGF 
Young men (n=8) 
   Sedentary 
 
255 [209-359] 
 
395 [275-754] † 
   Trained 369 [169-723] 394 [218-551] 
Older men (n=7) 
   Sedentary 
 
1239[488-20316] * 
 
1429 [591-20872] 
   Trained 569 [172-18205] * 590 [244-12561] 
Plasma levels in sedentary (n=8) and trained (n=8) young men and the older men (n=8) before 
(sedentary) and after training (trained). P-value represents a Student’s t-test (in young men) or a 
Mann Whitney U-test (in older men) to assess differences between baseline and exercise-
induced (post-EX). Values are means [lowest value-highest value] for the young men and 
median [lowest value-highest value] for the older men. * P<0.05 vs. young men, † P<0.05 
baseline vs. post-exercise. 
 
 
Single exercise bout. The single exercise bout in sedentary young and older men 
significantly increased the numbers of HSCs (figure 2A). Numbers of EPCs in young 
and older men did not change by an acute exercise bout (figure 2B). Plasma levels 
VEGF in young men significantly increased by cycling, while older men showed no 
change (table 2).  
 
Effect of training status on HSC and EPC in young men 
Maximal oxygen consumption, maximal workload, blood lactate production, and 
HDL in the trained young men were significantly higher than in the sedentary young 
men. Resting heart rate and the respiratory exchange ratio was significantly lower in 
trained than in sedentary young men. Other characteristics did not differ between 
both groups (table 1).  
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Baseline. Circulating numbers of HSCs and EPCs (table 1), and VEGF plasma levels 
(table 2) at baseline were similar between sedentary and trained young men. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Individual and average baseline (solid circles) and exercise-induced levels (open 
circles) of circulating numbers of hematopoietic stem cells (HSCs, A) and endothelial progenitor 
cells (EPCs, B) in sedentary young and older men (both n=8). Average values represent means ± 
SE. The 2-way ANOVA indicates that higher baseline and exercise-induced numbers of HSCs in 
young men compared with older men, while the exercise-induced increase in HSC showed a 
tendency to dependent on age.  
 
 
 
Single exercise bout. The acute exercise-induced increase in numbers of HSCs in 
sedentary and trained young men was not influenced by chronic training (figure 3A). 
Numbers of EPCs in sedentary and trained young men did not change by the single 
exercise bout (figure 3C). Plasma levels of VEGF in trained young men did not 
change by the acute exercise bout (table 2). 
 
Effect of training on HSC and EPC in older men 
The 8 week endurance training significantly decreased resting heart rate and 
increased maximal workload (table 1) in the older men. Maximal oxygen 
consumption was increased, although not significant (t-test: P=0.09). 
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Figure 3. Baseline (filled circles) and exercise-induced levels (open circles) of circulating 
numbers of hematopoietic stem cells (HSCs, A-B) and endothelial progenitor cells (EPCs, C-D). 
In young men, numbers of HSCs (A) and EPCs (C) were presented in the sedentary (n=8) and 
trained (n=8) subpopulation. In older men (n=8), numbers of HSCs (B) and EPCs (D) were 
represented before and after training. Values represent mean ± SE. Baseline and exercise-
induced numbers of HSCs and EPCs were independent of physical fitness.  
 
 
Baseline. Baseline numbers of HSCs were not altered after endurance training (table 
1), while EPCs (table 1) and plasma levels of VEGF (table 2) were significantly lower 
after training.  
Single exercise bout. The acute exercise-induced increase in numbers of HSCs in 
older men is independent on physical fitness (figure 3B). Before as well as after the 
endurance training, the single exercise bout test did not change numbers of EPCs 
(figure 3D) and VEGF concentrations (table 2). 
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Figure 4. Linear regression between baseline and exercise-induced numbers of hematopoietic 
stem cells (HSCs, A) and endothelial progenitor cells (EPCs, B) in young sedentary (n=8, open 
triangles) and trained men (n=8, open circles) and older men (n=8) before (solid triangles) and 
after training (solid circles). This analysis assessed the correlation between baseline and 
exercise-induced numbers of HSCs and EPCs. 
 
 
 
Linear regression analysis 
The linear regression analysis indicated a significant relationship between baseline 
and exercise-induced numbers of HSCs (figure 4A, P=0.001) and EPCs (figure 4B, 
P<0.001) in both sedentary and trained healthy men.  
The absolute acute exercise-induced increase in numbers of HSCs in young men 
(due to the higher baseline numbers of HSCs) was larger than in older men (figure 
5A). However, the relative acute exercise-induced change in HSCs was similar 
between young and older men (figure 5B). As such, the relative exercise-induced 
increase in HSCs is independent of age. 
The exercise-induced relative increase in numbers of HSCs and EPCs in young 
(r2=0.07 and 0.001, P=0.31 and 0.93, respectively) as well as in older men (r2=0.12 
and 0.04, P=0.20 and 0.63, respectively) did not correlate with the relative change in 
VEGF plasma levels. Maximal oxygen consumption did not correlate with the 
baseline or exercise-induced levels of HSCs (r2=0.17 and 0.07, P=0.12 and 0.33, 
respectively) nor EPCs in young men (r2=0.10 and 0.20, P=0.23 and 0.08, 
respectively). Also older men show no correlation between maximal oxygen 
consumption and baseline or exercise-induced levels of HSCs (r2=0.001 and 0.03, 
P=0.90 and 0.56, respectively) nor EPCs (r2=0.05 and 0.07; P=0.0.42 and 0.51, 
respectively). 
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Figure 5. Exercise-induced change in hematopoietic stem cells (HSCs) in sedentary (black bars) 
and trained (white bars) young and older men, expressed as the absolute (A, in cells⋅ml-1) and 
relative (B, in X-fold change) from baseline numbers. Because data were not normally 
distributed, a Mann Whitney U-test (between groups) or Wilcoxon Signed Rank test (within 
groups) was used to assess differences between groups. Values are means ± SE. 
 
 
 
 
Discussion 
 
This study provides several interesting findings. First, the number of hematopoietic 
stem cells (HSCs) and endothelial progenitor cells (EPCs) in young men is higher than 
in older men. Second, this inverse correlation in age and HSC numbers was not 
altered after endurance training in young men, whereas EPCs numbers even 
decreased further after 8 weeks of endurance training of older men. Third, a single 
exercise bout in young as well as in older men acutely mobilizes HSCs, but not EPCs, 
to the peripheral blood. Fourth, the single exercise bout-induced change in numbers 
of HSCs is not influenced by training status, while advanced age is associated with 
an attenuated mobilization in numbers of HSCs. Fifth, numbers of HSCs and EPCs 
were not correlated to VEGF levels. Thus, our results suggest an age-related decrease 
in baseline and exercise-induced levels of HSCs and EPCs, which is not influenced 
by a change in training status. 
We compared three well-defined populations, based on their age and training status. 
The maximal oxygen consumption of the sedentary (17) and active (8, 14, 15) young 
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men and the older men (7, 18, 34, 35) is comparable with previous studies. Although 
the cycling training in older men did not significantly improve maximal oxygen 
consumption, 7 out of 8 subjects increased their maximal oxygen consumption and 
all men completed a higher maximal workload during the post-training cycling test. 
Moreover, the ~8% increase in oxygen consumption is larger than reported in 
previous studies in which older men were trained for 12 weeks (6, 34, 35). 
 
Effect of aging on numbers of HSCs and EPCs 
Sedentary older men demonstrate markedly lower baseline levels of HSCs and EPCs 
than their younger peers. Since EPCs correlate inversely with the incidence of 
cardiovascular events (38), the age-related down-regulation in numbers of HSCs and 
EPCs may contribute to the increased cardiovascular risk in the older population. 
Although lower baseline numbers of HSCs and EPCs with advancing age is in 
agreement with previous studies (28, 37), others (5, 11, 29) reported no difference 
between young and older men. This variation among studies likely results from 
differences in the method used. We analyzed HSCs and EPCs in whole blood, while 
studies in which no difference was found (5, 11, 29), numbers of stem cells was 
measured in the mononuclear cell fraction, isolated by Ficoll density gradient 
centrifugation. This method may cause loss of cells and underscores the importance 
of the choice of the method used. 
 
Effect of a single exercise bout on HSCs and EPCs 
The finding that acute exercise increases the level of HSCs is in accordance with a 
previous study in healthy young subjects (19). Given the ability of HSCs to promote 
angiogenesis and promote vascular repair (12, 20, 24, 36), the acute exercise-
induced mobilization may serve as a physiological repair or adaptation mechanism. 
To examine whether the aging process influences the exercise-induced number of 
HSCs, we assessed this response in young and older men. Young men report a 
significantly larger increase in exercise-induced absolute numbers of HSCs than older 
men. However, expressing the increase as a relative change, our data demonstrate no 
differences between young and older men in the exercise-induced increase in HSCs. 
This indicates that the larger exercise-induced number of HSCs in young men is 
primarily caused by the higher baseline numbers of HSCs in young compared with 
older men.  
Acute exercise did not alter the numbers of EPCs in young and older sedentary men, 
which is consistent with a previous study using a similar exercise protocol for 
middle-aged healthy subjects and middle-aged patients suffering from non-ischemic 
coronary artery disease (CAD) (1). Interestingly, in ischemic CAD-patients numbers of 
EPCs were significantly increased, which coincided with higher levels of VEGF, 
implying that the ischemic stimulus is the initiating factor for EPC increase. During an 
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ischemic episode, VEGF levels seem to correlate with EPC levels in patients with 
cardiovascular disease (1, 30) or in animals (2, 3), while this was not the case for b-
FGF, GM-CSF and TNF-α. Interestingly, we and others (15, 25) demonstrated that the 
exercise-induced increase in stem cells is not accompanied by a change in VEGF 
plasma levels in healthy men. In the absence of an ischemic stimulus, VEGF levels 
may therefore not predict an exercise-induced change in HSCs and EPCs in healthy 
men. Although we can only speculate, the well-established exercise-induced 
increase in nitric oxide bioavailability may be a potential mechanism by which 
mobilization of EPCs is regulated. This is supported by the finding that in mice the 
exercise-mediated upregulation of EPCs was absent in nitric oxide synthase "knock-
out" mice or in the presence of a nitric oxide synthase inhibitor in healthy mice (16). 
In addition, the hepatocyte growth factor (HGF), a potential stimulator of bone 
marrow derived cells (13), may also be involved in the upregulation of HSCs. 
Recently, HGF is demonstrated as a good marker for progenitor proliferation at rest 
and after an acute exercise bout in healthy controls and in subjects with chronic 
pulmonary obstructive disease (23).  
 
Effect of training on numbers of HSCs and EPCs 
Interestingly, neither baseline numbers nor the exercise-induced numbers of HSCs 
and EPCs are different between sedentary and age-matched trained young men. This 
suggests that chronic endurance training in young men does not influence baseline 
or exercise-induced numbers of HSCs and EPCs. This is supported by the lack of 
correlation between oxygen consumption and levels of HSCs and EPCs in young 
men. To further extend this knowledge, we examined the older men after 8 weeks of 
training. Apart from a small but significant decrease in baseline EPCs levels, there are 
no differences in baseline and exercise-induced levels of HSCs and EPCs in older 
men after training. This supports our hypothesis that training status does not influence 
baseline or exercise-induced HSCs and EPCs.  
To date, endurance training as an intervention to alter numbers of HSCs and EPCs is 
only examined in patients with peripheral arterial occlusive disease, coronary artery 
disease, or with cardiovascular risk factors (16, 27, 32). Increased numbers of EPCs 
have been reported only when patients have symptomatic ischemia during exercise 
training (27). Our finding of a decrease in numbers of EPCs in healthy older men after 
endurance training prompt the question on the physiological mechanism, although 
we can only speculate. Important to notice is that our participants were free of 
cardiovascular risk factors, which is in marked contrast with the populations in 
previous studies (16, 27, 32). In healthy older men, the EPCs may be involved in 
exercise-induced angiogenesis and/or repair processes, which consequently could 
result in lower baseline numbers of EPCs. On the other hand, bioavailability of nitric 
oxide is decreased during aging (33), which may also affect the number of circulating 
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EPCs. Interestingly, nitric oxide has been shown to differentially support mobilization 
of endothelial committed progenitors but did not affect HSCs. Under nitric oxide-
deficient conditions, G-CSF failed to increase EPCs numbers, while the HSC 
population was unaffected (21). This may, at least in part, explain the decrease in 
EPCs upon chronic training in older subjects. Nevertheless, the responses of HSCs 
and EPCs to endurance training may differ between health and disease. 
 
Limitations. In addition to the quantity (numbers), also the quality of stem cells can 
be examined (survival, migration, and proliferation). Advancing age, for example, has 
recently been associated with functional deficits of the stem cells (11). As such, 
physical exercise may lead to changes in functional characteristics, rather than in the 
numbers of HSCs or EPCs. Future studies should examine changes in stem cell 
function after exercise training. 
Comparing the results from the trained young men with the trained older men, one 
should take the amount of weekly exercise into account. The duration of training in 
older men is relatively short (8 weeks, 3 sessions per week), while young men trained 
chronically (>8 h a week). Despite these differences, the young as well as older 
trained men demonstrated baseline and acute exercise-induced values of HSCs and 
EPCs that are comparable to their sedentary counterparts. 
 
In conclusion, this study demonstrates that advancing age is associated with lower 
numbers of circulating hematopoietic stem cells (HSCs) and endothelial progenitor 
cells (EPCs), while the exercise-induced mobilization of HSCs is attenuated in older 
compared with young healthy men. Interestingly, in healthy young as well as in older 
men, endurance training does not affect baseline or exercise-induced numbers of 
HSCs or EPCs.  
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The detrimental effects of physical inactivity and aging on cardiovascular risk are 
well recognized. However, the physiological processes that explain the effects of 
inactivity and aging on blood vessels are less well characterized. In this thesis, we 
explored the vascular adaptations to physical inactivity and aging on both conduit 
arteries and resistance vessels, but also the restorative capacity of exercise training. 
Aging and physical inactivity are characterized by an increase in vascular tone. 
Endothelin (ET-1) is an important endogenous vasoconstrictor that may play a role in 
the development of cardiovascular diseases. Therefore, we examined the 
contribution of endogenous ET-1 in the resistance vessels in aging and physical 
inactivity. In this final chapter, our results are summarized and the consequences of 
our findings will be discussed and related to other studies. We also introduced a 
conceptual framework that may help to understand vascular changes to 
deconditioning and aging. 
 
 
Conduit arteries 
Endothelial function of conduit arteries is commonly assessed by flow-mediated 
dilation (FMD) (11, 45), which concerns the vasodilator response of a conduit vessel 
to elevations in blood flow-associated shear stress (8). The goal of this procedure is to 
create a shear stress stimulus that produces a nitric oxide(NO)-dependent response in 
order to assess the NO pathway (26). NO is of interest as it is an anti-atherogenic 
molecule and reduction in its bioavailability may play a role in cardiovascular 
diseases (10). In the brachial artery, NO is the main vasodilator substance responsible 
for the shear stress-induced dilation (45). Since limb differences are present for 
vascular regulation (41), one may argue whether the FMD in the leg also reflects NO 
bioavailability. This is of special interest, since we have examined the superficial 
femoral artery FMD in this thesis (Chapter 3, 4, 5 and 7). Experiments from our 
laboratory showed that the increase in the superficial femoral artery diameter during 
the FMD is significantly reduced during NO-synthase blockade (submitted data). This 
indicates that the FMD in the superficial femoral artery is NO-dependent.  
In subjects with a diminished FMD, other factors than NO may contribute to changes 
in this response. For example, in Chapter 3 we showed that the sympathetic nervous 
system likely contributes to the attenuated superficial femoral artery FMD in older 
men. In addition, high levels of shear stress induce NO release via endothelial ETB-
receptors. Therefore, theoretically, also an altered regulation of the ET pathway could 
contribute to changes in the FMD. 
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Resistance arteries 
The nitric oxide (NO) pathway is frequently examined to understand the mechanisms 
underlying the cardioprotective effects of exercise. For example, physical exercise is 
associated with increased basal NO production in the forearm (31), increased nitrite-
nitrate levels (35), and improved NO-dependent endothelial function (20, 21, 38). 
Thus, the current idea is that exercise improves vascular function through the NO 
pathway. Deconditioning, i.e. the opposite of exercise, leads to detrimental effects on 
structural and functional characteristics of the vasculature (2-4). Parallel to this, one 
may expect the NO pathway to contribute importantly to these changes. However, 
short- (lower limb suspension) and long-term (spinal cord injury (SCI)) deconditioning 
did not alter the contribution of NO to baseline vascular tone (4). In addition, a 
preserved FMD (NO-dependent endothelial dilation) is found after lower limb 
suspension (2) and bed rest (3, 5). Therefore, the process of vascular adaptations to 
physical activity is not simply the reverse of inactivity. Vascular changes to 
deconditioning are unlikely explained by the NO pathway; rather, other processes 
may be involved.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Relative increase in blood flow ratio at the end of the 75-min infusion of ET-receptor 
antagonists (Chapter 6 and 8). Data are presented as mean ± SE. 
 
 
In this thesis we observed that extreme deconditioning in the legs of SCI individuals 
(Chapter 6) leads to a marked increase in the contribution of ET-1 to baseline leg 
vascular tone (figure 1). This indicates that ET-1 importantly contributes to the 
vascular changes in deconditioned human skeletal muscles. This hypothesis is 
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supported by the reversed contribution of ET-1 to leg vascular tone after 6 weeks of 
functional electrostimulation(FES)-cycling training in SCI individuals. Therefore, ET-1 
(which opposes the vascular effects of NO) could be a key regulator of vascular 
changes during deconditioning (the opposite of exercise training). 
Hypercholesterolemia (7), heart failure (34), and (pulmonary) hypertension (6) are 
characterized by an increased ET-1-mediated forearm vascular tone. Interestingly, 
these conditions are also often characterized by physical inactivity (deconditioning). 
Based on our findings, one should realize that the level of physical inactivity might 
confound the negative effects of ET-1 in these cardiovascular diseases. Inactivity, 
rather than the cardiovascular disease itself, emerges as a strong candidate to explain 
the increased ET-1-mediated vascular tone in these pathologies.  
 
We demonstrated that the ET pathway contributes to the increased vascular tone in 
healthy older men (Chapter 8). Based on the vasoconstrictive actions (leading to 
increased peripheral vascular tone) and proliferative capacity (resulting in media 
hypertrophy (50)), the increased ET-1-mediated vascular tone in older men may 
partly explain the predisposition of older men to cardiovascular pathology such as 
hypertension. Theoretically, the increased contribution of ET-1 to leg vascular tone in 
healthy sedentary older men (Chapter 8) is caused by the physiological aging process 
or deconditioning. After 8 weeks of cycling training, older men demonstrated a 
decreased leg vascular tone, which is partly explained by a diminished ET-1-
mediated vasoconstriction. Thus, physical inactivity contributes to the enhanced ET-
1-mediated vasoconstriction in older men. More important, exercise training is an 
effective non-pharmacological intervention to improve cardiovascular function in 
older men, in part through the ET pathway. 
Although the ET pathway plays an important role in the increased leg vascular tone 
in older men, other factors may also contribute to the altered vascular function. For 
example, Dinenno et al. (14) showed that an augmented α-adrenergic sympathetic 
vasoconstriction is present in the legs of older men. In the forearm, the NO pathway 
contributes to the increased vascular tone in older men (1, 12, 53). ET-1, NO, and 
the sympathetic nervous system have the ability to inhibit or potentiate each other’s 
vascular effects. Later this chapter, we introduce a conceptual framework that helps 
to explain the mechanisms to regulate vascular tone in aging and deconditioning. 
 
 
 
Localization and time course of vascular adaptations 
Localization. Studies investigating vascular adaptations to exercise training (cycling, 
walking), often examine non-exercised areas (brachial and carotid artery). Whether 
non-trained areas present similar vascular adaptations as observed in the trained 
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areas can be questioned. In this thesis, we performed 3 training studies (Chapter 4, 5, 
and 7) in which we examined conduit artery and peripheral vascular changes in the 
trained and non-trained areas. These findings are summarized in table 1. FES cycling 
in SCI individuals included stimulation of the hamstring, quadriceps and gluteal 
muscles. Interestingly, both FES cycling interventions (Chapter 4 and 5) resulted in 
vascular adaptations in the exercised area only (e.g. thigh, table 1). Adjacent non-
stimulated areas, such as the calf, did not show a change in vascular function. Similar 
results are observed in the older men after endurance training. While vascular 
adaptation in the exercised thigh vascular bed occurred, the non-trained forearm and 
carotid artery demonstrated no change. 
 
 
 
 
Table 1. Vascular adaptations to exercise training as demonstrated in this thesis.  
 
 SCI (n=10) 
4 weeks FES cycling
(Chapter 4) 
SCI (n=8) 
6 weeks FES cycling
(Chapter 5) 
Older men (n=8) 
8 weeks cycling 
(Chapter 7) 
Forearm  
  BA diameter 
 
= 
 
= 
 
= 
  BA FMD = = = 
  Baseline vascular resistance = = = 
 
Carotid artery 
  CA diameter 
 
 
= 
 
 
= 
 
 
= 
  CA compliance NA NA = 
 
Thigh 
  CFA diameter 
 
 
↑ 
 
 
↑ 
 
 
↑ 
  CFA FMD NA ↓ NA 
  Baseline vascular resistance ↓ ↓ ↓ 
  Peak blood flow ↑ ↑ ↑ 
 
Calf 
  SFA diameter 
 
 
= 
 
 
= 
 
 
= 
  SFA FMD = NA = 
  SFA compliance NA NA ↑ 
  Baseline vascular resistance = = = 
(BA; brachial artery, FMD; flow-mediated dilation, CA; carotid artery, CFA; common femoral 
artery, SFA; superficial femoral artery, ↑; increased compared with pre-training, ↓; decreased 
compared with pre-training, =; no change compared with pre-training, NA; not available). 
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The lack of vascular adaptations in the non-trained areas emphasizes the importance 
to accurately choose the goal of your training intervention. For example, to improve 
general vascular function one should include a large muscle mass (i.e. whole-body 
exercise training). In addition, a question arises regarding the importance of brachial 
artery endothelial function for cornary vessel quality. Brachial artery endothelial 
function is often regarded as a surrogate marker for general endothelial function (i.e. 
coronary arteries). Based on our findings, changes in brachial artery endothelial 
function unlikely reflect similar changes in an unrelated vascular bed such as the 
coronary circulation or lower leg conduit arteries. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 2. Relative change in resting diameter of the common femoral artery after FES cycling 
in SCI individuals (in % from baseline). The grey bars represent data from this thesis; ‘FES 
cycling (2 wk)’ and ‘FES cycling (6 wk) are presented in Chapter 5 and ‘FES cycling (4 wk)’ is 
derived from Chapter 4. The black bar is from Gerrits et al. (19) using 6 weeks of FES cycling). 
Data are means ± SE. 
 
 
 
Time course. Although the beneficial muscular (23, 37, 47) and vascular changes (9, 
19, 24, 39, 40) of FES cycling in SCI individuals are widely accepted, it is not clear 
whether these benefits are proportional to the time and effort the patients must invest. 
To date, studies only reported exercise-induced adaptations after a prolonged period 
of FES exercise (6 weeks to 7 years). In this thesis (Chapter 4 and 5) we show that the 
femoral artery diameter change after 2 and 4 weeks of FES cycling is comparable to 6 
weeks FES cycling (figure 2). This indicates that a significant part of the FES cycling 
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induced vascular adaptations are reached after a few exercise bouts, with relatively 
small additional improvements thereafter. Therefore, training intensity (e.g. frequency 
or duration) should be adapted after a few weeks for further vascular improvements. 
Cessation of FES cycling in SCI individuals results in an immediate return of the state 
of extreme inactivity in the leg muscles. To date, no studies examined the time 
course and whether vascular effects of FES cycling are maintained during the period 
of detraining. We demonstrated that within 1 week after cessation of the FES 
exercise, baseline and peak leg blood flow, femoral diameter, and femoral artery 
FMD are reversed towards baseline (Chapter 5). This rapid decline advocates the 
continuation of FES training to (partially) preserve the benefits of FES training. We 
hypothesize that a relatively low intensity of training is sufficient to maintain some of 
the exercise-induced adaptations. However, the ideal level FES exercise to preserve 
the acute adaptations in arterial function is unknown at this moment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Correlation between the relative change in blood flow of the infused leg during ET-
blockade and baseline plasma levels of ET-1. 
 
 
 
ET-1 plasma levels 
Previous studies found increased plasma ET-1 levels in SCI (46) and in older subjects 
(36) and and suggested that these changes in ET-1 plasma levels reflect vascular 
adaptations. In this thesis controls, SCI and older men demonstrated similar ET-1 
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plasma levels, while SCI as well as older men report an increased contribution of ET-
1 to leg vascular tone (Chapter 6 and 8). Therefore, one may question whether ET-1 
plasma levels are suitable to examine the role of the ET pathway to regulate vascular 
tone. Interestingly, after reanalysis of our data we found no correlation between ET-1 
plasma levels and the contribution of ET-1 to leg vascular tone (r2=0.001, P=0.82) 
(figure 3) or between ET-1 plasma levels and leg baseline vascular tone (r2=0.01, 
P=0.52). However, an inverse relationship is present between the ET-1-mediated 
increase in blood flow and baseline leg blood flow (r2=0.12, P=0.03). This suggests 
that a low baseline leg blood flow correlates with an increased contribution of ET-1 
to regulate vascular tone, but not with ET-1 plasma levels. Therefore, we question the 
relevance of ET-1 plasma levels to examine the vascular effects of ET-1 and advocate 
the use of local infusion of ET-receptor blockers to assess the role of ET-1. 
 
 
Conceptual framework 
The ET pathway, the sympathetic nervous system and the NO pathway contribute to 
the regulation of vascular tone. In addition to direct vascular effect, these pathways 
are likely to interact. In this conceptual framework, the direct and indirect actions of 
these 3 pathways are summarized. This may help to understand the physiological 
mechanisms that underlie the (changes in) regulation of vascular tone during aging, 
deconditioning and exercise training. We acknowledge that a variety of other 
mechanisms may contribute to the vascular homeostasis. For example, evidence is 
available for a crosstalk between angiotensin II and the sympathetic nervous system, 
but also between angiotensin II and ET-1 (56).  
 
Deconditioning. In this thesis we demonstrate the profound effect of deconditioning 
on the ET pathway, leading to an increased ET-1-mediated vascular tone (Chapter 6). 
In addition to its direct vasoconstrictor effect, ET-1 may also have indirect effects to 
regulate vascular tone (figure 4). As discussed in Chapter 1, NO and ET-1 have a 
reciprocal effect on vascular tone. Based on this reciprocal regulation, NO could be 
involved in the detrimental vascular changes during deconditioning. However, the 
effects of deconditioning on the NO pathway are controversial. While a diminished 
release of endothelial NO is reported after bed rest (29), Bleeker et al. (4) recently 
demonstrated a preserved contribution of NO to baseline vascular tone in extreme 
long-term deconditioning (spinal cord injury) as well as moderate short-term 
inactivity (unilateral lower limb suspension). Also animal hindlimb unloading studies 
show conflicting results, demonstrating a preserved (54) or decreased expression of 
endothelial NO synthase (25, 51, 54). Nevertheless, deconditioning leads to a 
change in the balance between ET-1 and NO, with predominance for ET-1. In 
addition to the direct vasoconstrictor effect, the ET pathway may also have an 
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indirect vascular effect via the NO pathway. Synthesis of NO through the endothelial 
ETB-receptor represents a feedback mechanism to limit the vasoconstrictive effects of 
ET-1 (figure 4). Although speculative, the net result of deconditioning on the ET/NO 
pathways could be an increased constriction to ET-1, but maintained dilation to NO.  
Previous studies that examined the effects of bed rest in humans demonstrated a 
preserved α-adrenergic vascular responsiveness after short-term (30) and long-term 
(33) deconditioning in humans. However, a large body of evidence indicates that 
prolonged bed rest or space flights markedly increase baseline sympathetic nerve 
activity (15, 17, 28-30), but also plasma concentrations of norepinephrine are 
increased (15, 17). These findings suggest that the sympathetic nervous system 
contributes to the increased vascular tone during deconditioning. Given the ability of 
the ET pathway to potentiate norepinephrine(NE)-induced effects (see Chapter 1), an 
interaction between ET-1 and sympathetic nervous system could contribute to the 
vascular changes during deconditioning in healthy subjects.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. A schematic representation of 3 important clinical conditions with the putative 
pathways that may contribute to the changes in vascular tone. The black lines indicate direct 
pathways that underlie the changes in vascular tone. The grey arrows indicate hypothetical 
interactions between pathways that indirectly affect vascular tone. 
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Aging. In addition to the effects of ET-1, also the sympathetic nervous system 
contributes to the age-related increase in leg vascular tone. Advanced age is known 
to result in an increase in basal leg muscle sympathetic nerve activity (13), but also 
with an elevated α-adrenergic sympathetic vasoconstriction (14). In addition to these 
direct vasoactive effects of ET-1 and the sympathetic nervous system, the ability of 
ET-1 to potentiate norepinephrine(NE)-induced effects on vascular smooth muscle 
cells (18, 22, 32, 55) may further contribute to the increased vascular tone in older 
men. Stimulation of the ET pathway leads to an increase in vascular tone, but also 
triggers the sympathetic system (and vice versa) (figure 4). This interaction between 
ET-1 and the sympathetic nervous system may have important consequences for the 
vascular changes in older humans.  
In this thesis we found a decreased superficial femoral artery flow-mediated dilation 
in older men (Chapter 3), suggesting a downregulation of the NO pathway. In 
parallel, a decreased NO bioavailability in the resistance arteries of the forearm of 
healthy older men is present (1, 12, 53). Whether a decreased NO bioavailability is 
also present in the leg resistance arteries is not yet examined. Based on the 
antagonistic interplay between ET-1 and NO, a decreased NO-availability in leg 
resistance arteries is in agreement with the increased ET-1-mediated vasoconstriction 
(figure 4). While ET-1 inhibits the production of NO, also the sympathetic nervous 
system and NO seem to have an antagonistic regulation (49). For example, it is 
demonstrated in animals (48) and humans (43) that NO leads to a reduction of basal 
sympathetic vasoconstrictor tone. Given the inhibitory actions of ET-1 (see Chapter 1) 
and the sympathetic nervous system on the vasodilatory capacity of NO, one may 
hypothesize that aging (at least indirectly) inhibits the actions of the NO pathway 
(figure 4). 
 
Physical activity. In this thesis, we demonstrated the restorative capacity of exercise 
training in deconditioning (Chapter 6) and aging (Chapter 8) on the increased 
contribution of ET-1 to leg vascular tone. The exercise-induced decrease in vascular 
tone may be regulated through a direct vasoactive effect of ET-1, but also via indirect 
actions (NO and sympathetic nervous system). We are not aware of any studies that 
examined the physiological mechanism of the effects of exercise training in 
deconditioning. To date, studies in older men only examined the effect of exercise on 
the endothelium dependent dilation of the forearm vascular bed and demonstrated 
an enhanced NO bioavailability (12, 53). Since differences are present between the 
upper and lower limb regarding the regulation of vascular tone (41, 42, 44), one may 
question whether these changes are also present in the legs. Future studies are 
necessary to elucidate the mechanism of the vascular changes in older men (and the 
interactions between ET-1, the sympathetic nervous system, and NO pathway within 
this process). 
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Implications of the studies and future directions 
Deconditioning and advanced age are two important cardiovascular risk factors that 
contribute to functional and structural vascular changes. The underlying 
physiological mechanism for the distinct vascular changes to deconditioning and 
aging represents an interesting and relatively new field. Given the rapidly increasing 
numbers of older humans and physically inactive subjects, insight into these 
physiological mechanisms is of special interest. An important finding in this thesis is 
that ET-1, the most powerful vasoconstrictor in the human body, is a key mediator of 
the increased leg vascular tone during deconditioning, but also with advanced age. 
Interestingly, physical training of the older men partly restores the increased 
contribution of ET-1 to vascular tone. This finding can be of interest in the prevention 
of the adverse vascular changes during advanced age and deconditioning, but still 
several aspects are not known. 
To further elucidate the underlying physiological mechanism behind the distinct 
vascular changes to deconditioning and aging, the individual contribution of the ETA- 
and ETB-receptors and the nature of this change (change in sensitivity to ET-1 or 
density of the receptors) will provide important new information. In addition, insight 
into the time course of the adaptations in the ET-pathway in physical (in)activity and 
identification of the physical stimuli for the exercise-induced changes of the ET-
pathway will contribute to a better understanding of the exercise-induced effects. 
Furthermore, current advances in the field of genetics (micro-array technology) yield 
the ability to further explore the underlying mechanisms of the ET-1-mediated 
adaptations to deconditioning and aging. This knowledge will eventually help to 
optimize training modalities and strategies to improve the cardiovascular function. 
The ET-pathway has been suggested to play an important role in the pathogensis and 
progression of several cardiovascular diseases: pulmonary hypertension, heart failure, 
artherosclerosis, and essential hypertension. However, pharmacological treatment 
opposing the effects of the ET-pathway seem to result is some problems, such as liver 
toxicity (prolonged use) or a lack of efficiency (i.e. in heart failure). Exercise training 
could be a safe and effective alternative physiological strategy to reverse the 
detrimental vascular effects that are caused via the ET-pathway, and thereby retard 
disease progession or improve functional outcome measures. In addition, this will 
provide interesting information about the role of deconditioning to cause the ET-1-
mediated changes in cardiovascular disease. 
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The vascular endothelium plays a key role in the regulation of vascular tone and 
structure by the production of several endothelium-derived vasodilators and 
vasoconstrictors. Under normal physiological conditions a balance between these 
vasoactive compounds is present. As a consequence, small changes in this critical 
equilibrium may have important effects on vascular tone. For example, 
deconditioning of skeletal muscles is characterized by a marked elevation of vascular 
tone. Endothelin-1 is the most powerful vasoconstrictor in the human body and may 
contribute to these changes in vascular tone during deconditioning. Therefore, the 
main focus of this thesis concerns the contribution of the ET-pathway to leg vascular 
tone in deconditioning and the potential reversibility of this contribution after 
exercise training. In addition, advancing age is often accompanied with 
deconditioning and is also associated with an increase in vascular tone that in part 
may be caused by changes in the ET-pathway. As such, also the role of the ET-
pathway in the regulation of leg vascular tone was examined in older men before 
and after training. 
 
In Chapter 1 the role of ET-1 in the regulation of vascular tone in the human body is 
discussed. In addition, the main sites of action of ET-1 and its effects in several tissues 
are discussed. Furthermore, a review of the current knowledge on the physiological 
actions of the ET-pathway in the regulation of cardiovascular adaptations during 
physical (in)activity in health and disease is presented. The end of the chapter deals 
with the purposes and hypotheses of the studies presented in this thesis and the 
applied research methods. 
 
In Chapter 2 short-term (hours) and medium-term (week) reproducibility of forearm, 
calf and thigh blood flow measurement with venous occlusion plethysmography was 
determined for baseline and reactive hyperemic blood flow. Reproducibility was 
assessed by the coefficient of variation. Forearm, calf and thigh baseline and post-
ischemic hyperemic blood flow measured by plethysmography had an acceptable to 
good short- and medium-term reproducibility. Forearm and calf baseline blood flow 
short- and medium-term reproducibility were acceptable and thigh baseline blood 
flow had a good short- and medium-term reproducibility. Thus, plethysmography is a 
suitable tool to assess changes in baseline and reactive hyperemic blood flow in the 
legs and arms in response to deconditioning interventions. 
 
In Chapter 3 we examined whether acute changes in the sympathetic nervous 
system (sympathetic stimulation or attenuation of the sympathetic responsiveness) 
can alter the flow-mediated dilation (FMD) of the superficial femoral artery in healthy 
young and healthy older men. In young men, neither sympathetic stimulation nor 
attenuation of the sympathetic responsiveness changed the FMD-response of the 
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superficial femoral artery. In older men, who are characterized by a chronically 
elevated sympathetic nerve activity, a low FMD-response of the superficial femoral 
artery is present. Interestingly, attenuation of the sympathetic responsiveness partly 
restores the FMD-response in these subjects. In conclusion, these data suggest that 
the lower FMD of the superficial femoral artery in older men can, at least in part, be 
explained by an elevated sympathetic nerve activity. 
 
Previous studies that examined vascular adaptations in active and non-exercised 
areas, used whole body exercise training and show conflicting results. In Chapter 4 
we could demonstrate that 4 weeks of functional electro-stimulation (FES)-cycling in 
spinal cord-injured individuals leads to vascular adaptations in the stimulated active 
areas (thigh). However, no vascular changes are found in the adjacent non-
stimulated areas (calf), which is probably the result of a lack of activity of the calf 
muscles. This finding demonstrates that vascular adaptations to exercise training 
seem to be a truly local phenomenon and are limited to the active areas only.  
 
The only method to effectively exercise the paralyzed legs of SCI individuals is 
functional electro-stimulation (FES). Although the method effectively improves 
muscular and vascular function, it is not clear whether the benefits are proportional 
to the time and effort the patients must invest in FES training. Chapter 5 deals with 
the time course of the vascular adaptations to training and detraining in SCI 
individuals. According to our hypothesis, rapid vascular adaptations in the exercise 
area are present within 2 weeks (4 sessions) after onset of exercise training. 
Interestingly, these vascular adaptations found after 2 weeks are in line with 
adaptations reported in previous studies that used longer and more intensive training 
periods. After cessation of the FES training, vascular characteristics are rapidly 
reversed towards pre-training values within only 1 week. Therefore, the vascular 
adaptations to training or detraining have a different time course, suggesting that 
detraining is not simply the reverse process of training. 
 
In Chapter 6 the contribution of ET-1 to baseline leg vascular tone in able-bodied 
controls and in SCI individuals, representing a model of nature of deconditioning, is 
studied. According to our hypothesis, we found that endogenous ET-1 minimally 
contributes to baseline vascular tone in the legs of healthy able-bodied control 
subjects, while in SCI individuals ET-1 has a prominent role in the regulation of 
vascular tone in the deconditioned legs. In addition, animal studies suggested that 
the increased vascular tone in situations of physical inactivity are linked to the ET-
pathway. As such, the second purpose of this study was to examine whether the 
contribution of ET-1 to vascular tone in SCI individuals can be altered by physical 
activity. Interestingly, exercise training in SCI individuals reverses the ET-1-pathway, 
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which normalizes basal leg vascular tone. In conclusion, extensive long-term 
inactivity in humans results in a significant, though reversible, ET-1-mediated 
vasoconstrictor state in the skeletal muscle vascular bed.  
 
Because the age-related changes in the large conduit arteries are associated with 
cardiovascular pathology, prevention is of paramount importance. In Chapter 7 we 
examined the effect of an 8 weeks endurance training (a non-pharmacological 
treatment) on structural and functional vascular function in a group of healthy older 
sedentary men. After training, functional and structural characteristics of the lower 
extremity vasculature were improved, while we were unable to demonstrate vascular 
adaptations in the less active areas, such as the forearm vascular bed and the carotid 
artery. In conclusion, cycling training in sedentary older men improves vascular 
function, which may explain the clinical benefit of exercise on cardiovascular risk. 
  
Advanced age is associated with an increase in vascular tone. This age-related 
change in blood flow is in part mediated by a chronically elevated sympathetic α-
adrenergic vasoconstriction. Chapter 8 focuses on the contribution of ET-1 to leg 
vascular tone in healthy older men. According to our hypothesis, we could 
demonstrate that the normal aging process leads to an increase in the contribution of 
ET-1 to leg vascular tone. This suggests that ET-1 plays a causal role in the age-
related increase in leg vascular tone. In addition, older age is also associated with a 
decreased physical fitness. Based on our findings from Chapter 6, we examined 
whether 8 week endurance training in sedentary older men can reverse the increased 
contribution of ET-1 to leg vascular tone. Indeed, the increase in leg vascular tone 
after training in older men is partially mediated through a diminished contribution of 
ET-1.  
 
Hematopoietic stem cells (HSC) and endothelial progenitor cells (EPC) are able to 
improve vascular function and induce vascular repair and angiogenesis. Since 
physical inactivity and aging are associated with changes in vascular function, these 
factors may influence the numbers of HSCs and EPCs. Therefore, in Chapter 9 we 
examined the number of baseline and exercise-induced numbers of circulating HSCs 
and EPCs stem cells in sedentary and trained young and older men. To assess the 
influence of aging on these stem cells, a population of young and older sedentary 
men was examined. We were able to demonstrate that advancing age results in 
lower circulating numbers of HSCs and EPCs and attenuates the exercise-induced 
increase in HSCs. In addition, to study the effect of physical activity, inactive and 
trained young men were compared. Moreover, the sedentary older men were trained 
for 8 weeks. In contrast to our hypothesis, in young as well as in older men, 
endurance training does not affect baseline and exercise-induced numbers of HSCs 
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and EPCs. Thus, our results suggest an age-related decrease in baseline and exercise-
induced levels of HSCs and EPCs, which is not influenced by a change in training 
status. 
 
In Chapter 10 the current knowledge on the ET pathway and physical (in)activity in 
humans was reviewed and discussed from previous studies and available data from 
this thesis. In addition, we speculated about a conceptual framework that may help 
to understand vascular changes to physical inactivity and aging. In this framework, 
we discussed the interactions between 3 important pathways that regulate vascular 
tone and structure; the ET-1-pathway, the sympathetic nervous system, and the NO-
pathway. In addition to the direct vasoactive effects, these pathways seem to have an 
antagonistic or agonistic interaction.  
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De binnenbekleding van de bloedvaten wordt in de vakliteratuur het vasculaire 
endotheel genoemd. Dit endotheel speelt een belangrijke rol in de regulatie van de 
bloedstroom en van de vaatwandstructuur middels de productie van diverse 
vaatverwijdende en vaatvernauwende stoffen. Onder normale fysiologische 
omstandigheden is er een balans tussen deze  vaatverwijdende en –vernauwende 
stoffen. Echter, een subtiele verandering in dit kritieke evenwicht kan belangrijke 
gevolgen hebben voor de bloedstroom. Fysieke inactiviteit gaat bijvoorbeeld samen 
met een afgenomen bloedstroom. Endotheline-1 is een van deze endotheliale 
vaatvernauwende stoffen, en lijkt zelfs een van de meest krachtige vaatvernauwende 
stoffen uit het menselijk lichaam. Endotheline-1 draagt mogelijk bij aan de 
verminderde bloedstroom tijdens fysieke inactiviteit. In dit proefschrift wordt de 
bijdrage van endotheline-1 aan de verminderde bloedstroom bij fysieke inactiviteit 
bestudeerd, maar ook de mogelijkheid om dit proces om te keren met fysieke 
training. Ook het natuurlijk verouderingsproces gaat gepaard met een verminderde 
bloedstroom, die mogelijk ook door endotheline-1 verklaard kan worden. Daarom is 
de bijdrage van endotheline-1 aan de bloedstroom ook onderzocht bij ouderen, 
zowel voor als na een periode van training. Om beter inzicht te verkrijgen in het 
fysiologische mechanisme van fysieke activiteit (training), zijn de lokalisatie en het 
tijdspad van de vaataanpassingen na training onderzocht. 
 
In Hoofdstuk 1 worden de diverse fysiologische eigenschappen van endotheline-1 
uiteen gezet. Tevens worden de belangrijkste organen waar endotheline-1 een effect 
op heeft bediscussieerd. Er is een overzicht gegeven van de huidige kennis over de 
rol van het endotheline-systeem op aanpassingen van hart- en bloedvaten tijdens 
(in)activiteit. Aan het einde van dit hoofdstuk worden de doelen en de hypothesen 
van de studies in dit proefschrift en de gebruikte onderzoeksmethoden besproken. 
 
In Hoofdstuk 2 beschrijven we experimenten waarbij de reproduceerbaarheid op 
korte (uren) en middellange termijn (week) van de basale en de hyperemische 
bloedstroom in de onderarm, het boven- en onderbeen middels veneuze occlusie 
plethysmografie werd gemeten. De reproduceerbaarheid werd weergegeven als 
variatiecoëfficiënt. De reproduceerbaarheid op korte en middellange termijn van de 
meting met plethysmografie van basale en hyperemische bloedstroom in de 
onderarm en in het bovenbeen en onderbeen is acceptabel tot goed. De 
reproduceerbaarheid van de meting van de bloedstroom in de onderarm en in het 
onderbeen is acceptabel, terwijl de reproduceerbaarheid van de meting van de 
bloedstroom in het bovenbeen goed is. Hieruit volgt dat veneuze occlusie 
plethysmografie een goede meetmethode is om de veranderingen in basale en 
hyperemische bloedstroom in armen en benen onder invloed van lichamelijke 
(in)activiteit te bepalen. 
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In Hoofdstuk 3 onderzoeken we of acute veranderingen in de activiteit van het 
sympathisch zenuwstelsel (toename of afname van de sympathische respons een 
invloed heeft op de flow-gemedieerde dilatatie (FMD) van de oppervlakkige 
beenslagader bij gezonde jonge en oude mannen. Acute verandering van de 
sympathische respons bij jonge mannen zorgt niet voor een verandering van de 
FMD. Oudere mannen (65 jaar of ouder) hebben een chronisch toegenomen 
activiteit van het sympathisch zenuwstelsel en tevens een verminderde FMD-respons 
in de oppervlakkige beenslagader. Afname van de sympathische respons bij de groep 
oudere mannen zorgt voor een toename van de FMD-respons. Dit suggereert dat de 
verminderde FMD-respons in de oppervlakkige liesslagader bij oudere mannen 
gedeeltelijk wordt verklaard door de chronisch toegenomen activiteit  van het 
sympathische zenuwstelsel.  
 
Studies die het effect van fysieke training onderzoeken in actieve en niet-actieve 
delen van het lichaam, laten tegenstrijdige resultaten zien. In Hoofdstuk 4 
onderzoeken we een groep personen met een dwarslaesie die gedurende 4 weken 
getraind hebben met functionele elektrische stimulatie op een fiets. Middels 
elektrische stimulatie ontstaan spiercontracties, waardoor de verlamde benen 
getraind worden. Deze training zorgt voor vaataanpassingen in de gestimuleerde 
delen van het lichaam (bovenbeen), terwijl we geen aanpassingen in de naastgelegen 
niet-gestimuleerde delen (kuit) vinden. Deze bevinding wijst erop dat 
vaataanpassingen door fysieke training een lokaal proces is, dat zich beperkt tot de 
actieve delen tijdens de training. 
 
De enige effectieve manier om de verlamde benen van personen met een 
dwarslaesie te trainen is functionele elektrostimulatie. Hoewel deze methode de 
spier- en vaatfunctie verbetert, is slechts weinig bekend over de ideale frequentie en 
duur van de stimulatie. Hoofdstuk 5 bestudeert het tijdspad van de 
vaataanpassingen tijdens training en tijdens de periode na stoppen van de training bij 
mensen met een dwarslaesie. Wij hebben aangetoond dat vaataanpassingen reeds 
binnen 2 weken (4 trainingssessies) aanwezig zijn. De aanpassingen die wij vinden 
na 2 weken zijn vergelijkbaar met studies die een langere of intensievere 
trainingsperiode hebben toegepast. Na afloop van de 6 weken training, waren de 
vaataanpassingen binnen één week verdwenen. De vaataanpassingen door training 
en de periode direct na training hebben dus een ander tijdspad. Dit suggereert dat de 
vaataanpassingen door training niet zondermeer het omgekeerde proces is van 
training. 
 
In Hoofdstuk 6 wordt de bijdrage van endotheline-1 aan de basale vaattonus 
onderzocht bij gezonde controlepersonen en mensen met een dwarslaesie (deze 
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laatste groep kan worden gezien als een model voor inactiviteit). We tonen aan dat 
endotheline-1 een kleine bijdrage levert aan de basale vaattonus in de benen van 
gezonde controlepersonen. Bij mensen met een dwarslaesie, daarentegen, vervult 
endotheline-1 een prominente rol in de regulatie van de vaattonus in de benen. In 
het tweede doel van het onderzoek bestuderen we of de verhoogde bijdrage van 
endotheline-1 aan de vaattonus in de benen van mensen met een dwarslaesie kan 
worden beïnvloed door fysieke activiteit. Wij laten zien dat fysieke training (6 
weken) in de benen van mensen met een dwarslaesie zorgt voor een vermindering 
van de bijdrage van endotheline-1 aan de vaattonus. Hierdoor normaliseert de 
vaattonus in de verlamde benen van de mensen met een dwarslaesie. De conclusie 
van dit hoofdstuk is dat fysieke inactiviteit resulteert in een significante, maar 
omkeerbare, endotheline-1-afhankelijke verhoging van de vaattonus. 
 
Veroudering gaat gepaard met veranderingen in de grote geleidingsvaten van het 
lichaam, die geassocieerd zijn met hart- en vaatziekten. Preventie van deze 
veranderingen is daarom van groot belang. In Hoofdstuk 7 beschrijven we het effect 
van een 8-weken durende fietstraining (niet-farmacologische behandeling) op de 
vaatfunctie bij een groep inactieve oude mannen. Na de training vinden we een 
verbeterde vaatfunctie in de benen, terwijl de minder actieve delen van het lichaam 
tijdens deze training (armen en halsslagader) geen verandering lieten zien. 
Concluderend blijkt dat fietstraining bij inactieve oudere mannen zorgt voor een 
verbetering van de vaateigenschappen. Deze verbetering draagt mogelijk bij aan het 
positieve effect van training op het risico van hart- en vaatziekten. 
 
Het ouder worden gaat gepaard met een toename van de vaattonus. Deze 
leeftijdsafhankelijke verandering wordt deels veroorzaakt door vaatvernauwing op 
basis van een chronisch verhoogde sympathische activiteit. Hoofdstuk 8 richt zich 
op de bijdrage van ET-1 aan de vaattonus in de benen van gezonde oudere mannen 
(67 jaar en ouder). Op basis van onze gegevens blijkt dat het normale 
verouderingsproces zorgt voor een toegenomen bijdrage van endotheline-1 aan de 
vaattonus. Dit suggereert dat endotheline-1 een sleutelrol speelt in de 
leeftijdsafhankelijke toename van de vaattonus. Omdat veroudering tevens 
geassocieerd is met fysieke inactiviteit, hebben we het effect van een 8 weken 
durende fietstraining op de bijdrage van endotheline-1 aan de vaatweerstand bij 
oude inactieve mannen onderzocht. Uit deze resultaten blijkt dat door training de 
vaattonus afneemt. Deze afname wordt deels veroorzaakt door een verminderde 
bijdrage van endotheline-1. 
 
Hematopoietische stamcellen (HSC) en endotheel progenitor cellen (EPC) zorgen 
voor een verbetering van de vaatfunctie, herstel van de vaatwand en het reguleren 
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van aangroei van nieuwe vaten. Fysieke inactiviteit en veroudering zijn geassocieerd 
met een verminderde vaatfunctie, die mogelijk invloed heeft op de aantallen HSC’s 
en EPC’s. In Hoofdstuk 9 worden de basale en inspanninggeïnduceerde aantallen 
HSC’s en EPC’s beschreven bij jonge en oudere mannen. Het blijkt dat een 
toegenomen leeftijd resulteert in een lager circulerend niveau van HSC’s en EPC’s en 
een lagere inspanninggeïnduceerde toename van HSC’s. Om het effect van training 
te bekijken, hebben we de responsen bij actieve (meer dan 8 uur sport per week) en 
inactieve jonge mannen onderzocht. Daarnaast hebben de oudere mannen 8 weken 
getraind. In tegenstelling tot onze verwachting, geeft duurtraining (bij jonge alsmede 
oude mannen) geen verandering van de basale en inspanninggeïnduceerde aantallen 
van HSC’s en EPC’s. Onze resultaten suggereren een leeftijdsafhankelijke afname van 
de basale en inspanninggeïnduceerde aantallen van HSC’s en EPC’s, welke niet 
omkeerbaar is door een verandering van de training status. 
 
Hoofdstuk 10 bevat een algemene discussie over de resultaten uit dit proefschrift en 
hun relatie tot de resultaten van eerdere studies. 
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Hoewel je tijdens het promoveren soms in je eentje oneindig lang naar een 
computerscherm zit te staren, is wetenschappelijk onderzoek toch echt “teamwork”. 
Ik wil daarom graag een aantal mensen die mij de afgelopen jaren geholpen, 
gestimuleerd en ondersteund hebben persoonlijk bedanken. De afgelopen jaren heb 
ik met zeer veel mensen prettig samengewerkt, dus mocht ik uitgerekend jou 
hieronder niet persoonlijk vermelden, zie dit dan als een persoonlijk bedankje.  
Allereerst gaat mijn dank uit naar alle proefpersonen die hebben deelgenomen aan 
de verschillende studies. Zonder jullie was dit onderzoek onmogelijk geweest. Met 
name de personen die meegedaan hebben aan de intensieve trainingsstudies ben ik 
zeer dankbaar. Vroeg opstaan, lange reizen, geen koffie of ontbijt voor de metingen, 
pittige trainingen, hand in ijswater, vingerprikje hier en een dikke naald daar, het 
afbinden van armen en benen en dan weer een maximale inspanningstest. Ondanks 
dit alles hebben jullie jezelf altijd volledig ingezet voor het onderzoek. 
 
Beste Maria, jij was de drijvende kracht achter het onderzoek, waar ik altijd op kon 
terugvallen. Ik bewonder jouw enthousiasme, positivisme, vindingrijkheid en inzicht; 
eigenschappen die maken dat samenwerken erg prettig is. Ik wil je graag bedanken 
voor het vertrouwen dat je in mij stelde aan het begin van het onderzoek, maar nog 
meer voor het vertrouwen dat ik van je kreeg tijdens je verlof. Hartelijk dank voor de 
prettige samenwerking, die hopelijk een lang en succesvol vervolg krijgt. 
Beste Paul, ondanks je overvolle agenda, had je altijd tijd wanneer ik (volgens 
afspraak of op ongelegen momenten) langs kwam met vragen of opmerkingen. Je 
interpretatie van data, het vinden van nieuwe invalshoeken en hulp tijdens het 
schrijven waren zeer leerzaam. Bedankt voor je warme en persoonlijke begeleiding.  
Beste Gerard, jouw bijdrage bij de praktische uitvoering, de data-interpretatie en het 
schrijven van de ‘ET’-artikelen was zeer waardevol. Ik heb veel geleerd van jouw 
kennis over de farmacologie en je inzicht in het structureren van stukken tekst. 
 
De afgelopen jaren heb ik met een leuke groep onderzoekers mogen samenwerken 
op de afdeling Fysiologie. Het is prettig samenwerken met collega’s waar je altijd op 
kunt rekenen; tijdens het uitvoeren van onderzoek (hulp of als proefpersoon), het 
analyseren van data, maar ook voor de nodige afleiding, het uiten van frustraties en 
gezelligheid. Miriam, hartelijk dank voor alle keren dat ik je mocht storen voor 
praktische en theoretische hulp en adviezen. Michiel, ondanks dat we in vrijwel al 
onze opvattingen lijnrecht tegenover elkaar staan, was onze samenwerking zeer 
prettig en heb ik veel van je geleerd. Patricia, ik heb vaak gebruik gemaakt van je 
echovaardigheden, maar ook van je gezelligheid bij een biertje. Erg jammer dat je de 
wetenschap verlaat. Jan, ik ben je dankbaar voor je kritische kijk op en inzicht in 
dataweergave. Noortje, het is prettig samenwerken met iemand die altijd fluitend 
over de gang loopt en erg geïnteresseerd is in onderzoek. 
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Beste René, ik bewonder je enorme inzet voor de wetenschap. Hartelijk dank voor 
jouw snelle reacties en je nuttige adviezen en hulp wanneer dat nodig was. Beste Jos, 
je enthousiaste en oprechte betrokkenheid zorgen voor een prettige samenwerking. 
Hartelijk dank dat je altijd klaarstond met een helpende hand tijdens de 
experimenten, analyses en trainingen. Ook andere personen op de afdeling 
Fysiologie (Piet, Louis, Annelies, Heleen, Fleur, en Jan M.) wil ik graag bedanken 
voor de samenwerking en alles wat ik van jullie heb geleerd. 
 
Beste Peter en Arie, jullie bewijzen dat het inbrengen van een arteriële lijn een kunst 
op zich is! Hartelijk dank voor jullie geweldige ‘prikkwaliteiten’, deskundigheid, 
flexibele inzet en adviezen bij het schrijven van de ‘ET’-artikelen.  
 
Beste Petra, heel erg knap hoe je de trainingsstudie uit hoofdstuk 4 tot een succesvol 
einde hebt gebracht. Hartelijk dank voor de fijne samenwerking. Beste Jacques, ik 
vond het erg leuk dat onze samenwerking tijdens mijn afstuderen een vervolg heeft 
gekregen tijdens mijn promoveren. Berbke van Ginneken, Dirk van Kuppevelt en Rik 
Berkelmans bedankt voor de samenwerking. 
 
Het onderzoek met de stamcellen uit hoofdstuk 9 was niet mogelijk geweest zonder 
de inzet en deskundigheid van de afdeling Nierziekten van het Leiden UMC. Hetty 
en Anton Jan, ik ben jullie enorm dankbaar voor jullie vertrouwen (in mij en het 
onderzoek) en kritische adviezen tijdens het schrijfproces. Joost en Caroline, hartelijk 
dank dat jullie altijd weer klaar stonden wanneer wij de buisjes bloed brachten. Fred 
Sweep en Anneke Geurts-Moespot (Chemische Endocrinologie, UMC St Radboud), 
hartelijk dank voor de VEGF-bepalingen en de hulp voor het ‘stamcel’-artikel.  
 
Na een jaar vergeefse pogingen om endotheline te meten in plasma, hebben we 
contact gehad met Dr. Frans Boomsma (Erasmus MC). Hartelijk dank voor je 
deskundige en nauwkeurige plasmabepalingen van endotheline. 
 
Afdeling statistiek (George Borm, Oscar Lemmers, Huub Straatman) heb ik de 
afgelopen jaren verschillende keren mogen lastig vallen. Ik heb veel van jullie 
geleerd over diverse aspecten van de statistiek. 
 
De wekelijkse AGIKO-besprekingen waren een goede mogelijkheid om data voor te 
leggen aan een zeer kritische, maar stimulerende groep onderzoekers. Gezien de 
grootte van de groep en de snelle wisseling van samenstelling is het moeilijk om 
iedereen persoonlijk te bedanken. Een aantal wil ik toch even noemen. Bas, Niels en 
Alexander, jullie hebben mij diverse keren geholpen wanneer er medische 
handelingen moesten worden uitgevoerd tijdens de screening of tijdens metingen.  
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De afgelopen jaren zijn er diverse studenten geweest waarmee ik heb samengewerkt. 
Zonder anderen tekort te doen, wil ik een paar studenten noemen die een 
belangrijke bijdrage geleverd hebben aan dit proefschrift. Reinier en Linda van V., 
jullie waren de eerste studenten die ik onder mijn hoede kreeg. Jullie hebben een 
zeer belangrijke rol vervuld bij het opzetten en het uitvoeren van de training bij de 
personen met een dwarslaesie. Marcia en Thijs, jullie hebben hoofdstuk 3 
uiteindelijk over de eindstreep getrokken. Jullie vormen een merkwaardig, maar leuk 
en efficiënt duo waar ik prettig mee heb samengewerkt. Rebecca, tijdens jouw stage 
heb je mij veel werk uit handen genomen door de trainingen van de ouderen te 
begeleiden en metingen over te nemen. 
 
Familie en vrienden, bedankt voor jullie steun en interesse (endothe-wattus?). 
Froukje, bedankt voor het doorlezen van de Nederlandse stukken. Willeke, hartelijk 
dank voor je hulp en adviezen voor de lay-out van het boekje. Wanneer je weet wat 
de gevolgen zijn van inactiviteit, behoor je eigenlijk veel te sporten. Helaas lukt dit 
niet altijd, maar gelukkig komt er op de dinsdagavond veel voetbalkwaliteit bij elkaar 
(om daarna vooral te presteren aan de bar). Joris, bedankt voor de leuke uurtjes 
squash op zondag (en de spierpijn op maandag). Martijn, Hans en Bart, bedankt voor 
alle keren ’links van de toren’, de diverse discussies en de bijbehorende biertjes. 
Ook wil ik graag mijn paranimfen bedanken. Frank en Bregina, erg fijn dat jullie mij 
terzijde willen staan. Beste Bregina, zonder jouw fantastische echovaardigheden was 
het grootste deel van dit proefschrift niet tot stand gekomen. Tijdens metingen, 
‘Fysiorunnen’ of andere activiteiten was de samenwerking altijd prettig en gezellig.  
Ook bedankt voor het prachtige ontwerp dat de voorkant van het proefschrift siert. 
Beste Frank, helaas zien we elkaar te weinig door de grote afstand. Vrienden hoef je 
niet altijd in de buurt te hebben; als ze er maar zijn als je ze nodig hebt. 
Mieke en Paul, bedankt voor jullie steun en dat we, ondanks onze uiteenlopende 
karakters, goed met elkaar overweg kunnen. Pap en mam, hartelijk dank voor de 
mogelijkheden die jullie mij geboden hebben om mijn eigen weg te gaan. Zonder 
jullie hulp was dit boekje er nooit gekomen. 
 
Het beste heb ik voor het laatst bewaard. Lieve Susanne, meer dan jij denkt heb je 
bijgedragen aan dit boekje. Frustraties over het onderzoek zijn snel verdwenen als ik 
bij jou ben. Samen zijn en lachen om domme grappen die alleen wij begrijpen is het 
mooiste wat er is. Hartelijk dank dat je er voor me bent! 
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Curriculum Vitae 
 
Dick Thijssen werd op 21 maart 1979 geboren te Boxmeer en groeide op in het nabij 
gelegen Sambeek. In juni 1996 behaalde hij zijn diploma aan het Elzendaalcollege 
te Boxmeer, waarna hij begon met de studie Fysiotherapie aan de Hogeschool 
Arnhem-Nijmegen. Deze opleiding werd in 2000 afgerond. Van augustus 2000 tot 
december 2004 is hij parttime werkzaam geweest als fysiotherapeut in een 
particuliere praktijk in Well (Lb). Inmiddels geïnteresseerd geraakt in het 
wetenschappelijk onderzoek, startte hij in september 2000 met de opleiding 
Biomedische Gezondheidswetenschappen aan de Radboud Universiteit Nijmegen. 
Deze opleiding werd in 2003 afgerond. Tijdens zijn afstudeerstage deed hij onder 
leiding van Prof. Dr. Jacques Duysens onderzoek naar balanscorrecties bij mensen 
met een multiprothese, welke bekroond werd met de facultaire scriptieprijs 2003.  
In april 2003 begon hij aan zijn promotieonderzoek op de afdeling Fysiologie van 
het UMC St Radboud, in samenwerking met de afdeling Farmacologie-Toxicologie. 
Onder begeleiding van Dr. Maria Hopman, Prof. Dr. Paul Smits en Dr. Gerard 
Rongen heeft hij gewerkt aan het in dit proefschrift beschreven onderzoek. In 2004 
mocht hij de Jonge Fysiologen prijs van de Nederlandse Vereniging voor Fysiologie 
in ontvangst nemen. Samen met Maria Hopman en Bregina Kersten heeft hij in 2005  
Fysiorun opgericht, een afsplitsing van de afdeling Fysiologie waarbinnen 
wetenschappelijk onderzoek wordt verricht in opdracht van bedrijven. Op dit 
moment is hij werkzaam op de afdeling Fysiologie van het UMC St Radboud te 
Nijmegen. 
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“If I lay here, if I just lay here 
Would you lie with me and just forget the world?” 
(Snow Patrol, Chasing Cars) 
